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Abstract 
 
Clostridium difficile infections (CDIs) have historically been associated with exposure to 
healthcare settings. In recent years, however, the incidence of community-acquired Clostridium 
difficile infections (CA-CDI), along with the number of patients requiring hospitalization for it, 
has been increasing. This research uses a framework grounded in Complex Adaptive Systems 
(CAS) to reveal new and different epidemiological findings on CA-CDI to indicate novel health 
equity leverage points. It explores the epidemiology and established risk factors associated with 
CA-CDI in the Niagara Region, Ontario, and compares them with those of healthcare-associated 
CDI (HA-CDI) in the same area.  
The first manuscript evaluates the literature on existing evidence of risk factors for CA-
CDI by applying The Joanna Briggs Institute (JBI) Reviewers’ Manual 2015, Methodology for 
JBI Scoping Reviews. The review identifies that CA-CDI is seen more often than HA-CDI in 
younger and female populations. Exposure to antimicrobials is common but not as common as in 
HA-CDI cases. The scoping review establishes the need for further epidemiological studies on 
CA-CDI. The second manuscript provides a nonparametric descriptive analysis, comparing CA-
CDI and HA-CDI cases in Niagara Health System (NHS) hospitals, based on a retrospective case 
series design. Hospitalized CA-CDI patients have a lower median age and less exposure to 
antimicrobials and other medications. Gender proportions are similarly distributed between the 
two groups. The emerging recommendation is that CA-CDI must be considered as a potential 
diagnosis in patients admitted to hospital with diarrhea, even in the absence of conventional CDI 
risk factors. The third and final manuscript evaluates the spatial and genotype features of CA-
CDI and HA-CDI. It finds that geographical clustering, temporal patterns, and genotypic features 
are unique in each category. These studies point to the need for a better understanding of 
 III 
transmission routes between communities and healthcare settings; further research is required to 
establish community CA-CDI risk factors.  
Together, these evaluations establish that we must develop a systems approach to explore 
health problems and respond effectively at a population level. The research and policy 
environment must be strengthened by modifying current practices, setting priorities, and 
providing funding for empirical studies and equitable health policies. 
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Chapter One – Introduction 
Specific Aims of the Study 
Recent studies in North America point to the rising occurrence of community-acquired 
Clostridium difficile infections (CA-CDI) (Khanna et al., 2012). Indeed, up to one third of 
hospitalized Clostridium difficile infection (CDI) cases now originate in the community (CDC, 
2008; Dumyati et al., 2012; Khanna et al., 2012; Levy et al., 2015; McLeod, 2017). Concern is 
growing that what used to be an exclusively healthcare-associated infection is now increasingly a 
cause of infectious diarrhea in the community (Khanna & Pardi, 2010; Khanna et al., 2012).  
HA-CDI cases are a major source of concern for hospitals and healthcare systems. 
Although many years of clinical and epidemiological studies have established the risk factors, 
clinical presentation, and treatment options, the growing incidence of this infection in 
communities (from 1/100,000 to 22 /100,000 population between 1994 and 2004 in the United 
States), presenting in individuals without the traditional risk factors, calls for more complete 
studies on the epidemiology of CA-CDI and the identification of transmission patterns that can 
inform focused preventive strategies in hospital and in communities. Knowledge about the 
epidemiological patterns of CA-CDI may also help postulate future research questions about 
novel and unknown reservoirs of this infection in communities.  
The aim of this dissertation was to gain insight into the epidemiology and the risk factors 
associated with CA-CDI in the Niagara Region from 2011 through 2013 and compare them with 
those of HA-CDI in the same area. The three specific research objectives and their corresponding 
research questions explored during the process of this dissertation are: 
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1. To document and collect the research on epidemiology of CA-CDI by conducting a 
scoping study. 
Research question 1: What is our current knowledge about the epidemiology of CA-CDI? 
2. To document the epidemiology of hospitalized CA-CDI in Niagara Health System’s 
(NHS) hospitals and for the Niagara Region. This involves the descriptive univariate 
analysis of the characteristics and epidemiology of CA-CDI and its comparison with HA-
CDI. 
Research question 2: Is the epidemiology (demographic, patient characteristics) of CA-
CDI in the Niagara region different from that of HA-CDI in NHS hospitals? 
Question 2 originates from the assumption that systems-level study of hospitalized CA-
CDI cases in the Niagara Region has a new narrative that may be different from that 
found by other studies and that certainly varies from the HA-CDI experience in the same 
region. 
3. To document the incidence, identify seasonal and temporal patterns, study the spatial 
distribution of CA-CDI cases, and examine the differences in strain variations of CA-CDI 
and HA-CDI in the Niagara Region. 
Research question 3: Are the temporal, spatial, and strain assortment patterns of CA-CDI 
different from those of HA-CDI? 
The postulations guiding this research and its three main questions are rooted in a population-
level exploration of the risk factors, patient characteristics, strains of pathogens, and the temporal 
and spatial epidemiology of CA-CDI. Figure 1.1 depicts the main objectives and identifies the 
gaps in current practice and knowledge. 
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Background and Significance 
Clostridium difficile as a pathogen.  
Clostridium difficile (C. difficile), a gram-positive, spore-forming anaerobic bacillus, is 
one of the most common enteropathogens isolated from stool cultures (Dumyati et al., 2012). 
Different strains of C. difficile are able to produce various toxins (A, B, and/or binary (CDT)). In 
recent years, the spread of a new and more virulent strain of CDI (027/BI/NAP1), presenting 
more serious complications and a higher mortality rate, has caught the attention of hospital 
epidemiologists throughout North America and around the world (He, 2013). C. difficile was first 
isolated from the stool cultures of asymptomatic (colonized) neonates (Barbut & Petit, 2001). In 
susceptible individuals, C. difficile can cause infection, with symptoms ranging from self-
limiting, mild diarrhea to severe diarrhea, with or without pseudomembrane formation, toxic 
megacolon, perforation, and peritonitis in susceptible hosts, especially the elderly (Poxton, 
Mcoubrey, & Blair, 2001). However, up to 15% of healthy adults can be asymptomatic carriers 
of the spores (Viscidi, Willey, & Bartlett, 1981). 
CDI cases have predominantly been attributed to antimicrobial exposure and the resulting 
imbalance in the normal flora in the colon due to the selection of organisms resistant to the 
antimicrobial agent. This may result in an increase of the colonization of C. difficile 
(asymptomatic cases that carry the pathogen in their gut flora), but one third of susceptible 
individuals will end up presenting the signs of infection listed above (Poxton et al., 2001; 
Wilcox, 2009). In addition to an imbalance of flora, direct or indirect acquisition of C. difficile 
has been attributed to ingestion or to environmental exposure to surfaces or devices 
contaminated with spores of the organism (Patterson, Johnson, & Schmulen, 1984). This can 
happen in healthcare settings due to insufficient hygiene practices throughout the processes of 
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care (Barbut & Petit, 2001). If spores of a toxigenic strain of C. difficile are ingested, they can 
survive exposure to gastric acid and cause colonization or infection—two outcomes that are 
based on host susceptibility (immune status or degree of comorbidities) or on the virulence of the 
C. difficile strain.  
C. difficile is a ubiquitous organism and has been isolated from soil and flood water, farm 
animals, and commercial poultry and meat (Keessen, Harmanus, Dohmen, Kuijper, & Lipman, 
2013; Lin, Wade, & Hilborn, 2015; Rodriguez et al., 2017; Rodriguez-Palacios, Staempfli, 
Duffield, & Weese, 2007; Weese, Reid-Smith, Avery, & Rousseau, 2010).  Therefore, exposure 
to C. difficile can be a threat for individuals who have contact with it in occupations other than 
those of health care, such as farming, agriculture or meat production. This characteristic of C. 
difficile, along with the increased incidence of CDI in communities, indicates the need for further 
exploration of factors contributing to the appearance of CA-CDI in the community. 
The burden of Clostridium difficile infections, diagnosis, and treatment. 
CDIs are the main source of healthcare-associated infectious diarrhea in developed 
countries (Collins, Hawkey, & Riley, 2013). In 2013, the Center for Disease Prevention and 
Control in the United States declared CDI an “immediate public health threat,” with over 
450,000 infections and an estimated 29,000 deaths annually attributed to all cases of this 
infection (CDC, 2013; Lessa et al., 2015). In Canada, the overall burden of CDI cases was 
estimated to have been more than 37,000 cases in 2012 (Levy et al., 2015).  
In addition to the overall increase of incidence, the mortality rate due to CDI has been 
increasing gradually, from 1.5% in 1997 to 5.4% in 2010 (PHAC, 2013). To place this in a 
financial context, the economic burden of all CDIs in the United States has been estimated at 
≥$496 USD million in hospital costs, ≥$547 USD million in third-party payer costs, and ≥$796 
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million in societal costs (McGlone et al., 2012). However, considering that many of these studies 
and statistics rely heavily on HA-CDI cases as a source of information (Table 1.1), the true 
burden of CA-CDIs is unclear and is likely to be much higher.  
Although the definitions for CA-CDI and HA-CDI point to an important differentiation in 
their etiology, most focused costing studies have been conducted on HA-CDI (Greco et al.).  A 
patient with CA-CDI is somewhat arbitrarily defined as a person who has not had exposure to 
any healthcare facility in the previous four weeks or has not had HA-CDI in the past eight weeks. 
A CA-CDI case is usually either admitted to hospital with signs and symptoms of CDI (diarrhea, 
with laboratory confirmation of the sample taken upon admission or within 72 hours of 
admission, or visualization of pseudomembranes on sigmoidoscopy, or colonoscopy, or 
histological/ pathological diagnosis of pseudomembranous colitis) or experiences the onset of the 
symptoms within the first 72 hours of hospitalization. An HA-CDI patient is a case who did not 
have symptoms or a positive laboratory test in the eight weeks prior to hospitalization, does not 
present with CDI upon admission, and shows symptoms more than 72 hours after admission. 
Another definition is that an HA-CDI case is hospitalized for CDI symptoms related to a 
hospitalization in the same healthcare facility within the previous four weeks (PIDAC, 2011).  
Diagnostic tests to confirm CA-CDI or HA-CDI use a range of laboratory methods, 
including enzyme immunoassay (EIA) and PCR, checking for C. difficile toxins or anaerobic 
microbiological culture, and glutamate dehydrogenase assays, checking for the bacterium in the 
stool samples (Cohen et al., 2010). An unformed stool sample from a symptomatic patient is 
collected and used for diagnostic testing, that is, predominantly toxin testing methods for cost-
effectiveness purposes. Guidelines for treatment of confirmed cases of CDI recommend use of 
metronidazole and vancomycin as first-line therapies; however, recurrence has been reported 
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after use of both first-line antibiotics (47.2% after treatment with metronidazole and 25.3% after 
treatment with vancomycin) (Cohen et al., 2010).  
The recent changes in CDI incidence and severity have been attributed to the increased 
use and misuse of antibiotics, the emergence of hypervirulent strains, and an increase in the 
number of vulnerable and susceptible populations (Khanna & Pardi, 2010). The advent of the 
new and more virulent strain of CDI (027/BI/NAP1), with its higher mortality rate, has added to 
the burden of CDI management and control. Although the virulent strains of CDI are mostly 
detected in healthcare settings, some studies have reported sporadic virulent strains amongst CA-
CDI cases (CDC, 2008; Lessa et al., 2015). While there are no reports of resistance to the 
antibiotics for C. difficile, limited treatment options after recurrence and overall efforts to 
decrease antimicrobial exposure in the population, especially in healthcare settings, mandate 
informed preventive strategies. The Canadian Nosocomial Infections Surveillance Program 
(CNISP) reports that although HA-CDI rates have not shown a noticeable variation between 
2007 and 2011, the number of deaths attributable to HA-CDI has increased more than two times 
(Table1). Although no national Canadian data exist to report the rate of and mortality from CA-
CDI over the years, a study from Quebec reports the incidence rate of CA-CDI increased from 
20/100,000 person years in 1998 to almost 60/100,000 person years in 2004 (Dial, Kezouh, 
Dascal, Barkun, & Suissa, 2008).  
To date, particularly in Canada, limited studies evaluate the community pattern or risk 
factors associated with CA-CDI.  Figure 1.2 presents an estimate of the number of C. difficile 
infections in Canada in 2012 (Levy et al., 2015). While the increase of HA-CDI cases is a source 
of concern for hospitals and healthcare systems, the sizable numbers of this infection in 
communities and in individuals without the traditional risk factors, as well as the sparse number 
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of studies focusing on CA-CDI, warrants further exploration of possible risk factors to inform 
preventive policies.  
Niagara Region’s CDI problem, September 2011 through December 2013. 
The Niagara Region is located in southern Ontario, Canada. It has a total area of 1852 
square kilometres and a population of 427,421. The Niagara Region consists of 12 
municipalities: Fort Erie, Grimsby, Lincoln, Niagara-on-the-Lake, Niagara Falls, Pelham, Port 
Colborne, St. Catharines, Thorold, Wainfleet, Welland, and West Lincoln. Figure 1.3 is a map of 
the Niagara Region and its municipalities, based on the 2011 census (Niagara Region, 2012; 
Statistics Canada, 2016). The Niagara Health System (NHS) is the largest multisite hospital 
amalgamation in Ontario’s Niagara Region, providing a comprehensive range of health programs 
and services to meet the healthcare needs of Niagara Region residents.  
Between September 2011 and December 2013, NHS experienced multiple outbreaks of 
CDI across multiple sites. In addition to a significant number of HA-CDIs, hospitals experienced 
an unusually high number of CA-CDI cases. In healthcare settings such as the NHS sites, 
surveillance activities follow a cause and effect pattern, and mainly look for contributory origins 
or follow up on HA-CDI patients. Even though management and care of CA-CDI cases put a 
high level of stress on NHS healthcare facilities and communities, no studies or analyses of the 
CA-CDI cases were conducted. The notable number of CA-CDI cases admitted to NHS hospitals 
demands further analysis to provide a better understanding of the contributing factors and 
characteristics of this infection at a population level, with possible applicability elsewhere. 
Methodological Considerations 
 To meet the objectives of the dissertation and to explore the research questions, the 
following methodological concerns were considered.  
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Application of a conceptual framework. 
In clinical research, theory serves as a guiding framework for the research hypotheses 
(Cresswell, 2009). Theory explains natural phenomena through a series of organized and 
dependent constructs, definitions, and suggestions, and presents a methodical view of events by 
postulating relations between variables (Kerlinger, p. 64). The application of theory-based 
processes allows researchers to mitigate problems encountered during the research process in a 
more simplistic quasi-experimental design (Mertens, 2010). This is not to say a theory-based 
approach is less effective: Mertens argues that linking social sciences theories and evaluations 
not only guides research questions and data gathering but also increases the effectiveness of a 
research program (Mertens, 2010). A research process using a theoretical lens can efficiently and 
purposefully achieve its objectives.   
More specifically, theories provide frameworks for conceptual thinking and research 
designs through which hypothesis formation, observation, analysis, and inference are guided. 
Small or program-level theories allow clarity about the components of a program and the 
mechanism of its activities, allowing the evaluation of key outcomes and describing how 
measurement and evaluation tools and methods function (Davidoff, Dixon-Woods, Leviton, & 
Michie, 2015). Small theories are intervention-specific and comprise a mix of formal and 
informal theories that collectively map the descriptors of an intervention’s components to the 
aim of the intervention, using descriptions related to the behavioural process or contextual 
features of the process (Lipsey, 1993).  
Mid-range theories are used to understand problems or to develop interventions, such as 
the diffusion of innovation theory in healthcare improvement interventions; this has led to 
innovative interventions, from recruiting opinion leaders to customizing innovations for 
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individual systems (Rogers, 1995; Rogers, Medina, Rivera, & Wiley, 2005). For academics, 
clinicians, or researchers, mid-range theories are bounded in their area of application, between a 
program-level and an all-inclusive abstract grand theory.  
The concept of grand theory offers a generalized worldview across multiple domains, at a 
high level of perception that uncovers assumptions across multiple domains and disciplines. 
Theories such as the theory of social inequity do not offer a customized way of thinking for 
specific circumstances, but a universal semantic guide to the logical articulation of situations at 
an abstract level (Davidoff et al., 2015). Theoreticians have traditionally proposed that a 
postpositivism metatheoretical paradigm is the dominant worldview guiding our understanding 
of studies involving human beings (Lincoln & Guba, 1985).  
The advent of the patient safety movement in the years following the Institute of 
Medicine report, Crossing the Quality Chasm: A New Health System For the 21st Century. 
(Institute of Medicine (IOM), 2001), resulted in enforced measurement, reporting, and 
improvement of infection prevention and control (IPAC) indicators. However, few studies in 
infection prevention and control offer a theoretical perspective that explains the conceptual 
thinking behind the process of the hypothesis/research question formation, observation, and 
analysis. Although healthcare systems and substructures are increasingly adopting a 
comprehensive approach to patient safety and the improvement of the quality of care, many 
population safety questions remain unanswered, probably due to the expansive continuum of 
hospital-based issues that can be rooted beyond hospital boundaries.  
A systems-based approach to the complex and multifaceted problems in health care can 
guide and mitigate these challenging problems. Given the interrelatedness of IPAC programs 
with internal and external stakeholders, a broad viewpoint must guide the processes of research, 
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from objectives and question postulation to evaluation and inference. Accordingly, this 
dissertation is guided by the theoretical background of complex adaptive systems (CAS); this is 
described in detail in Chapter Two.   
Conducting a scoping review. 
Scoping reviews are evaluative studies that can bring together literature within disciplines 
where new evidence is emerging (Peters et al., 2015). Scoping reviews are acknowledged as 
particularly useful when a body of literature does not have a full and systematic review of a 
particular intervention or treatment (Peters et al., 2015). While systematic reviews can answer 
questions on the effectiveness of specific interventions or treatment options, scoping reviews can 
summarize and disseminate the research findings, identifying research gaps, and making 
recommendations about future research. In general, scoping reviews enable a broader approach 
to extensive research questions, as they are able to map the literature and the key concepts 
underpinning the research area (Arksey & O'Malley, 2005). Scoping reviews can map a body of 
literature with respect to time, location, or origin. They have the power to identify gaps in the 
research, clarify concepts, and identify evidence to inform practice from a comprehensive 
evidence-based examination of the literature.  
Our knowledge of CA-CDI is evolving, and new information has been emerging as I 
have been working on this dissertation. Therefore, to present an overview of the evidence for the 
questions addressed in Chapters Four and Five, I have conducted a scoping review on the extent 
of CA-CDI research (Chapter Three).    
Use of administrative data. 
In Chapters Four and Five, administrative data are used to investigate the epidemiological 
patterns of CA-CDI in the Niagara Region. Administrative data, such as those data found in 
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quality improvement and patient safety databases, infection prevention and control databases, or 
decision support databases, are collected for healthcare administrative purposes. Administrative 
data enable researchers to access a large repository of information relatively quickly and to 
combine several databases (Williams & Young, 1996). The risks of recall bias, social desirability 
bias, or acquiescence bias are also reduced, as the data gathering process does not rely on self-
reporting or the memory of the participants (Mertens, 2010).  
As the initial purpose of collecting these administrative data was not for research, unfilled 
data fields may expose the study to the risk of bias because of missing outcome data (Stern et al., 
2009). There are three types of missing data: 1) data missing completely at random (MCAR), 
defined as when there are no systematic differences between the missing values and the observed 
values; 2) data missing at random (MAR), defined as when a systematic difference between 
missing values and observed values can be explained by differences in observed values; and 3) 
data not missing at random. The risk of bias is subject to the reasons why data are missing. There 
are several statistical methods to compensate for missing data: complete-case analysis, available 
case analysis, available case estimates, single value imputation and multiple imputation. Many 
studies recommend multiple imputation to handle missing data. However, this method requires 
approximation and multiple algorithm runs that may cause difficulties if run in settings different 
from those in which they were developed and can result in false outcome data and wrong 
conclusions. Deletion methods, such as complete-case analysis (CCA), have been recommended 
for their simplicity and comparability across analyses. But CCA can reduce the statistical power 
(lower n), does not use all the information, and may result in biased outcome estimates if data are 
not MCAR (Dong & Peng, 2013; Pigott, 2001).  
I found no systematic differences between the missing values and the collected data for 
 12 
CA-CDI and HA-CDI, possibly because a standardized surveillance tool and unified standards of 
practice were used across NHS sites. Therefore, the dissertation uses a complete-case analysis 
method for statistical analysis. 
Time series and temporal analysis.  
To explore the temporal postulations in this research, I applied three different methods. 
First, as suggested in Benneyan (1998), I used the Statistical Process Control (SPC) approach to 
show unusual variations and exceptional changes in CDI infection rates between months and 
seasons (Benneyan, 1998).  
Next, in a more specific experiment, I identified non-random temporal clusters amongst 
CA-CDI and HA-CDI using Scan Statistic, which applies the Bernoulli binominal distribution to 
search for non-random clusters of high CDI concentrations. A Bernoulli distribution is a 0/1, 
case-control type of binary data analysis. Scan Statistic uses multiple different window sizes to 
gradually scan across time and/or space and documents the number of observed and expected 
observations within the windows. The risk inside the clusters is compared to that outside the 
clusters, measuring for irregularity, based on a likelihood ratio (Lawson, Banerjee, Haning, & 
Yugarte, 2016). The cluster that yields the most extreme ratio is least likely to be by chance 
(Lawson et al., 2016). In this step, the null hypothesis assumes that the temporal clusters of 
hospitalized CA-CDIs and HA-CDIs occur at the same time. The alternative hypothesis suggests 
the presence of clusters in hospitalized CA-CDIs does not show up at the same time as clusters in 
HA-CDIs.  
The third temporal experiment was a test of seasonality for small datasets (under 50 data 
points). To find out whether seasonal properties have a role in the increase of CDIs in certain 
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periods, the time series data for both CA-CDIs and HA-CDIs were adjusted for seasonal 
components (Carlberg, 2015), with seasonally adjusted values for each season of the study.  
The methods supplement to the dissertation provides more detailed information on each 
method described in this section.  
Spatial analysis. 
For the three main epidemiologic variables influencing the dynamics of disease 
transmission—host, agent, and environment—environmental factors (such as the topographical 
distribution of a disease) are frequently the more challenging to explore and visualize (Choi, 
2013). Environmental influences on the health of individuals can be a random or non-random 
experience that stimulates exposure to the disease. Technological advances offer researchers the 
opportunity to differentiate these phenomena and quantify the variations in geographical 
patterns, allowing them to make projections for managing, planning, and even preventing public 
health interventions (Jacquez, 2007). Spatial clusters of a disease are defined as a geographically 
bounded group of occurrences of sufficient size and concentration that are unlikely to have 
occurred by chance (Aldstadt, 2009). Exploratory spatial data analysis identifies patterns through 
visualization and geo-statistics and recognizes the location and magnitude of the statistically 
significant descriptors. The analysis, in turn, leads to the test of a hypothesis that attempts to 
interpret the geographical patterns through further epidemiological studies. To explore this 
postulation, I used spatial Scan Statistics; this allows researchers to measure the significance and 
location of a general or focused cluster (Kulldorff & Nagarwalla, 1995), subsequently leading to 
clues about the disease under investigation. Further details about this method appear in a 
supplement at the end of the dissertation. More methodological considerations also appear in 
each manuscript comprising the dissertation.  
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Policy and Equity Considerations 
The dissertation will provide a better understanding of the epidemiology of CA-CDI in 
general and in the Niagara Region specifically. It has the potential to inform policy solutions that 
will support CDI reduction programs in the community and achieve more equitable health 
practices. This fits with current policy goals. In 2010, Ontario’s Excellent Care for All Act stated 
that high quality health systems must “deliver world-leading effective, patient centered services; 
efficiently and in a timely manner, resulting in optimal health status for all communities” 
(Ontario Ministry of Health and Long-Term Care, 2010). In 2016, to complement the Act, Health 
Quality Ontario stated that creating a safe, effective, patient centred, timely, efficient, and 
equitable health system requires a systems improvement approach (Health Quality Ontario’s 
System Quality Advisory Committee, 2016).  
Health equity is an essential feature of an equitable healthcare system, with concrete 
implications for policy decisions (Culyer, 2001).  Health inequities have been defined as 
differences in health experiences that “are not only unnecessary and avoidable but, in addition, 
are considered unfair and unjust” (Kawachi, Subramanian, & Almeida-Filho, 2002; see also 
Whitehead, 1992). In her ground-breaking work on defining health inequities, Whitehead (1992) 
maintained that individuals should have a fair opportunity to attain their full and normative 
health potential, and, what is more, that all inequitable approaches and disadvantages should be 
avoided. Inequitable approaches include “irrelevant” characteristics such as race/ethnicity, age, 
gender, education, and income; these should not affect the way a patient is treated unless there 
are legitimate grounds for the different handling of the patient (Kawachi et al., 2002). To 
quantify inequitable approaches empirically and to inform health equity policies objectively, 
Culyer (2001) indicates that practical implications for policy on health equity are shaped by 
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“research into the actual distribution of health and sickness: performed in advance of policy 
initiatives so that the initiatives be informed by the results” (Culyer, 2001; Culyer & Wagstaff, 
1993).  
A variety of methods have been used to measure and quantify health inequities. The most 
frequently applied method is to compare a health indicator in a disadvantaged group to a  similar 
indicator in a reference, and advantaged, group (Braveman, 2006).  However, in a report 
published by the World Health Organization in 2000, this method was criticized for its prejudged 
causation effect, as this can obscure differences between groups (Murray, Gakidou, & Frenk, 
1999; World Health Organization, 2000). Therefore, some propose measuring health inequities 
across individuals by means of social groups’ defining criteria, such as community location 
(Murray et al., 1999). This research looks for inequity indicators without applying the previously 
established markers of social disadvantages (such as income or race). This allows the comparison 
of sick and healthy individuals rather than rich and poor.  
The concept of health equity has been categorized as vertical equity (the unequal, but 
equitable, treatment of unequals) and horizontal equity (the equal treatment of those with equal 
needs) (Mooney & Jan, 1997). Whitehead’s remarks (1992) encouraged me to look at healthcare-
associated infections through a different lens. Accordingly, I explored explainable but new and 
different patterns in the epidemiology of a community-acquired infection, in a quest to locate 
vertical and horizontal equity policy intervention points to create a fair healthcare system for all. 
Thesis Overview 
The dissertation consists of six chapters, as summarized in Figure 1.4. The first chapter 
(this chapter) provides a general introduction to the concepts and premises, and the last chapter 
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provides an overall conclusion. Three of the other four chapters represent manuscripts prepared 
for submission to a peer-reviewed journal.  
Chapter Two introduces the theoretical lens guiding the conceptual framework of the 
dissertation. The conceptual framework brings the epidemiologic triad of host, agent, and 
environment together with the complex adaptive system (CAS) view. Chapter Three offers a 
scoping review of CA-CDI; the chapter represents the literature review of this dissertation. 
Chapter Four consists of a manuscript titled: “Epidemiology of patients hospitalized with 
Clostridium difficile infection in the Niagara Region, Ontario, Canada, September 2011 through 
December 2013: A comparative analysis of community-associated and healthcare-associated 
Clostridium difficile infections.” The chapter analyzes the host factors—including characteristics 
and experiences confirmed by the scoping review. It also includes a univariate comparative 
analysis of the attributing factors to incidences of CA-CDI and HA-CDI.  
Chapter Five is a manuscript titled: “A spatial, temporal, and molecular epidemiology 
study of hospitalized patients infected with community-acquired or healthcare-associated 
Clostridium difficile in the Niagara Region, Ontario, Canada.” The chapter applies a variety of 
the methods described earlier to address the research questions on temporal and spatial patterns 
and the genetic relatedness of CA-CDI, and it considers how these compare with those of the 
HA-CDI cases in the Niagara Region during the study period.  
Chapter Six offers an overall conclusion and a summary of the findings. It touches on the 
study limitations, implications for conducting future research and practice, and potential policy 
implications. A supplement at the end of Chapter Six provides more detail on the methodologies 
used for the research.  
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Tables 
Table 1.1 – A comparison of the rate per 10,000 patient days, the number of deaths, and the 
mortality rate per 100 cases of HA-CDI in Canada between 2007 and 2011.   
 
 Year 
Rate per 10,000  
patient days 
Number of deaths  Mortality rate/100 HA-CDI cases 
2007 4.51 33 4.9 
2008 5.49 25 5.0 
2009 4.75 33 3.1 
2010 4.53 88 6.1 
2011  5.35 88 5.3 
Note. Adapted with permission from Canadian Nosocomial Infection Surveillance Program 
(CNISP). Healthcare-associated Clostridium difficile infection (HA-CDI) 2007 – 2011. Ottawa, 
ON: Author. Retrieved from http://www.phac-aspc.gc.ca/nois-sinp/projects/cdad-eng.php 
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Figures 
 
  
 
Figure 1.1 – Framework depicting the formation of research questions explored in this study to 
better understand the epidemiology of CA-CDI in the Niagara Region between September 2011 
and December 2013. 
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Figure 1.2 – Estimated number of infections and of Clostridium difficile in Canada in 2012, base 
infection and sensitivity analysis (Levy et al., 2015). 
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Figure 1.3 – Niagara Region and population of each municipality (Statistics Canada, 2016). 
 
  
 29 
 
 
 
 
Figure 1.4 – Dissertation structure: A summary of the objectives and studies presented in each 
chapter.  
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Chapter Two – Conceptual Framework 
The epidemiology of Community-acquired Clostridium difficile infections in the Niagara 
Region, Ontario, Canada, between September 2011 and December 2013 
 
Introduction 
The value of combining population-level epidemiological studies in disease prevention 
with the biology and pathogenesis of diseases has been acknowledged since the 19th century, 
when John Snow’s spatial study of cholera cases in London revealed water contamination as a 
source of the outbreak (Gordis, 2000). For this, and numerous other reasons, including the 
complexities of healthcare practices, as well as the multiple aspects of diagnosis, treatment, and 
care delivery settings, scholars in the field of healthcare quality improvement and patient safety 
argue the need for a systems approach. As two leading researchers in healthcare quality 
improvement and patient safety make clear: “Systems approaches are necessary for sustained 
improvement because they consider clinical workflows, care processes, and the overall 
environment clinicians practice in” (Baker & Axler, 2015). Following this line of thinking, the 
2016 recommendations for improving healthcare quality in Ontario urge institutional and 
organizational leaders to connect with other parts of health systems using their relationship 
management skills and applying systems thinking throughout their practices (Health Quality 
Ontario’s System Quality Advisory Committee, 2016).  
Systems thinking also appears in recommendations for a systems-based approach to 
reporting (Howley & Chuang, 2011; Petula, 2005). A systems-based approach, such as the 
National Healthcare Safety Networks for reporting healthcare-associated infections (HAI) in the 
United States, has been proven to promote safe practices through well-crafted policies, prevent 
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diseases through interdisciplinary efforts, support evidence-based collaborative practices, and 
improve healthcare quality outcomes. 
Given the recent push to apply systems-based approaches to healthcare challenges, in this 
chapter, I view my dissertation topic through the lens of Complex Adaptive Systems (CAS) 
theory, a modern and inclusive archetype of systems thinking. In what follows, I explain my 
choice of a conceptual framework and show how it shaped my research questions and 
methodologies.  
Background 
In hospitals, patients with multiple complications are frequently exposed to 
antimicrobials causing healthcare-associated Clostridium difficile infections (HA-CDI), making 
Clostridium difficile infections (CDI) largely a hospital problem. Historically, surveillance and 
investigation of healthcare-associated infections have been conducted within the scope of 
practice of hospital-based infection prevention and control (IPAC) programs, with little attention 
to cases meeting the definition of community-acquired infections. For cases or outbreaks of 
infectious diseases in hospitals, IPAC programs commonly use a cause-and-effect model of 
investigation (e.g., a Fishbone diagram), looking for contributing factors, brainstorming, sorting 
through ideas, and identifying causes of infections from a hospital perspective and within 
hospital boundaries (Chuang et al., 2015; Wu, Lipshutz, & Pronovost, 2008). The intent of this 
approach is to identify and eliminate the hospital-based factors that contribute to the problem. 
However, recent years have seen a surge in cases of community-acquired CDI (CA-CDI), 
without the traditionally recognized risk factors for HA-CDI (Khanna et al., 2012). In addition, 
the cause-and-effect approach using hospital surveillance data alone has proven insufficient, 
even for hospitals, as we repetitively witness outbreaks; simply stated, this type of approach 
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occasionally lacks the evidence-based support for successful interventions that reduce infection 
outbreaks. 
In order to allocate the right resources to IPAC services or public health programs and to 
come up with more effective preventive measures in hospital and communities, we must develop 
a better understanding of the flow and the pathways of CDI infection, both in hospitals and 
between communities and hospitals. The proposition of this research is that by applying an 
analytic systems-wide lens, we can transform data on CA-CDI and HA-CDI into epidemiological 
patterns and actionable knowledge that can objectively inform future preventive practices and 
equitable health policies to improve the effectiveness of the preventive strategies in hospital 
settings and extend that knowledge to communities, thus expanding our focus from a solely 
institutional level to include a population level.  
To uncover the epidemiological patterns of diseases, we need a framework that reflects 
the interrelationships and interdependencies both within and between hospitals and communities. 
This is not a new idea. For example, when a systems lens was applied to study the epidemiology 
of other infectious diseases such as Severe Acute Respiratory Syndrome (SARS), Middle East 
Respiratory Syndrome (MERS), or Ebola virus disease, studies found that despite the high rate of 
person-to-person transmission and the associated high mortality of these infections in hospitals 
and healthcare settings, the possibility of single or multiple introduction and reintroduction from 
the community played an integral role in the spread and outbreak of these infections in hospitals 
(Assiri et al., 2013; Lloyd-Smith, Galvani, & Getz, 2003; Rico, 2016).  
A systems level understanding of the transmission pathways of infections that spread 
along the continuum of hospitals and communities can prevent emergent infections by making 
effective interventions. The bottom line is that preventing and reducing transmission in 
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communities reduces the overall burden on healthcare resources. For instance, tuberculosis (TB) 
outbreaks are disproportionally prevalent in homeless populations; in the United States, there 
was a10-fold increase in the TB rate (6%) in this group compared to the non-homeless 
population between 1994 and 2010 (Bamrah et al., 2013). The prevalence has been associated 
with equity indicators, including crowding and poor ventilation in shelters for the homeless 
(Figueroa-Munoz & Ramon-Pardo, 2008; Hripcsak et al., 1999). Consequently, in 2005 the US 
Center for Disease Control and Prevention (CDC) recommended improved ventilation standards 
for shelters (CDC, 2005), but providing proper housing and social services is obviously a better 
solution. It would decrease the number of homeless- and shelter-associated cases of TB and 
reduce hospital and healthcare utilization. 
In 2003, in a World Health Organization (WHO) communication, Pang and colleagues 
proposed an inclusive agenda for health research systems. In their view, researchers from 
different disciplines should form an interconnected system of scientific knowledge, accessing 
research-based information with the ultimate goal of improving and solving health and health 
equity problems (Pang et al., 2003). Other scholars in the field of quality and health systems 
have supported this proposal, with cross-disciplinary, theory-driven collaboration between 
hospitals and public health departments noted as a way to broaden the epidemiological tools used 
to evaluate and investigate causal factors in population health (Perneger, 2005). However—and 
despite calls for systems-level safety and quality initiatives—very few studies reflect on the 
interrelatedness of CA-CDI and HA-CDI infections at a population level using a systems and 
epidemiological lens (Baker & Axler, 2015; Barbut & Petit, 2001). Discussions of this nature are 
called for, especially given the trans-connectivity of hospital-based IPAC programs with other 
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in-house or external programs and with the movement of patients between hospitals and the 
community, on what I refer to above as the continuum of health care.  
To describe the conceptual lenses through which the questions for this research were 
proposed, the next section explains some fundamental concepts of IPAC programs. It begins 
with the IPAC mandate and framework, outlined in the most recently published IPAC standards 
in Ontario. Next, to support the search for a suitable theory for this research, I present examples 
of the theoretical concepts used in IPAC and health studies. I then discuss the rationale for theory 
selection and the final choice of theory. Finally, I explain the guiding conceptual framework of 
this research; I show how it directed the formulation of the research questions and the data 
collection, evaluation, and interpretation. 
The Role of IPAC Programs in Healthcare Organizations 
IPAC goal and function. 
The goal of IPAC programs is to protect patients, healthcare workers, and others in the 
healthcare environment (APIC, 2013; PIDAC, 2011). Put more pragmatically, IPAC programs 
seek to do the following: obtain and manage critical information, develop or recommend policies 
and procedures, prevent infection, and provide education for patients, caregivers, and others 
involved in the process of care (APIC, 2013; PIDAC, 2011). By taking these steps, IPAC 
programs promote patient safety and improve quality of care in healthcare organizations, 
including hospitals and long-term care facilities, by reducing and preventing mortality, 
morbidity, complications, and the extra hospital days needed due to healthcare-associated 
infections. The programs work closely with external organizations, such as public health 
departments, nursing homes, community care providers, and homecare services, and with 
services within healthcare organizations, such as laboratories, clinical care services, and 
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occupational health and support services. Importantly, IPAC programs seek guidance from local 
or global evidence-based guidelines and standards to carry out their mandate. In Canada, IPAC 
programs and services are directed by multiple federal or provincial standards or guidelines.  
Standard IPAC framework. 
In Canada, the IPAC foundational framework is an integral part of the IPAC program 
standards developed by Infection Prevention and Control–Canada (IPAC–Canada, 2016). 
Although the standards clarify the role of internal and external stakeholders, such as public 
health departments, for event or outbreak management purposes or for service-specific 
consultations, the narrative of the framework focuses mainly on the governance, administration, 
and performance aspects of IPAC programs (IPAC–Canada, 2016). My review of guidance for 
IPAC programs and services did not reveal recommendations for a macro-level theory-driven 
conceptual framework that can guide practices or research within the discipline. In my view, this 
type of framework would be extremely useful, and in this chapter, I propose one possibility. 
Figure 2.1 depicts an approximation of current processes of IPAC practice in healthcare 
settings in Canada related to CDI surveillance. The cause-and-effect model of surveillance and 
evaluation shown in the figure classifies patients into one of two categories, HA-CDI or CA-
CDI, collects patient demographic and previous medical history, implements isolation 
requirements, and follows up patients until discharge from the hospital. Since the emphasis of the 
IPAC practices is on hospital cases, little attention is paid to the CA-CDI cases other than 
surveillance data collection and isolation precautions and treatment when patients are admitted to 
hospital. The approach lacks many aspects of the traditional method advocated by the 
epidemiological triad of host, agent, and environment, the interaction of which produces diseases 
found both in communities and in hospitals’ emergency departments.  
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As seen in Figure 2.2, disease formation is considered a product of the human host’s 
characteristics, such as genetics or occupation, an infectious agent, and the environment that 
promotes the exposure (Gordis, 2000). Therefore, to better understand the exposure risks and 
contributing factors to the disease transmission processes, the dynamics of disease transmission 
and their interplay must be evaluated from all aspects. The present surveillance practices omit 
the systems’ view that is needed to clearly understand communicable diseases’ processes and the 
factors contributing to infection formation.  
Frameworks Guiding IPAC Studies 
A literature search reveals that a few IPAC studies have followed conceptual models, 
particularly when implementation, adoption, and the application of quality improvement or 
patient safety initiatives are the focus. Table 2.1 lists the IPAC studies using models or 
conceptual or theoretical frameworks to guide their research or interventions. Researchers and 
practitioners in IPAC often heuristically select either program theories (small or micro theories) 
or mid-level theories (meso theories) when a model for understanding a problem or a guide to 
developing interventions is required (Davidoff, Dixon-Woods, Leviton, & Michie, 2015). 
Frameworks such as Kotter’s change leadership model, Rogers’ diffusion of innovation (DOI) 
theory, or Langley’s model for improvement have been used to guide hypothesis postulation or 
program implementation, such as developing a hand hygiene program (Mitchell & Gardner, 
2013; Pittet, Hugonnet, Harbarth, & Mourouga, 2000). As described in Chapter One, program-
level theories specific to a program are helpful in providing clarity about the component of a 
program or the mechanism that leads the input to outcomes. They are useful tools to understand 
evaluation and methods functions (Davidoff et al., 2015). More specifically, mid-level theories, 
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such DOI, allow a better understanding of a problem or function as a guiding principle for 
developing targeted interventions (Davidoff et al., 2015).  
However, micro and meso theories lack the scope required to address the complexities of 
multidimensional preventive strategies at a program and population level. The application of 
macro theories has been recommended to academics and researchers as a means to uncover 
assumptions and explain phenomena across multiple different disciplines; this proposed usage 
fits with the present research. Despite their potential utility, macro-level theories have seldom 
been applied, however. With the exception of one study applying a macro-level theory or grand 
theory (systems theory) for management and control of scabies outbreaks, most studies have 
used mid-level or program-level theories. A review of the studies listed in Table 2.1 shows that 
the majority used the theory of DOI (n=4) or the theory of continuous quality improvement (n=3) 
for implementation studies, behaviour change studies, and measurement or education 
effectiveness measurement studies. Given their popularity, before explaining my own theory 
selection, in what follows, I discuss the diffusion of information (DOI) theory and the theory of 
continuous quality improvement (CQI). Although each is clearly useful, neither works within the 
context of my research.  
The theory of DOI has been widely used in many disciplines, including healthcare. 
Initially, the foundations of this theory were set when researchers observed the communication 
patterns that influenced the behaviour of hybrid corn farmers. Rogers later formalized the 
concept of DOI as the “processes through which innovations are communicated, using certain 
channels and over time and amongst members of certain social systems” (Rogers, 1995).  
Although initially presented as an adoption theory at an individual level, emphasis on 
innovation and the desire to apply a staged model led to its adaptation for use at an organization 
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level. The staged model covers the span of an innovation, from “initiation” to “decision” and 
“implementation” over varying lengths of time (Rogers, 1995). Despite the evidence provided by 
Larson, Quiros, and Lin (2007) or Abbott et al. (2006) of their success adapting evidence-based 
practices to a DOI model (see Table 2.1), the implementation in both studies was limited to inter-
organizational teams or departments. This does not offer a pliable theoretical ethos for 
comprehensive, trans-organizational programs. In addition, the use of a staged model of DOI has 
been criticized for its lack of applicability to complex innovations where multiple paths and 
cycles are involved in inter- and intra-organizational innovation processes (Wolf, 1994). Given 
these limitations, I rejected DOI and tested other theoretical lenses. 
The theory of continuous quality improvement (CQI) has been used widely in healthcare 
for attaining, implementing, and monitoring quality improvement interventions. The operational 
and practical effectiveness of CQI theories has been demonstrated in numerous quality 
improvement initiatives (Scales et al., 2011; Misset et al., 2004; Vollman, 2006), Application of 
CQI models to the adaptation of quality improvement interventions in healthcare became 
common after the Institute of Medicine report on healthcare quality in 1999 and the advent of the 
patient safety movement (Kohn, Corrigan, & Donaldson, 1999). This model has essentially been 
used as a tool to measure the effectiveness of improvement initiatives (Langley et al., 2009). To 
reduce medical practice errors and to incorporate and maintain safety science in daily clinical 
tasks, CQI models have been applied to frameworks supporting a myriad of quality improvement 
and patient safety bundles (Pronovost, Wu, & Saxon, 2004). Many lives have undoubtedly been 
saved by applying the CQI theory to infection control safety bundles, such as the ventilator-
associated pneumonia reduction bundle, or the bundle for preventing surgical site infections. 
However, the CQI theory is recommended more as an overarching management philosophy for 
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operational processes and less as a grand theory (Public Health Ontario, 2018). A CQI model 
cannot provide the required philosophical context to explain the many phenomena of complex 
healthcare functions, hence my rejection of it as a theoretical framework.  
Reductionist and single cause approaches to disease formation and prevention have long 
been replaced by methods that consider biological, behavioural, and population-level factors and 
feature an analytical focus on their interrelatedness. Epidemiological studies increasingly focus 
on complex social, environmental, and individual factors to explain causes of disease (Galea, 
Riddle & Kaplan, 2010). In the field of infectious disease, the known dependence between 
individuals and communities at a local or a population level is an added reason to approach 
infections through a complex systems lens. The role of genetics in the significance of an 
individual’s risk factors, combined with the interplay of causative agents and the environment, 
work together to define the dynamics of a disease formation in an individual (Diez Roux, 2011). 
Correspondingly, scholars stress the value of unbiased health inequity evaluations by 
detecting patterns in different subgroups of a population (Braveman, 2006). Frameworks that 
apply an all-inclusive theoretical lens can conceptualize and capture the open dynamics of 
complexities at a population level, such as the interdependencies of health indicators and the 
environment. To understand and explain infectious disease pathways and enrich the research on 
possible routes of transmission, an all-encompassing and adaptable grand theory that tolerates 
the complexities of transdisciplinary, multi-organizational functions should guide research and 
practice processes.  
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Frameworks Guiding Health Studies 
Systems-thinking theories have historically been a dominant ethos guiding health 
research and practice (Dredger et al., 2007; Green, 2006; Leischow et al., 2008; Likosky, 2014; 
Perneger, 2005; Peters, 2014; Revere et al., 2007). With the advent of continuous process 
improvement movements in healthcare settings, systems thinking has increasingly been 
incorporated into clinical practices (Henriksen et al., 2005). Healthcare quality improvement 
scholars maintain that systems thinking improves transdisciplinary communication and team 
building, supports collaboration and trust, enhances conflict management, process orientation, 
and organizational learning, reduces power differentials, and ultimately promotes health (Petula, 
2005). Systems thinking can guide us to improved data collection methods, better data quality, 
new questions, and different ways of looking at the hypothesis formation processes. There are 
many theories of systems thinking, each explaining certain phenomena. Table 2.2 summarizes 
and compares several theories and their application in health studies (Peters, 2014).  
The table makes clear that systems theory is a dominant grand theory and a leading 
viewpoint used repeatedly in healthcare and public health to define biological and social 
phenomena. Von Bertalanffy says: “The characteristic of life does not lie in a distinctiveness of a 
single life process, but rather in a certain order among all the processes” (von Bertalanffy, 1968). 
As this comment suggests, systems theory refers to a general science of “wholeness” (Drack, 
2008). Through a systems theory lens, the conflict between “mechanisms” and “vitalism” can be 
solved by metaphysical sciences (i.e., the order among all life processes), rather than by 
empirical sciences (i.e., the distinctiveness of a single life process) (Cordon, 2013). General 
systems theory addresses the metaphysical field of science by integrating various sciences. 
Universal principles apply to the systems in general, such as holism, boundaries, hierarchy, 
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mutuality, equilibrium, equifinality, and entropy, as listed and explained in Table 2.3 (Drack, 
2008). For example, Chuang et al. selected a systems-oriented event analysis model to guide 
their interventions and to halt the ongoing scabies outbreaks in a hospital ward. They used 
systems modelling and analysis to prioritize hazards and integrated a set of risk control measures 
into the traditional root cause analysis and preventative guideline recommendations (Chuang et 
al., 2015). The challenges of applying systems theory to modern healthcare include the 
complexity of the problems, the unpredictability of events, and the multiplicity of agents 
involved in programs, but in the scabies study by Chuang and colleagues, the systems-level 
analysis was conducted only within a hospital ward, with fewer external interactions or 
distinguishing individualities of multiple and external agents.  
As in many other subunits of healthcare, the dynamic and evolving nature of IPAC 
programs requires a guiding theory to accommodate the continuous evolution of multiple 
interconnected stakeholders. A complex systems viewpoint is increasingly used in healthcare and 
the public health domain, mainly because of the insufficiencies of the traditional reductionist 
approaches in explaining the dynamic, emergent, and nonlinear behaviour of these systems 
(Plsek & Greenhalgh, 2001; Diez Roux, 2011). Complexity theory is now being applied to the 
frameworks guiding healthcare research, such as studies in epidemiology and infectious diseases, 
healthcare organization, biomedicine, health and social sciences, and health geography (Rickles, 
Hawe, & Shiell, 2007).  
As long ago as 1994, Anderson claimed that the interaction between various components 
that trigger and cause infections in individual patients and the factors that control the 
transmission in communities are complex, interrelated, and nonlinear (Anderson, 1994). In his 
research, Anderson applied mathematical modelling to infections and immunity pathways to 
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explain and study the role and the interaction of antigenic variation, pathogenic persistence, and 
vaccination policies to control childhood infections. He noticed themes of dynamic complexity 
deriving from explainable biological assumptions. Quite early on, Anderson’s study emphasized 
the value of viewing interdisciplinary research in the infectious diseases and immunological 
fields through a complex theoretical lens, underlining that a reductionist approach to disease 
prevention cannot be successful.  
An extension of complexity theory, the complex adaptive systems (CAS) theory, speaks 
to the challenges of 21st century health care (Plsek & Greenhalgh, 2001). CAS is a 
recommended paradigm for research perspectives on public health similar to those of Anderson 
(1994), where the complexity and co-evolution of the system components are continuously 
influencing evidence-based feedback (CPHA, 2016).  
The theory of complex adaptive systems postulates a dynamic, emergent, and intuitive 
paradigm within which the inconsistencies, interdependencies, and unpredictabilities associated 
with the human system and with health systems are explainable (Waldrop, 1992). The evolution 
of human responses to communicable disease dynamics that have caused pandemics or 
epidemics, such as the HIV/AIDS epidemic in Brazil or the Toronto-area SARS outbreak in 
2003, is typical of complex adaptive systems characteristics. In 1990, a World Bank study 
ranked Brazil and South Africa as the two countries with the highest number of HIV/AIDS cases, 
with Brazil having almost twice as many cases as South Africa. Although international 
organizations suggested an emphasis on preventive approaches, Brazilians at all levels responded 
to this problem with a cure-for-all mindset (Westley et al., 2007). All levels of society joined 
forces to manufacture and provide free treatment to everyone affected by HIV/AIDS, and to 
promote, market, and implement preventative measures at all levels using creative approaches. 
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Consequently, by 2000, Brazil’s HIV/AIDS infection rate had been reduced to 0.6 percent (1 
person in 160). South Africa now lagged behind Brazil, with one in four persons infected. 
Brazil’s experience with control and management of the HIV/AIDS epidemic is just one example 
in which unanticipated resources have been pulled together in response to a complicated health 
problem, and the response of individuals and group dynamics at various levels has impacted 
disease outcomes and incidence at a population level.  
With the understanding that IPAC services are faced with multiple complex inter-
organizational problems influenced by both hospital and community dynamics, the theory choice 
for this dissertation must include internal and external stakeholders and their collaborative 
interplay, while maintaining the individuality of each organization. 
Theory Guiding the Conceptual Framework: Epidemiology Informing Health Equity 
Policies 
Health systems and their human and environmental adjuvants are complex, unpredictable, 
and evolving (Plsek & Greenhalgh, 2001). Systems thinking has been used as an umbrella theory 
underpinning the philosophy of practice and research in health care. But the trans-dependencies, 
interrelatedness, and unknowns associated with this research context must also be embraced by 
theory. The general systems theory, which posits that efficient health systems function as well-
oiled machines, omits the dynamic living aspect of the practices and the people, or ignores the 
individuality of the stakeholders or their collective effect on the system’s relationships. Hence, 
the reductionist approach of the traditional systems theory cannot explain the unpredictability of 
health systems or the greater impact that can be achieved by summing together the systems’ 
various agents (Westley, Zimmermann, & Patton, 2007). According to Diez Roux, questions 
about population-level health disparities are difficult to answer because there is a lack of clarity 
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on dynamic processes. Knowledge of these processes could better inform the etiology or policy 
enquiries (Diez Roux, 2011). Systems methodologies that consider the heterogeneity, adaptation, 
non-linear dynamics, and stochasticity of these dynamic agents at various levels are able to 
reveal patterns at various scales (Diez Roux, 2011). In turn, identifying new and emergent 
patterns can improve our understanding of the factors contributing to infectious diseases 
incidence, thus reducing health problems at a population level. Given the above considerations, 
in this dissertation, I opt for a CAS lens.  
Complex Adaptive System (CAS) Theory 
Complex adaptive system theory is often used as a subset of complexity theory.  
Complexity science embraces life as it occurs, as an unpredictable, emergent, evolving, and 
adaptable phenomenon (Westley et al., 2007). The concept of complexity is based on the work of 
Laplace, an 18th-century philosopher and mathematician whose research led to Neumann’s study 
of dynamic weather system models in the 1950s (Rogers, Medina, Rivera, & Wiley, 2005). It is 
thought that an interdisciplinary team of experts developed the term “complex adaptive systems” 
(CAS) in the 1980s. CAS theory has since been used to study weather, ecosystems, immune 
systems, and organizational and human behaviour. CAS is widely used in recent medical 
sciences literature as a modern prototype of general systems theory (Plsek & Greenhalgh, 2001; 
Zimmermann, Lindberg, & Plsek, 1998). More specifically, the feedback mechanisms that are 
key characteristics of this theory (discussed later) can inform future directions of practice, 
research and policies in population-level health.  
Organizational complexity theorists assert that complexity theory is the right ethos to 
explain processes that cannot be explained by analyzing their parts, just as human body or 
disease processes cannot be fully understood by simply itemizing their organs or agents (Westley 
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et al., 2007). Complexity results from the unpredictable inter-relationship and interconnectivity 
of the elements within a system and between the system and its environment (Chan, 2001). The 
relationships emerging from interactions in a complex system may result in new patterns that 
empower the system to structure new changes. As in Anderson’s childhood disease prevention 
and vaccine development process (mentioned previously), discovering the relationship between 
biological interactions, diseases processes, and interfaces amongst individuals and groups could 
yield findings relevant to population health.  
CAS has been defined as a range of critical and simultaneous interactions between 
multiple stakeholders with various goals and purposes, where ambiguous outcomes may be 
anticipated (Zimmermann et al., 1998). For example, the reaction of multiple stakeholders to 
natural disasters such as hurricanes can be explained by this theory. The non-linear, spatio-
temporal interactions between and within the components, factors, and mechanisms of 
stakeholders and their environments at different levels comprise a CAS (Glann-Mann, 1995/96). 
Many inseparable natural and artificial systems involved in healthcare, such as the human body, 
body organs, and computer systems, are characterized by these CAS behaviours, making CAS 
theory increasingly applicable to health problems and increasingly popular with population 
health researchers. 
A CAS is equally dependent on relationships, emerging patterns, and iterations of 
multiple complex subsystems that are constantly adapting to their environment (The Health 
Foundation, 2010). Operators and stakeholders in a CAS are active participants in a system 
through connections, relationships, and insights about how the world is changing (Westley et al., 
2007). For example, the transformation and/or adjustments of CAS participants in one subsystem 
can motivate the development and evolution of other subsystems; to give one example, practice 
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modification in operating rooms can reduce post-surgical site infections and reduce the burdens 
to the health system and the patient caused by additional hospitalization.  
Figure 2.3 gives a simple representation of CAS components. As the figure shows, the 
experiences and feedback from patterns formed through interactions and relationships inform the 
agents and the system(s), and shape the emergence of future patterns, causing them to evolve.  
Properties of CAS Theory 
Unlike mechanical systems with well-defined boundaries, a CAS has undefined and 
variable boundaries to allow interaction and exchange between the subsystems and between the 
subsystems and their environment, while maintaining the individuality of each subsystem. The 
following five principles are the main differentiating and unique characteristics of a CAS 
(McDaniel, Lanham, & Anderson, 2009; The Health Foundation, 2010). 
Connectivity: A CAS is interactive, with interactions leading to reciprocal feedback and 
the influence of agents or systems on each other. In fact, the relationship of agents and 
subsystems is critical to the survival of a CAS (The Health Foundation, 2010). CAS behaviour 
evolves from the interactions between agents and/or systems, and systems are more than just a 
collection of agents. These interactions are inevitably complex and will change the context for 
other agents. Many examples in nature (colonies of bacteria), human groups (families or a 
healthcare team), and organizations show this characteristic of a CAS. 
Emergence: A characteristic distinguishing a CAS theory from a reductionist theory is the 
rise of unexpected and new structures, patterns, properties, or processes. Emergent phenomena 
have their own rules, laws, and possibilities, but they can be created from a few simple rules or 
“minimum specifications” (Plsek & Wilson, 2001). Four elements associated with minimum 
specifications that promote innovative and complex behaviour are: direction pointing, 
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boundaries, resources, and permissions (Baker, 2001). As an example, the Institute of Medicine 
in the United States used a minimum specification process, in the form of reflecting on 
innovations presented by various groups of healthcare teams, to transition to a new design of the 
healthcare system for the 21st century. While coping with anxiety and stresses related to human 
systems is considered an influence of minimum specification, the significance of emergent 
phenomena may be downplayed because the control mechanisms generated by organizational 
hierarchies may have a limiting effect on emergence.  
Adaptation: An essential feature of a CAS is its ability to adapt by changing the rules and 
patterns of interactions within subsystems or amongst agents. Adaptation has been also 
interpreted as improved performance over time, with different outcomes based on the timeline of 
adaptation. These time frames include a single event’s adaptation with internal or external 
systems (resulting in learning) or lifetime adaptation (resulting in evolution). Studies of CAS 
indicate that adaptation is a result of self-organizing processes related to the internal dynamics of 
a system. As an example, Lloyd-Smith et al. (2003) found the hospital implications of SARS 
could be reduced by implementing measures that reduced community–hospital transmission. 
What appeared to be a hospital infection with a high rate of transmission amongst healthcare 
workers in initial stages of this outbreak ended up having roots in the community, with a lower 
potential rate of transmission. In this case, interaction and learning from explorations of different 
subsystems resulted in adaptation, with the implementation of stronger screening and isolation 
policies upon hospitalization. 
  Nonlinearity/Iteration: A CAS is often nonlinear, in that small changes in the initial 
agents can lead to huge differences within the system. In nonlinear systems, outputs are not 
proportional to inputs; therefore, tallying the parts of the system does not result in a logical 
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combination of its separate parts. An ongoing challenge for public health is to find ways to apply 
and incorporate the experiences of other academic disciplines to tackle health policies (Clarke et 
al., 2007). In public health, the will to use methods used in health services for other purposes—
such as etiological epidemiology—could help develop multidisciplinary methods to evaluative 
interventional epidemiology (Clarke et al., 2007). As an example, the HIV/AIDS recovery in 
Brazil described earlier was the result of a combined collection of solutions over time, which 
magnified the spread and impact of the interventions at a societal level (Westley et al., 2007). 
Drawing on experiences in other areas of science could result in improvements in the function of 
the healthcare system. 
Self-organization: Patterns, properties, and innovations emerge naturally and universally 
throughout CAS, without input from or the influence of a hierarchy of command or external 
forces. This constant process is the system’s method of reorganizing itself to find the best fit for 
a changing environment. A vivid example of this characteristic is Toronto’s experience during 
the SARS outbreak in 2003. At this time, hospitals and public health departments were dealing 
with many unknowns. Multiple groups in healthcare organizations at various levels came 
together to respond to an evolving outbreak. Emergent ideas and innovative practices, such as 
treatment options or modifying personal protective equipment and isolation requirements, were 
continuously changing as a result of changing case definitions and with new information on 
transmission routes.  
The ideal condition for self-organization to materialize is called the “edge of chaos,” that 
is, the zone between too much rigidity and too much lenience (Plsek & Greenhalgh, 2001; 
Zimmermann et al., 1998). This is a critical phase of a dynamic complex system, as depicted in  
Figure 2.4, when the potential for the emergence of new and more adaptive patterns is at its 
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maximum (Zimmermann et al., 1998) and where new attractors are formed as a result of a 
system’s dynamics. In natural systems, such as health care, the edge of chaos conditions (also 
called far-from-equilibrium conditions) lead to critical thresholds for the manifestation of self-
organization and emergence. Organizational innovation is likely to happen in an edge of chaos-
like condition (Zimmermann et al., 1998).  In the SARS example, guidelines for personal 
protective equipment were changing as exposure to infection and numbers of infected cases were 
increasing and information about the new cases’ exposure revealed new routes of transmission. 
Bifurcation of various resources and an edge of chaos-like environment led practitioners and 
researchers to recognize new patterns in this community infection (attractors), despite initial 
beliefs that SARS infections had their roots in healthcare facilities. The new patterns resulted in 
practice and policy changes. A limitation of CAS theory has been cited as the lack of firm 
criteria to gauge a “complex system” or the ambiguity on how to enrich bifurcation or the edge 
of chaos-like condition in organizations to allow emergence and innovation (Rickles, Hawe, & 
Shiell, 2007a).  
A feature of a CAS is the possibility of multiple interconnected agents and/or systems 
embedded within each other, where the evolution of one influences others (Rhodes & 
MacKechnie, 2003). Good examples are healthcare teams, programs, or systems. The initially 
heterogeneous agents or subsystems become linked through continuous interactions. While this 
may increase the interdependencies of the systems or agents, the whole system will acquire an 
increased organism-like structure (Zimmermann et al., 1998), with work being done 
collaboratively toward achieving crucial goal/s for the subsystems. A CAS positions its functions 
in continuously determined trajectories toward achieving a fundamental purpose rather than 
arriving at a point. This can be compared to multiple interconnected micro improvement cycles 
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in clinical units; each section of the unit has goals, but together they move towards an umbrella 
goal (i.e. improving quality of health in that unit). The greater the variety of agents and 
subsystems, the stronger the system will be in achieving new possibilities and co-evolution.  
A CAS doesn’t have to be perfect (The Health Foundation, 2010). Theorists claim that 
the energy used to maintain a flawless CAS—a substitute for a system/subsystem that is better 
than other alternatives—is wasted energy. Overall, the two key distinguishing characteristics of a 
CAS are self-organization in a non-equilibrium environment and emergence (McDaniel et al., 
2009). The flexible adaptability of a CAS is in tune with the random mutation and transformation 
of its internal models, its environment, and natural selection (Zimmermann et al., 1998). This is 
partially a result of the continuous learning and evolution in a dynamic CAS and a side effect of 
the collective experiences and feedback of its components.  
Feedback and, more specifically, feedback loops are important to the functioning of 
complicated and dynamic systems. Feedback loops occur when the output of a practice or 
development from within a system serves as an input into the same system (Rickles, Hawe, & 
Shiell, 2007b). In this fashion, feedback loops are able to address the complexity of the delivery, 
implementation, and usage of multifaceted healthcare preventive measures (Gericke, Kurowski, 
Ranson, & Mills, 2005). In healthcare, feedback loops can uncover practices inconsistent with 
evidence-based medicine and lead to positive change. For example, providing cost information 
feedback to physicians or informing physicians about the cost of diagnostic testing has been 
reported to influence their ordering behaviour (Busato & Künzi, 2008; Fisher & Wennberg, 
2003; Krumholz, 2008). In general, positive feedback can have an amplifying effect, informing 
and encouraging change in processes or practices, such as access to healthy food to promote a 
healthier diet, which, in turn, increases the demand for healthy food. Negative feedback often has 
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an inhibiting effect and a moderating influence on the system’s equilibrium, such as the 
moderating effect of childhood immunization on the prevalence of a disease in communities and 
on epidemic prevention. 
 Feedback loops have been successful in identifying variations in quality of care between 
organizations based on their geographical positioning. For example, in a study of provider 
behaviour amongst local clinical practices , Fisher and Wennberg (2003) found that uneven care 
delivery processes throughout the healthcare system in American institutions were based on 
geographic variations, organizational settings, or payment systems (Fisher & Wennberg, 2003). 
The feedback loops caused by practice inconsistencies resulted in the delivery of ineffective care 
and showed differences in providers’ practices. Feedback loops have been also used to explain 
the mechanisms through which social determinants influence health (Paina & Peters, 2012). For 
example, in the vicious cycle of poverty, malnutrition, and ill health, each factor has an 
amplifying effect on the others. Poverty reduces access to food, resulting in immune systems that 
are more vulnerable due to malnutrition, leading to illnesses that prevent the individual from 
functioning and working. This result has an amplifying influence (positive feedback) in that it 
leads to more poverty, driven by lack of employment. 
To sum up: Table 2.4 lists the main properties and characteristics of a CAS. As the table 
suggests, CAS theory appreciates healthcare systems as a mix of dynamic environments and 
agents, where interaction and the relationship of various components simultaneously affect each 
other. Current IPAC practices, at best, are focused on healthcare-associated cases (HA-CDI), and 
surveillance activities are aimed at antimicrobial exposure or hospital environment cross-
contamination as the main risk factors. However, this traditional approach omits the investigation 
of contributing factors to a large proportion of CDI cases that are occurring in our communities 
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but influence the hospital environment. Evaluating half of the problem cannot inform objective 
and equitable policies.  
This research is based on three main research foci that integrate the dynamics of disease 
spread, based on the epidemiologic triad of disease transmission (see Figure 2.2) through a CAS 
lens. In the epidemiologic triad, three categories of risk factors are associated with an increased 
likelihood of human disease: host characteristics, the types of agent that cause disease, and 
environmental factors (Gordis, 2000). A CAS–IPAC paradigm elucidates the association and 
considers various disciplines’ interrelationship by providing a model for practice and research. A 
macro-level analysis of these experiences can result in meaningful epidemiological findings that 
can influence disease prevalence at a population level.  
Epidemiology of CA-CDI in the Niagara Region: A Conceptual Framework 
The questions postulated to meet the objectives of this research are described in detail in 
Chapter One. They are repeated here for ease of access:  
Question1: What is our current knowledge about the epidemiology of CA-CDI?  
Question 2: Is the epidemiology (demographic, patient characteristics) of CA-CDI 
different from that of HA-CDI in NHS hospitals?  
Question 3: Are the temporal, spatial, and strain assortment patterns of CA-CDI different 
from those of HA-CDI?  
The antecedents for the questions are the following specific CAS properties:  
Connectivity (many interacting parts): The dynamic interaction of individuals and 
programs in healthcare settings can lead to productive, novel approaches to tackle the 
challenging issues faced by IPAC. More specifically, in this research, translating data to 
actionable epidemiological knowledge is made possible by connecting internal and external 
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services to elucidate the transmission routes between communities and NHS hospitals. 
Highlighting connectivity may reveal risk factors beyond the traditional healthcare-associated 
risk factors or community patterns, such as population proximity to farmland, animals, and 
animal rearing practices. The identification of patterns will suggest that the research framework 
has successfully identified the underlying contributing factors. The goal of this research is to 
promote the interplay of multiple stakeholders, such as NHS hospitals’ clinical and nonclinical 
programs and public health programs in communities, to move towards a systems approach and 
reduce infections at a population level. These considerations are the antecedents for questions 2 
and 3.  
Emergence (emergent behaviour): Dynamic relationships and interactions between the 
agents of a CAS may result in the emergence of novel patterns between groups in the study (CA-
CDI and HA-CDI groups), leading to a better understanding of CA-CDI epidemiology or 
potential health equity factors that explain the increase in community cases and the resulting 
increase in hospitalized cases. For example, locating unusual CA-CDI activity with irregular 
spatial distributions or temporal patterns may encourage future research to explore indicators, 
such as the presence of food/waterborne sources, occupational exposure (from soil, animal farms 
or animal rearing stations), poor housing structures, or crowding in living accommodations. The 
research relies on the acquisition of empirical data, such as administrative data, surveillance and 
laboratory findings, to find answers. The search for unexpected emergent patterns using 
empirical data is the antecedent of all three questions.  
Adaptation (co-evolution): Long-term, transdisciplinary systems’-level adaptations 
between IPAC and multiple other stakeholders, such as new epidemiological trends, can result 
from the application of CAS and the knowledge adjustments of subsystems. Although a system 
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thinking evolution may not be an immediate possibility, the patterns identified in this research 
will inform future studies. As an example of how this works, during the 2003 SARS outbreak, a 
high proportion of patients infected with the SARS virus were healthcare workers (51% of cases 
in Toronto), and hospitals were recognized as the highest-risk settings for SARS (Lloyd-Smith et 
al., 2003). But the collaborative functions of hospitals, IPAC, and public health, and other 
community organizations, plus multiple simulation and modeling studies, revealed the initial 
sources of this infection to be in communities. With this knowledge, successful preventive 
interventions in hospitals, along with stringent screening and case management upon admission 
to hospitals, played a critical role in preventing the leakage of this infection back into 
communities and reduced its reintroduction into the hospitals from communities. The connective 
progression of IPAC and other stakeholders as a result of the interaction between internal and 
external departments guided the operationalization of this research and is the antecedent for 
questions 2 and 3. 
Iteration (nonlinearities): Complex adaptive systems are interactive and interrelated; their 
components provide feedback on the subsystems and on the entire system (Zimmermann et al., 
1998). The research looks at interactions between specialized modular and cooperative 
subsystems (interrelated subsystems) at a functioning level. This increases the research 
efficiency by accessing, analyzing, and interpreting encapsulated information in multiple 
subsystems (in a conceptual framework, as in Figure 2.5, they are exemplified as agents). Small 
outcomes of this study may lead to nonlinear but significant efficiencies in population health 
quality improvement initiatives through the feedback loops both in hospitals and in communities. 
Unanticipated large or small outcomes dependent on previous practices may influence future 
practices. This property of CAS is the antecedent for all three research objectives, with specific 
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focus on research question 3. Epidemiologic analysis of CA-CDI cases has the potential to 
identify the community drivers of CA-CDI that are rooted in the environment.  
Self-organization (decentralization): This research explores emergent patterns to reveal 
unique epidemiological properties and actionable knowledge that can point to new directions in 
research and equitable health policies. Multiple stakeholders are involved. In addition, novel and 
versatile statistical analysis allows the detection of new and emergent patterns, structures, or 
information. The diverse range of analysis (patient characteristics, temporal, spatial, and strains 
identification) is essential to understand emergent patterns at a time when NHS hospitals are 
experiencing unusually high numbers of cases (far-from-equilibrium condition). Identifying new 
patterns as a result of bifurcation of the outcome data of this research may lead to long-lasting 
improvements. Similar to what was seen in 2003 with SARS or during the Brazilian HIV/AIDS 
epidemic, in a CAS, self-organization and reorganization of the subsystems and the approach to 
studying and handling a problem results in the identification of novel intervention points, leading 
to long-lasting changes in behaviours and functioning. Identifying patterns among the CA-CDI 
partners and decentralizing the hospital study outcomes are antecedents for questions 2 and 3. 
Figure 2.5 summarizes the conceptual framework for the research on the epidemiology of 
CA-CDI in the Niagara Region and shows its grounding in CAS theory. The research is based on 
the transdisciplinary connectivity of the components, the emergence of new and different 
patterns, and the respective agents’ adaptation by forming nonlinear efficiencies as a result of 
positive or negative feedback derived from self-organization of the system’s (study’s) 
components. In this framework (see Figure 2.5), the role of the CAS in supporting the 
epidemiological study of CA-CDI is a foundational one, guiding internal and external 
stakeholders’ ongoing feedback and adaptation. Positive feedback can improve the overall 
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healthcare practices and health policies. In the long term, these changes will impact the infection 
rates in the community and in hospitals, improving population health. In contrast, negative 
feedback will have a moderating effect on healthcare practices and results by maintaining the 
status quo.  
In this study, the antecedents for the research questions are the trans-disciplinary 
connectivity and adaptation of the agents involved, leading to the emergence of new and 
different patterns.  By applying a CAS lens, this research will enhance our understanding of the 
fundamental variables of CA-CDI epidemiology. Findings will yield useful insights into factors 
contributing to the increased incidence of CA-CDI by looking at those who sought 
hospitalization and suggest improvements in the quality and equity of population health. The 
goal is to use current data and to identify patterns and previously unidentified leverage points in 
the surveillance and demographic information to inform health equity policies. As Diez Roux 
states: “The key question is no longer about partitioning groups and individual effects or social 
and biological effects but rather about understanding how these dynamically relate to generate 
the macro patterns that we see” (Diez Roux, 2011). 
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Tables 
Table 2.1 – Theories guiding IPAC studies. 
 
Research/publication, author, year Theory/model  
and key reference 
Introduction of an isolation policy in paediatric wards (Hall, 
Roopnarine, & McLean, 2007). 
Change leadership 
(Kotter, 1996)  
Achieving zero catheter-related bloodstream infections: 15 months’ 
success in a community-based medical center (Harnage, 2007). 
Model for 
improvement 
(Langley, 2009) 
(Langley, Nolan, 
Nolan, Norman, & 
Provost, 2009) 
Effectiveness of a hospital-wide program to improve compliance with 
hand hygiene (Pittet et al.) 
Behavioural theory 
(Kretzer & Larson, 
1998)  
Implementation of an industrial systems engineering approach to 
reduce the incidence of methicillin-resistant Staphylococcus aureus 
infection (Muder et al., 2008). 
 
Toyota production 
system  
(Spear & Bowen, 
1999)  
A multifaceted intervention for quality improvement in a network of 
intensive care units; a cluster randomized trial (Scales et al., 2011).  
Continuous quality 
improvement 
A continuous quality-improvement program reduces nosocomial 
infection rates in the ICU (Misset et al., 2004). 
 
Continuous quality 
improvement  
Ventilator-associated pneumonia and pressure ulcer prevention as 
targets for quality improvement in the ICU (Vollman, 2006). 
 
Continuous quality 
improvement 
Dissemination of the CDC's hand hygiene guideline and its impact on 
infection rates (Larson, Quiros, & Lin, 2007). 
Diffusion of 
innovations  
(Rogers, 1995)  
The impact of US-style infection control programs in an Asian country 
(Leu, 1995). 
Diffusion of 
innovations  
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Research/publication, author, year Theory/model  
and key reference 
(Rogers, 1995)  
Adoption of a ventilator-associated pneumonia clinical practice 
guideline (Abbott, Dremsa, Stewart, Mark, & Swift, 2006). 
Diffusion of 
innovations  
(Rogers, 1995)  
Hydration and nosocomial pneumonia; killing two birds with one stone 
(a toothbrush) (Farrell & Petrik, 2009). 
 
 
Diffusion of 
innovations  
(Rogers, 1995)  
Implementing systems thinking for infection prevention; the cessation 
of repeated scabies outbreaks in a respiratory ward (Chuang et al., 
2015). 
 
(von Bertalanffy, 
1969) 
Patient safety and healthcare-associated infections (Cole, 2011) 
 
 
Model of safety 
(Sammer et al., 
2010) 
Infection control; a psychological approach to changing practice 
(Elliott, 2009). 
Biopsychosocial 
approach  
(Elliott, 2009) 
Behavioural interventions to improve infection control practices 
(Kretzer & Larson, 1998). 
Multiple models:  
Health belief model 
(Janz & Becker, 
1984); 
Theory of reasoned 
action  
(Fishbein & 
Middlestadt,1987); 
Social cognitive 
theory  
(Banduar, 1986)  
Conceptual model for reducing infections and antimicrobial resistance 
in skilled nursing facilities; focusing on residents with indwelling 
devices (Mody et al., 2011). 
PRECEDE – Health 
education model 
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Research/publication, author, year Theory/model  
and key reference 
Infection control in the acute care setting; time for a change of 
perspectives (Nicol, Watkins, & Plant, 2007). 
Theory of planned 
behaviour  
(Schifter & Ajzen, 
1985); 
Health belief model 
(Janz & Becker, 
1984)  
The power of vivid experience in hand hygiene compliance (Nicol, 
Watkins, Donovan, Wynadan, & Cadwallader, 2009). 
Theory of planned 
behaviour  
(Schifter & Ajzen, 
1985) 
 
Knowledge systems, healthcare teams and clinical practice; a study of 
successful change (Olson, Tooman, & Alvarado, 2010). 
Soft knowledge 
system 
(Engle, 1997)  
Knowledge sharing and organizational learning in the context of 
hospital infection prevention (Rangarachi, 2010). 
Positive deviance 
systems 
(Sternin, 2003)  
For the good of many; an infection control perspective on ethics 
(Zimmerman, 2001). 
Ethical decision-
making framework 
(Soskolne, 1991)  
Accommodating patients with a history of colonization or infection 
with a multi resistant organism; a case study investigation 
(Zimmerman, Rowe, & Wallis, 2004). 
Practice 
development model  
(McCormack & 
Garbett, 2003) 
 
Note. Partly adapted from Zimmerman (2012) and Mitchell & Gardner (2013) and expanded 
with findings from the literature review. 
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Table 2.2 – Systems thinking theories and their application in health studies. 
 
Purpose and description of the theory in health studies Theory and  
key reference 
A theory in mathematics and geometry to study how small changes in 
parameters of a non-linear system can lead to sudden and large 
changes in the behaviour of a system. 
Catastrophe theory 
(Poston & Stewart, 
2014) 
Historically used as a synonym for systems theory, it is a field of study 
of the communication and control of regulatory feedback in both 
living and non-living (e.g., organizations, machines) systems. 
Cybernetics  
(Ashby, 1961) 
A field of study in mathematics with applications in a number of 
disciplines, to explain a dynamic system that is highly sensitive to the 
initial conditions so that small changes in initial conditions produce 
wildly different results. There are fixed rules about changing 
relationships, and changes are not random. 
Chaos theory 
(Strogatz, 2014; von 
Bertalanffy, 1969) 
Less a theory than a way of finding a general theory to explain 
systems in all fields of science. It is not intended to be a single theory 
of systems, but more a systematic inquiry into different domains of 
philosophy, science, and technology. 
General systems 
theory  
(von Bertalanffy, 
1969) 
Organizations facilitate learning amongst their members and 
continuously transform themselves. Systems thinking approaches are 
the conceptual basis for understanding the organization in its 
environment; they provide a basis for other key characteristics: a 
process of learning (personal mastery), the building of mental models, 
and the development of a shared vision and team learning. 
Learning 
organizations theory 
(Senge, 2006) 
Theories used in economics, social sciences, and physics, referring to 
explanations of why processes can have similar starting points yet lead 
to different outcomes even if they follow the same rules, and why 
outcomes are sensitive not only to initial conditions but also to 
bifurcations and choices made along the way. 
Path dependency 
theories  
(Arthur, 1994) 
Theory inspired by evolutionary biology (Eldredge & Gould, 1985; 
Eldredge & Gould, 1972) to explain long periods of stasis interrupted 
by rapid and radical change, particularly as applied to the evolution of 
policy change or conflict. 
Punctuated 
equilibrium (in 
social theory) 
(Baumgartner & 
Jones, 2010) 
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Purpose and description of the theory in health studies Theory and  
key reference 
Complex adaptive systems thinking is an approach that challenges  
simple cause and effect assumptions and sees healthcare  
and other systems as a dynamic process—one where the interactions  
and relationships of different components simultaneously affect and  
are shaped by the system. 
Complexity/complex 
adaptive system, 
1980s  
(Santa Fe Institute, 
1980) 
(Glann-Mann, 
1995/96) 
 
Note. Partly adapted from Peters (2014) and extended to include additional studies reviewed. 
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Table 2.3 – Principles of the general systems theory. 
Principles Interpretation 
Holism The whole is greater than the sum of its parts. 
Boundaries Systems regulate what happens between them 
and their environment. 
Hierarchy All parts must obey the rules of the whole to 
which they belong. 
Mutuality Interdependency prevents the knowledge 
about the cause/s of events. 
Equilibrium Systems tend to seek a steady state between 
their components. 
Equifinality There is more than one way to get from one 
point to another point. 
Entropy Systems tend to fall into disrepair unless 
maintained. 
  
Note. Source: Drack (2008). 
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Table 2.4 – Characteristics and properties of a Complex Adaptive System (CAS).  
Properties of CAS Description 
Main properties 
Connectivity/many 
interacting parts 
The relationship between agents is critical to the system’s 
survival. 
Emergence/emergent 
behaviour 
Patterns emerging because of agents’ interaction ultimately 
inform and change the behaviours of the agents and the system.  
Co-evolution/adaptation Systems and their environment evolve, adapt, and change 
continuously because of the interactions amongst agents and 
between agents and their environments.  
Iteration/nonlinearities Small changes in a system can lead to larger changes. 
Self-organizing 
/decentralization 
A CAS does not have a hierarchy of command; it reorganizes to 
find the best fit with the environment. 
Additional properties 
Nested systems  Systems are embedded within other systems. Therefore, the 
evolution of one influences others. 
Simple rules A CAS is governed by simple rules and is not complicated. 
Specialization, 
modularity/cooperation 
Differentiation as a result of interactions will result in fast, 
efficient, and encapsulated knowledge gains. Cooperating 
increases the chance of accomplishment. 
Sub-optimal A CAS does not have to be perfect. 
Mandatory 
variety/dynamic change 
The greater the variety, the stronger the system will be, allowing 
new possibilities and co-evolution. 
 
Note. From the Health Foundation, UK (2010); Edgeware, Zimmermann et al. (1998); Plesk & 
Greenhalgh (2001); www.trojanmice.com/articles/complexadaptivesystems.html 
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Figure 2.1 – Approximation of current practices related to control and management of 
Clostridium difficile infections in healthcare settings. 
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Figure 2.2 – Epidemiological triad of a disease and factors that may be associated with 
the increased risk of human diseases, adapted and modified from Gordis (2000). 
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Figure 2.3 – A representation of the components of a complex adaptive system, modified based 
on The Health Foundation (2010) report and Zimmerman et al. (1998).  
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Figure 2.4 – The certainty-agreement diagram: Edge of chaos zone where there is insufficient 
agreement and uncertainty to choose the next step, but not so much that the system is thrown into 
chaos, adapted and modified from Plsek & Greenhalgh (2001), based on Stacey (1996). 
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Figure 2.5 – The conceptual framework for epidemiological evaluation of CDI cases in the 
Niagara Region.  
 
 
 
 
 
 
  
Niagara Health Region Clostridium difficile infection cases, 
Sept. 2011 – Dec. 2013
Context
Epidemiological lens Host Environment Agent
Complex 
Adaptive 
System (CAS) 
lens
Infection Prevention
& Control
Surveillance
Case confirmation
Administration data
Temporal data
Spatial data
Public Health laboratories
Strain testing
Patterns / risk factors
Population level 
exploration and 
evaluation
Informing 
health equity policies 
and quality 
improvement 
practices
Improving quality of Clostridium difficile
infection prevention control
FeedbackFeedback
Improving Population Health
 82 
Chapter Three – The Epidemiology of Community-Acquired Clostridium difficile  
Infections (CA-CDI): A Scoping Review 
 
Maryam Salaripour, MSc, MPH, PhD ©;1 Jennie Johnstone, MD, PhD, FRCPC;2,3,5 Michael 
Gardam, MSc, MD, CM, MSc, FRCPC1,4,5 
 
1Department of Health Policy and Management, York University, Toronto, ON 
 
2Public Health Ontario, Toronto, ON 
 
3St. Joseph Health Center, Toronto, ON 
 
4University Health Network, Toronto, ON 
 
5Department of Medicine, University of Toronto, Toronto, ON 
 
Corresponding Author:  
Maryam Salaripour, MSC, MPH, PhD©  
School of Health Policy and Management, York University  
 
 
Alternate Correspondence to:  
Dr. Michael Gardam; MSc, MD, CM, MSc, FRCPC 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 83 
Abstract 
Objective: The purpose of this scoping study is to review the literature for existing evidence on 
risk factors for community-acquired Clostridium difficile infections.  
Methods: Recommended protocols published by the Joanna Briggs Institute (JBI) Reviewers’ 
Manual 2015, Methodology for JBI Scoping Reviews were followed. Three life sciences 
databases were searched for studies on the epidemiological aspects of CA-CD: Cumulative Index 
to Nursing and Allied Health Literature (CINAHL), Nursing and Allied Health Source 
(ProQuest), and MEDLINE. After applying the inclusion and exclusion criteria and full article 
reviews, 22 peer reviewed articles were examined for the study.  
Results: Compared to HA-CDI cases, CA-CDI is seen more often in younger, female 
populations. No seasonal patterns were consistently reported, and one spatial study identified that 
proximity to animal farms, animal services, and nursing homes was associated with a higher 
incidence of CA-CDI in the community. Although exposure to antimicrobials and use of PPI 
were associated CA-CDI, the associations were not as strong as those seen in HA-CDI studies. 
Conclusion: CA-CDI was seen more often in younger, female populations, but no significant 
temporal or spatial patterns were identified in the reviewed studies. Exposure to antimicrobials 
was still the foremost amongst all other medications, but not as significant as that observed in 
HA-CDI cases.  More epidemiological studies are required to inform the discourse of the 
community drivers of CA-CDI.  
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Background  
Clostridium difficile, a gram-positive, spore-forming anaerobic bacillus, is one of the 
most common enteropathogens (Lucado, 2012). While neonates can be asymptomatic carriers of 
this organism, C. difficile can cause a variety of complications in susceptible hosts, especially the 
elderly, ranging from self-limiting, mild diarrhea to severe diarrhea, with or without 
pseudomembrane formation, toxic megacolon, perforation, and peritonitis (Barbut & Petit, 2001; 
Kelly & Lamont, 1998; Poxton, 2013). Clostridium difficile infections (CDI) have a significant 
financial impact on healthcare systems across the world, due to the worsening of health 
outcomes and increased length of hospitalization (Gupta & Khanna, 2014; Kuijper, Coignard, & 
Tüll, 2006; Kelly & Lamont, 2008; Lemaire et al., 2015).   
 Historically, CDIs have been closely associated with exposure to healthcare settings. In 
recent years, quality improvement initiatives, such as rigorous infection control practices and 
antimicrobial stewardship programs, have resulted in an overall decline in HA-CDI infections 
(Furuya-Kanamori et al., 2016). Despite these efforts, the incidence of CA-CDI, including  
community cases infected with invasive strains previously associated with hospital settings, is 
increasing (Khanna et al., 2012; Kotila, Mentula, Ollgren, Virolainen-Julkunen, & Lyytikäinen, 
2016) and approximately one case out of four requires hospitalization (Kuntz, Chrischilles, 
Pendergast, Herwaldt, & Polgreen, 2011). For example, in Finland, the rate of CA-CDI increased 
from 30.8/100,000 to 37.5 /100,000 population between 2008 and 2013. Similarly, in the US, the 
CA-CDI rate greatly increased from 1/100,000 to 22 /100,000 population between 1994 and 
2004 (Kotila, Mentula, Ollgren, Virolainen-Julkunen, & Lyytikäinen, 2016; Dial, Delaney, 
Barkun, & Suissa, 2005). In Canada, almost 38,000 cases of CDI were reported nationally in 
2012, of which nearly 10,000 were community-acquired (Levy et al., 2015).  
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It is thought that when CA-CDI cases are admitted to hospitals, they can increase the risk 
of HA-CDI or hospital outbreaks of HA-CDI through increased bioburden and environmental 
contamination ((Kuntz, Chrischilles, Pendergast, Herwaldt, & Polgreen, 2011). Furthermore,  a 
study in Saskatchewan, Canada, reported that up to one third of HA-CDI cases showed symptom 
onset in the community (McLeod, 2017). Many years of research and surveillance have 
established that advanced age, exposure to antimicrobials, and the use of proton pump inhibitors 
are risk factors associated with HA-CDI (Kotila, Mentula, Ollgren, Virolainen-Julkunen, & 
Lyytikäinen, 2016; Dubberke et al., 2006; Henrich, Krakower, Bitton, & Yokoe, 2009). 
However, far less is known about the epidemiology of CA-CDI. To this end, the objective of this 
scoping review is to evaluate the research to date on epidemiological patterns and the risk profile 
for CA-CDI. The findings will inform the focus of future systematic reviews and primary 
research studies. 
Methods  
 This review followed the recommendations of The Joanna Briggs Institute (JBI) 
Reviewers’ Manual 2015, Methodology for JBI Scoping Reviews (Levac, Colquhoun, & O'Brien, 
2010; The Joanna Briggs Institute, 2015; Peters et al., 2015; Arksey & O'Malley, 2005; 
Colquhoun et al., 2010). Available literature on CA-CDI was searched in three medical and life 
sciences databases, with no date restriction. The three databases—Cumulative Index to Nursing 
and Allied Health (CINAHL), Nursing and Allied Health Source (ProQuest), and MEDLINE—
were searched for studies on the epidemiological aspects of CA-CDI and its incidence, risk 
factors, strain typing, environmental influences, and outcomes. 
Epidemiological features were defined as patient-specific characteristics and temporal 
and spatial patterns. Information on potential associated risk factors was collected for exposure 
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to antimicrobials, history of gastrointestinal (GI) comorbidities including previous GI surgery, 
use of proton pump inhibitors (PPI), and use of laxatives or corticosteroids. Strain-testing 
information was gathered regardless of laboratory testing methods to allow understanding of the 
variations in ribotype prevalence. During the study period, the invasive North American strain 
that was more resistant to fluoroquinolones and standard therapies (Lemaire et al., 2015) was 
referred to as the North American Pulsotype 1 (NAP1), if pulsed-field gel electrophoresis was 
used. However, if typing methods were used, it was referred to as Polymerase Chain Reaction 
ribotype 027 (or PCR ribotype 027). 
The three databases were searched from the date of database inception to June 7, 2017 
(search date), using the following search terms: 1-“community-acquired” OR “community-
associated” AND 2-“Clostridium difficile” OR “C. difficile”. Databases were searched for full 
text studies in the English language. We justified excluding non-English language articles, as no 
evidence exists of systematic bias caused by language restrictions (Morrison et al., 2012). A 
uniform, pre-piloted data collection tool was used to extract information from those studies, 
meeting the criteria for final review. 
Inclusion and exclusion criteria. 
The inclusion criteria for this scoping review comprised original studies on both genders 
of hospitalized and non-hospitalized humans with CA-CDIs. All definitions of CA-CDI as 
indicated in the studies were included.  
The exclusion criteria comprised of studies on HA-CDI only, C. difficile colonization, 
precision of C. difficile laboratory testing methods, efficacy of therapeutic interventions, and 
pediatrics studies, as children under two years of age can be asymptomatic carriers. Non-peer-
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reviewed publications, conference presentations, and opinion papers without original research 
findings were excluded. 
Bias reducing strategy. 
The objectives, inclusion criteria, and methods for this scoping review were specified and 
documented in a protocol a priori (The Joanna Briggs Institute, 2015). Due to the broad 
objective of scoping reviews, an assessment of risk of bias was not conducted (The Joanna 
Briggs Institute, 2015). Similarly, methodological quality assessment of the included studies was 
not required, due to the descriptive nature of scoping reviews in mapping out the body of 
literature under review.   
Results  
Three database searches identified a total of 146 articles. Nine studies were added 
through citation retrieval of a narrative review and a meta-analysis, bringing the total to 155 
articles. All citations were first appraised applying the eligibility criteria during title and abstract 
review. After screening by abstract and title, 66 articles met the criteria for full-text review. Full 
texts of the citations were accessed based on the inclusion and exclusion criteria; 44 articles did 
not meet the requirements. In the end, 22 peer-reviewed articles were compiled for the scoping 
review.  
Results for one of the studies were divided into two subgroups: Veterans’ Affairs and 
Durham County (Kutty et al., 2010). One study had a subgroup of children under two years of 
age (SØes et al., 2014); this subgroup was not included in the data extraction and interpretation. 
Figure 3.1 depicts the process of the literature search and selection.  
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Incidence of CA-CDI. 
Seven of the 22 studies included the incidence of CA-CDI, three used community-based 
data, one used hospital-based data, and three used a mix of community and hospitalized CA-CDI 
cases. In their study, Dial et al. (2008) noticed an increasing trend in the rate of CA-CDI that 
required hospitalization. They reported the rate of CA-CDI increased from 20/100,000 person 
years in 1998 to almost 60/100,000 person years in 2004 in Quebec, Canada (Dial, Kezouh, 
Dascal, Barkun, & Suissa, 2008).  
In one study, the active surveillance of a mixed urban and rural population in the US 
found the incidence of outpatient cases of CA-CDI was 51.9/100,000 population for 10 
geographic areas (Lessa et al., 2017), and a matched nested case-control study in Scotland found 
a rate of 20.3/100,000 population (Marwick et al., 2013). A study of outpatient research 
databases in the UK found a rate of 22/100,000 person years (Dial, Delaney, Barkun, & Suissa, 
2005), and an unmatched case-control study of Veterans’ Affairs hospital patients in North 
Carolina found an incidence for CA-CDI of 21/100,000 population (in the VA catchment area) 
and 46/100,000 population (in the Durham region) (Kutty et al., 2010). Two prospective studies 
of mixed hospitalized and community cases in Sweden and the US reported rates of 25/100,000 
and 11.6/100,000 population respectively (Norén et al., 2004; Kuntz, Chrischilles, Pendergast, 
Herwaldt, & Polgreen, 2011) and a prospective study from the UK that included cases from 
hospitals, long-term care, and community reported a rate of 7.3/100,000 patient years for CA-
CDI.  
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Epidemiology of CA-CDI. 
Demographics. 
Overall, 15 studies reported on age. In general, CA-CDI cases had a lower median age 
than those reported for HA-CDI. The median age varied quite widely, from 50 to 81 years (SØes 
et al., 2014; Miyajima et al., 2011), but only six of the 22 studies reported a median age higher 
than 65 years. Of these, three were conducted solely in elderly populations (those older than 65 
years), one was in the urban arm of the study, and one was in a small population (n=42) (Naggie 
et al., 2010). Nine of the 22 studies reported a median age lower than 65 years, and the semi-
rural arm of a study in the UK reported a median age of 45 years.  
The proportion of females with CA-CDI was higher than that of males, ranging from 
11% to 75% (Kutty et al., 2010; Lessa et al., 2017).  Fifteen studies reported a higher incidence 
of CA-CDI in the female population as compared to male; this ranged from 75% in Denmark to 
56% in the US and 63% in Quebec, Canada (Kutty et al., 2010; Naggie et al., 2010). Only one 
study reported a lower proportion of females, and it was conducted in a population of veterans in 
the US (Kutty et al., 2010). One report of active surveillance through the Emerging Infectious 
Diseases program by the CDC in 10 counties in the US found the CA-CDI incidence was 
61/100,000 persons in the female population compared to 42.5/100,000 persons in the male 
population for the year 2011 (Lessa et al., 2017). More details of demographics are listed in 
Table 3.1.  
Temporal and spatial patterns. 
Four studies looked into the seasonal temporality of CA-CDI incidences; of these, two 
found no seasonal pattern (Fawley et al., 2016; Anderson et al., 2017). One study in Sweden 
reported an increase in March (Norén et al., 2004) and another reported a peak in winter months 
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(December, January, and March), where samples were positive for both CDI and norovirus 
(Taori, Wroe, Hardie, Gibb, & Poxton, 2014).  
Six studies considered geographical patterns, and their findings are mixed. One of the 
studies, a population-based retrospective cohort study in the US, found that proximity to 
livestock farms (p=0.01), farming raw material services (p=0.02), and nursing homes (p=0.04) 
was associated with increased incidence of CA-CDI (Anderson et al., 2017). Although one study 
found a concentration of CA-CDI in a Swedish rural county (Dial, Delaney, Barkun, & Suissa, 
2005), another study found no association between CA-CDI and residence in rural areas (p= 
0.789) (Norén et al., 2004; Taori, Wroe, Hardie, Gibb, & Poxton, 2014). One study found that 
one of five CA-CDI cases was associated with community-based residential care (Fawley et al., 
2016), but another did not find geographical clustering of CA-CDI cases amongst those who 
lived in their own homes or in a nursing home care facility (Miyajima et al., 2011). A study in 
Scotland noticed an increase associated with postal codes indicating more affluent areas, where 
care-home residences were located (Marwick et al., 2013).  
Molecular diversity. 
Eight of the 22 studies reported strain testing of the CA-CDI isolates. A UK study of CA-
CDI (n=42) found that PCR-ribotype 078 (n=8; 19.0%) was the most common epidemiological 
type, followed by PCR-ribotype 014/020 (n=7; 16.7%) (Taori, Wroe, Hardie, Gibb, & Poxton, 
2014). Another study conducted on CA-CDI cases in Monroe County in the US reported 12 
(31.6%) and two (5.3%) NAP1 and NAP1-related cases of CA-CDI (Dumyati et al., 2012). This 
study also reported 14 (36.8%) unnamed-strain cases. A recent UK study found that in 
comparison to HA-CDI, CA-CDI cases were more likely to be due to ribotype 002 (p0.0001), 
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020 (p=0.009), and RT056 (p 0.0001) (Fawley et al., 2016). In general, novel non-typical 
strains were mainly detected in strain testing of CA-CDI. 
In a prospective study from the UK, ribotypes 078 and 027 were the fourth and eighth 
most frequently identified ribotypes for CA-CDI cases respectively, and these ribotypes were 
more often noted in cases with healthcare exposure or institutional contact than in cases living at 
home (10.4% vs. 2.9% and 12.8% vs. 4.5% respectively, both p0.001) (Fawley et al., 2016). 
One study from Denmark reported 40 different PCR ribotypes in CA-CDI beef consumers, 
including types 078, 001, 012, and a series of minor ribotypes (SØes et al., 2014). A US study 
reported the top three strains in CA-CDI as NAP1 (18.8%), NAP4 (11.4%), and NAP11 (10.7%) 
(Lessa et al., 2017). In a UK study, four non-toxigenic strains (PCR ribotypes 009, 026 (n=2), 
and 039) and two toxigenic strains (PCR ribotypes 003 and 039) were identified out of seven 
samples acquired from the cases. One of the cases presenting with the toxigenic isolate had been 
working as a volunteer in a hospital where the strain was prevalent (Miyajima et al., 2011).  
Risk factors. 
 Ten of the 22 studies reported antimicrobial exposure for CA-CDI as a risk factor. The 
analysis showed a strong association between CA-CDI acquisition and antimicrobial exposure 
ranging from (OR, 3.1; 95% CI, 2.7-3.6) to (OR, 19.6; 95% CI, 7.6-51.0) (Dial, Delaney, 
Barkun, & Suissa, 2005; Kutty et al., 2010). The association was larger in studies conducted in 
elderly populations (aRR: 10.6; 95%CI, 8.9-12) (Dial, Kezouh, Dascal, Barkun, & Suissa, 2008). 
Only one of the studies did not find a significant association between the antimicrobial exposure 
and CA-CDI occurrence (OR, 1.083; 95%CI, 0.99-1.174) (Furuya-Kanamori et al., 2016).   
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Nine studies evaluated PPI use as a risk for CA-CDI. The reported association between 
PPI use and CA-CDI acquisition ranged from (aOR, 0.4; 95%CI, 0.2-1.23) to (aOR, 3.5; 95%CI, 
2.3-5.2) (Naggie et al., 2010; Dial, Delaney, Schneider, & Suissa, 2006).  
Association of CA-CDI with the use of corticosteroids was evaluated in three studies. 
One study reported no significant association (OR, 1.043; 95% CI, 0.952-1.133; p=0.34) 
(Furuya-Kanamori et al., 2016), but two reported association of (OR, 4.4; 95%CI, 0.9-20.5) and 
(OR, 2.3; 95% CI. 0.41-13) (SØes et al., 2014; Kutty et al., 2010). Three studies evaluated the 
association with laxatives; two found no significant association (OR: 1.056, 95%CI, 0.963-1.151, 
p=0.235) and (OR: 0.91; 95%CI, 0.2-4.1) (Furuya-Kanamori et al., 2016; SØes et al., 2014) but 
one reported an association of (OR: 6.6; 95%CI, 1.2-37.8) (Kutty et al., 2010).  
Seven studies assessed CA-CDI association with gastrointestinal disorders. Four studies 
showed associations for inflammatory bowel diseases ranging from (aOR, 46.1; 95% CI, 14.5-
146.7) to (OR, 3.6; 95%CI, 2.6-5.1) (Dial, Delaney, Barkun, & Suissa, 2005; Dial, Delaney, 
Schneider, & Suissa, 2006), but two did not report on an association with gastrointestinal 
disorders (Naggie et al., 2010; Taori, Wroe, Hardie, Gibb, & Poxton, 2014) (see Table 3.1). One 
study found that gastroesophageal reflux disease (OR 8.7; 95% CI, 1.9-39.1) was strongly 
associated with the occurrence of CA-CDI (Kutty et al., 2010).  
One study that evaluated the age-adjusted Charlson co-morbidity index (OR:1.12, 
95%CI, 0.99-1.04) did not find a significant difference between underlying comorbidities of CA-
CDI and HA-CDI (Taori, Wroe, Hardie, Gibb, & Poxton, 2014). More information about risk 
factors is shown in Table 3.1. 
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Outcome. 
Mortality and morbidity. 
Overall, mortality and post-infection morbidities were not well studied. Five studies 
comprising hospitalized CA-CDI cases or a mix of hospital and community-based CA-CDI cases 
reported mortality in the 30 days after CA-CDI diagnosis (see Table 3.1). An adjusted US 
national estimate of deaths associated with CDI reported the death rate associated with CA-CI 
was 0.7/100,000 persons for 2011(95%CI, 0.4-0.9), which translates to an estimated 2000 deaths 
(95% CI,1200-2800) (Lessa et al., 2017). A population-based, retrospective, nested case-control 
study of CA-CDI found 77 of 304 cases of CA-CDI were hospitalized as a result of their 
infection (Kuntz et al., 2007). A case control study of toxin-positive patients revealed that 13% 
of the cases (vs. 9% of controls) sought hospitalization as a result of their diarrhea, and 26 % of 
cases (vs. 14 % of controls) sought out short-term healthcare services (Wilcox, Mooney, Bendall, 
Settle, & Fawley, 2008). In another study, an active surveillance based on laboratory specimen 
test results discovered that 45% of the CA-CDI cases required hospitalization (Naggie et al., 
2010). A summary of reported results extracted for this review is shown in Table 3.1. 
Discussion   
Twenty-two studies were reviewed to summarize the research on CA-CDI 
epidemiological features and risk factors. CA-CDI were seen more often in younger, female 
populations than were HA-CDI cases and the control arm of the community-based studies. 
Limited studies reported an increase in winter months for CA-CDI, and one spatial 
epidemiological study stated that proximity to animal farms, animal services, and nursing homes 
was associated with a higher incidence of CA-CDI. Although exposure to antimicrobials and use 
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of PPI were associated with CA-CDI, the associations were not as strong as those seen in HA-
CDI studies. 
Although CA-CDI was found to cause infection in all age groups, in articles included in 
this scoping review, it was often reported in a younger population than HA-CDI; this could be 
explained by the comorbidities that bring older patients to hospitals and increase their risk of 
HA-CDI. After an eight-year study, Dial et al. (2008) reported almost a three-fold increase of 
CA-CDI amongst the elderly population in Quebec, Canada.  
The gender inclination of CA-CDI in communities has been attributed to healthcare 
seeking behaviours in the female population that subsequently result in more testing and 
diagnosis of CDI, or to females’ exposure to the C. difficile spores as a result of environmental 
contamination in healthcare settings (Fellmeth, Yarlagadda, & Lyer, 2010). Increased contact 
with fecal matter as a result of diaper changing practices has also been hypothesised as a 
potential contributing factor (Gupta & Khanna, 2014). Establishing gender-specific risk factors 
may help reduce the community spread through interventions such as community awareness 
educational programs.  
Apart from the regional predominance of certain ribotypes in CA-CDI clusters, strain 
testing of CA-CDI and HA-CDI cohorts found comparable ribotype diversity and relative strain 
prevalence (Fawley et al., 2016). The ribotypes for CA-CDI cases with healthcare exposure tend 
to be more diverse (and include a higher proportion of the hypervirulent strain) even as they age, 
in contrast to what is seen in HA-CDI patients (Fawley et al., 2016). Unlike other community-
acquired infections (e.g., community–acquired methicillin-resistant Staphylococcus aureus) that 
are genetically divergent from their healthcare-associated counterparts (David & Daum, 2010; 
Huang et al., 2006), similarities in genetic relatedness and strain distribution of CA-CDI and 
 95 
HA-CDI have been demonstrated in multiple studies this could be interpreted as a bi-directional 
transmission pathway between communities and hospitals (Fawley et al., 2016; Miyajima et al., 
2011; Dumyati et al., 2012) .  
 Temporal studies failed to establish an effect of seasonality. Exposure to antimicrobials 
was cited as the leading risk factor for CA-CDI, and increase of CA-CDI was not consistently 
associated with increased use of antimicrobials during the influenza season (Taori, Wroe, Hardie, 
Gibb, & Poxton, 2014; Center for Disease Control, 2008; Lowe, Mamdani, Kopp, Low, & 
Juurlink, 2006). Records from community settings in the UK indicated that exposure to 
antimicrobials may not be a strong risk factor, but of those who used antimicrobials, cases using 
fluoroquinolones were at greater risk of CA-CDI (Delaney, Dial, Barkun, & Suissa, 2007). 
Notwithstanding the reports of association in several studies, the role of PPI as an 
independent risk factor was not consistently established. However, the strong association 
between the presence of GERD and incidents of CA-CDI can be interpreted as an increased risk 
in undocumented use of PPI by over-the-counter community consumers.   
Reported attributable mortality to CA-CDI has been lower (1.3%-4%) than the mortality 
attributable to HA-CDI (16.3%) (Lessa et al., 2017; Norén et al., 2004; Naggie et al., 2010; 
Gravel et al., 2009). However, a risk-adjusted study in senior Americans identified the likelihood 
of a three-fold increase in mortality in an elderly compared to a younger population when 
infected with CA-CDI (Collins et al., 2014).  
Implications for Research and Practice 
This review of CA-CDI within a traditional epidemiological triad (time, place, and 
person) evaluated temporal patterns, spatial distribution, and patient characteristics and 
experiences. Comprehensive epidemiological studies are required to evaluate and translate the 
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clinical, demographic, temporal, and spatial data into knowledge that may inform the discourse 
of population-level risks of CA-CDI. Modifying the traditional surveillance tools to include 
patients’ experiences in hospitals and communities may be a first step in hypothesising large-
scale studies.   
Limitations 
Although the JBI guidelines for a scoping review were followed, lack of another reviewer 
created a risk of screening bias and data extraction (charting) bias. To minimize potential 
partialities, a standard data extraction protocol was developed and used.  
Conclusion  
The number of CA-CDI cases with unique demographic patterns is gradually growing in 
communities with cases that require hospitalization. Studies reviewed indicated antimicrobial 
exposure could be one of the causes, but old age and use of PPI or other medications were not as 
strongly associated with CA-CDI. While this review provides insight into research to date on 
CA-CDI, the diversity of findings related to CA-CDI attributing variables suggests that 
identifying the unique risk factors and understanding the complex epidemiology and the 
community transmission pathways of CA-CDI calls for further research-based evidence. Until 
customized research and surveillance programs identify the community risk factors, 
epidemiological analysis of existing surveillance data can inform the immediate emphases of 
preventative measures and future research direction. 
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Tables 
Table 3.1 – Epidemiology and risk factor data extracted from studies included in the scoping review. 
Study information Demographics Risk Factors Temporal Spatial 
Geno-
typing Outcome 
 
 
 
 
Author/  
origin/ 
year 
Study 
design 
Me-
dian 
age 
Male 
n (%); 
Female n 
(%) Age 65 
Antimicro-
bial use up 
to 8 weeks 
prior to CDI 
GI co-
morbidi-
ties, 
including 
surgery 
Use of 
PPI 
Cortico- 
steroids 
Laxa-
tives 
Pre-
vious 
sur-
gery 
Pre-
vious 
CDI 
Seasonal 
patterns 
Geo 
pattern 
urban/ 
rural 
index Strains 
Incidence 
per 
100,000 
pt years 
Mortality 
(attribut-
able death 
in 30 d) 
or 
morbidity 
Taori et al.,  
UK, 2014, 
 
 
Prospective 
laboratory-
confirmed 
from 
hospital, 
LTC, & 
GP 
 
N=335 
CA=42 
(12.5%) 
 
69 12=m 
30=f 
26 (42%) 21(50%) 
 
p=0.005 
OR: 8.04 
CI,1.85-
35.02  
17 (42%) 
 
p=0.365 
OR: 1.55 
CI, 0.66-
4.3 
16 
(37%) 
 
2 
(4.8%) 
nr* nr nr Winter 
(Dec-Mar) 
(21/36) 
36 non-
rural/ 
5 rural 
 
p=0789 
Ribotype 
078=8, 
non-078 
=31 
 
p=0.006 
7.3/ 
100,000 
patient 
years in 
over-18 
pop’n, 
6.4 in 
under-18 
pop’n 
 
4 deaths 
(n=42) 
Immuno-
suppressed,  
 
p=0.035 
Dumyati et 
al., US,  
2012 
 
6-month 
surveillance 
of some  
lab-positive 
samples 
 
Active 
prospective 
population 
based 
surveillance 
20% 
hospitalized 
 
N=366 
CA= 67 
(18%) 
 
 
53 41 
(61%)=f 
nr 32 (76%) 
 
OR N/A 
nr 11 
(26%) 
nr nr nr nr nr nr Similar 
distri-
bution 
of 
various 
strains 
12 
(36%) 
NAP1 
N/A due 
to lack of 
complete 
lab 
catchment 
of 
samples 
nr 
Naggie et al., 
US, 2010 
 
Active 
prospective 
lab 
surveillance 
mixed 
settings, 
hospital, & 
LTC 
58 Majority 
male: VA 
populatio
n  
21 (68%) 15 (48%) 
<.001 
 
nr 12 
(39%) 
<.001 
nr nr 3 
(10%) 
nr nr nr nr nr 1(3.2%) 
 
p=0.06 
45% 
required 
hospital-
ization 
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Study information Demographics Risk Factors Temporal Spatial 
Geno-
typing Outcome 
 
 
 
 
 
Author/  
origin/ 
year 
Study 
design 
Me-
dian 
age 
Male 
n (%); 
Female n 
(%) Age 65 
Antimicro-
bial use up 
to 8 weeks 
prior to CDI 
GI co-
morbidi-
ties, 
including 
surgery 
Use of 
PPI 
Cortico- 
steroids 
Laxa-
tives 
Pre-
vious 
sur-
gery 
Pre-
vious 
CDI 
Seasonal 
patterns 
Geo 
pattern 
urban/ 
rural 
index Strains 
Incidence 
per 
100,000 
pt years 
Mortality 
(attribut-
able death 
in 30 d) 
or 
morbidity 
Kutty et al., 
USA, 2010 
 
 
 
 
Case 
control of  
hospital 
cases 
62 
(VA) 
 
 
 
 
 
 
61 
(Dur-
ham) 
4 
(11%)=f 
 
 
 
 
 
 
 
57 
(58%)=f 
nr 24 (66%) 
cases  
10 (9%) 
controls 
OR:19.6 
CI 7.6-51.0 
p<0.05 
 
32 (44%) 
cases 
8 (17%) 
controls 
OR:3.9 CI, 
1.6-9.5) 
p<0.05 
 
 
 
 
 
 
 
 
GERD 
20 (27%) 
cases 
2 (4%) 
controls 
OR: 8.7  
CI,1.9-
39.1 
p<.05 
13 
(36%) 
cases 
26 
(24%) 
controls 
OR:1.7 
CI 0.7-
4. 
 
9(12%) 
Cases 
2(4) 
control
s 
OR:3.2 
CI,0.7-
15.7 
4 (11%) 
cases 
3 (3%) 
controls
OR4.4 
CI 0.9-
20.5 
 
 
 
 
n/a 
4 
(11%) 
cases 
2 (2%) 
controls 
OR 6.6 
CI, 
1.2-
37.8 
nr nr nr nr nr 21/100000 
 
46/100000 
 
nr 
Naggie et al., 
USA, 2011 
 
66 cases 
114 
controls; 
5 hospital 
cases 
reported 
through lab  
64  56% =f 
 
49% cases 
47% 
controls 
 
p=.74 
aOR.99 
CI, 0.96-
1.01 
61% cases 
25% 
controls 
 
p<.001 
aOR:6.07 
CI, 2.62-14 
38% cases 
45% 
controls 
 
p=.37 
aOR:1.00
8 CI, 
0.23-5.12 
33% 
cases 
39% 
controls 
 
p=.48 
aOR:0.
49 
CI, 0.2-
1.23 
20% 
cases 
13% 
controls 
 
p=.24 
nr 17% 
cases 
8% 
con-
trols 
 
p=.07 
aOR: 
6.8 
CI, 
1.74-
26.6 
nr nr nr nr 162 
cases= 
15% of all 
CDI 
 
nr 
Fawley et al.,  
UK, 2016 
Prospective 
laboratory 
surveillance 
of samples 
from 
outside of 
hospitals 
 
nr More 
female 
467/701 
25%  
519/693 
58% used 
39% not 
used  
 
p<0.0001 
nr nr nr nr nr nr Not seen 
in two 
years of 
study 
1/5 
assoc. 
with 
commu- 
nity-
based 
residen-
tial care 
125/525 
002, 
020, 
RT056 
078 and 
027 
were 4th 
and 8th 
ribotypes 
in CA-
CDI  
Otherwise 
ranking 
and 
prevalence 
similar in 
two group 
nr 
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Study information Demographics Risk Factors Temporal Spatial 
Geno-
typing Outcome 
 
 
 
Author/  
origin/ 
year 
Study 
design 
Me-
dian 
age 
Male 
n (%); 
Female n 
(%) Age 65 
Antimicro-
bial use up 
to 8 weeks 
prior to CDI 
GI co-
morbidi-
ties, 
including 
surgery 
Use of 
PPI 
Cortico- 
steroids 
Laxa-
tives 
Pre-
vious 
sur-
gery 
Pre-
vious 
CDI 
Seasonal 
patterns 
Geo 
pattern 
urban/ 
rural 
index Strains 
Incidence 
per 
100,000 
pt years 
Mortality 
(attribut-
able death 
in 30 d) 
or 
morbidity 
Delaney et 
al., UK, 2007 
Population-
based case-
control 
from GP 
research  
database 
nr nr nr 37% cases 
used, 13% 
controls 
used  
aOR: 3.7 
CI,3.1-4.4 
Increased 
risk of CA-
CDI 2-3-
fold with 
any Abx.  
use, 6-fold 
if FQ used 
nr nr nr nr nr nr nr nr nr nr nr 
Norén et al.,  
Sweden, 2004 
Prospective 
in hospital 
and in 
community 
 
 
64 nr nr nr nr nr nr nr nr nr March In main 
county 
and 
main 
hospital  
SE17 C 25/100000 
person 
4% 
Dial et al., 
UK, 2005 
Case 1233 
control 
12330 
 
Retrospec-
tive from 
GP 
research 
database 
 
 
71 
(mean) 
65=f 
cases 
58=f 
controls 
aOR1.3; 
CI,1.1-
1.3 
75% cases 
74% 
controls 
 
37% cases 
13% 
controls 
aOR: 3.1  
CI, 2.7-3.6 
IBD:5% 
cases 
1% 
controls 
aOR:3.6 
CI;2.6-5.1 
23% 
cases 
8% 
controls 
aOR: 
2.9 
CI, 2.4-
3.4 
nr nr nr nr nr nr nr 22/100000 
person 
nr 
SØes et al., 
Denmark, 
2014 
Prospective 
matched 
case n=177 
control 
n=242 
lab testing 
of 
community 
patients 
with 
symptoms 
50 75% nr 48% cases  
13% 
controls 
OR: 6.7 
CI, 3.4-13 
 17% 
cases 
22% 
controls 
OR: 
0.68 
CI,0.34
-1.4 
3% 
cases 
1% 
controls 
OR: 2.3 
CI, 
0.41-13 
2% 
cases 
2% 
controls 
OR: 
0.91 
CI,0.2-
4.1 
nr nr nr nr type 078, 
001, 012, 
014/020/
077, 015, 
017, 023, 
027, 029, 
066, 070, 
106/117, 
and 107 
nr nr 
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Study information Demographics Risk Factors Temporal Spatial 
Geno-
typing Outcome 
 
 
 
Author/  
origin/ 
year 
Study 
design 
Me-
dian 
age 
Male 
n (%); 
Female n 
(%) Age 65 
Antimicro-
bial use up 
to 8 weeks 
prior to CDI 
GI co-
morbidi-
ties, 
including 
surgery 
Use of 
PPI 
Cortico- 
steroids 
Laxa-
tives 
Pre-
vious 
sur-
gery 
Pre-
vious 
CDI 
Seasonal 
patterns 
Geo 
pattern 
urban/ 
rural 
index Strains 
Incidence 
per 
100,000 
pt years 
Mortality 
(attribut-
able death 
in 30 d) 
or 
morbidity 
Lessa et al.,  
US, 2015 
 
Active 
surveillance 
of 
population 
and 
laboratory 
results, 
outpatient 
samples   
Na 42.5 
/100000 
=m 
61 
/100000 
=f 
146.2 
/100000 
nr 
 
nr nr nr nr nr nr nr nr 18.8% 
=NAP1  
11.4+N
AP4 
10.7+N
AP11 
 
 
 
 
 
51.9 
/100000 
incidence, 
higher in 
females, 
rate ratio 
1.26; CI, 
1.25-1.27  
 
1.3% in 
30 days 
after dx. 
CA-
CDI=0.7 
CI (0.4-
0.9) HA-
CDI= 8.9 
CI, 5.0-
12.8) 
/100,000 
persons 
 
Anderson et 
al., US, 2017 
 
 
Population-
based 
retrospec-
tive cohort  
in and 
outpatient  
54.5 
mean 
62%=f 47% nr nr nr nr nr nr nr No 
seasonal 
or 
temporal 
linear 
trend 
Proxi-
mity to 
livestock 
farms 
(p=0.01), 
farming, 
raw 
material 
services  
 
(p=0.02), 
nursing 
homes(p
=0.04) 
 
nr nr nr 
Garg et al., 
US, 2013 
Retrospec-
tive CDI 
positive, 
randomly 
chosen 
from 
hospital 
admits 
with ICD 
codes 
53.8 31.4%=m 21.9% 41.8% 
 
p<.05 
nr 43% 
 
p<0.00
01 
nr nr nr nr nr nr nr nr nr 
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Study information Demographics Risk Factors Temporal Spatial 
Geno-
typing Outcome 
 
 
 
Author/  
origin/ 
year 
Study 
design 
Me-
dian 
age 
Male 
n (%); 
Female n 
(%) Age 65 
Antimicro-
bial use up 
to 8 weeks 
prior to CDI 
GI co-
morbidi-
ties, 
including 
surgery 
Use of 
PPI 
Cortico- 
steroids 
Laxa-
tives 
Pre-
vious 
sur-
gery 
Pre-
vious 
CDI 
Seasonal 
patterns 
Geo 
pattern 
urban/ 
rural 
index Strains 
Incidence 
per 
100,000 
pt years 
Mortality 
(attribut-
able death 
in 30 d) 
or 
morbidity 
CDC, 
MMWR,  
US, 2008, 
Surveillance 
summary 
of lab 
reports 
hospital, 
LTC, and 
GP 
 
 
 
 
 
 
80=33% 
m 
161=67% 
f 
33% 68% nr nr nr nr nr nr nr nr 12 were 
tested:  
3 NAP1 
8 
NAP1-
like 
nr nr 
Furuya-
Kanamori et 
al., 
Australia, 
2016 
Cases 
series-  
community 
n/a n/a n/a Not 
significant 
OR 1.083,  
CI,0.990-
1.174 
p=0.067 
nr Not 
sig. 
OR= 
1.052 
CI,0.94
3-1.163 
 
p= 
0.348 
Not sig. 
OR=1.0
43 
CI, 
0.952-
1.133 
 
p=0.348 
Not 
sig. 
OR=1.
056 
CI,0.96
3-
1.151 
 
p=0.23
5 
nr nr nr nr nr nr nr 
Wilcox et al., 
UK, 2008 
Prospective 
surveillance 
of 
community 
-derived 
fecal 
samples 
 
Urban 
=73 
 
 
Semi-
rural 
=45 
44%=m 
56%=f 
nr 52%  
 
p=0.001 
nr 2% 
 
p=1.0 
nr nr nr nr nr nr 60% =U 
13% Sr 
PCR 
ribotype 
001 
urban 
cases 
one 
subtype, 
semi-
rural, 
different 
subtypes  
 
nr Death 
10% CA-
CDI cases 
1% 
controls   
 
p=0.023 
hospital-
ization 
13%; 
short-term 
26% 
Suissa et al., 
UK, 2012 
Retrospec-
tive 
population 
-based  
C-C of GP 
research 
database 
 
NR 
 
 
 
NR NR 50.1% 
 
p<.0001 
nr 26.2% 
 
p<.000
1 
22% 
 
p=0.065 
nr nr nr nr nr nr nr nr 
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Study information Demographics Risk Factors Temporal Spatial 
Geno-
typing Outcome 
 
 
 
Author/  
origin/ 
year 
Study 
design 
Me-
dian 
age 
Male 
n (%); 
Female n 
(%) Age 65 
Antimicro-
bial use up 
to 8 weeks 
prior to CDI 
GI co-
morbidi-
ties, 
including 
surgery 
Use of 
PPI 
Cortico- 
steroids 
Laxa-
tives 
Pre-
vious 
sur-
gery 
Pre-
vious 
CDI 
Seasonal 
patterns 
Geo 
pattern 
urban/ 
rural 
index Strains 
Incidence 
per 
100,000 
pt years 
Mortality 
(attribut-
able death 
in 30 d) 
or 
morbidity 
Lowe et al.,  
Canada, 2006 
Population-
based, 
nested,  
case 
controlled, 
linked 
health 
database 
 
Mean 
78.7 
+/- 
7.2S
D 
59.8 =m All cases 
over 65 
78.1 cases 
77.3 
controls  
used one 
Abx. 
IBD 2.8% 
cases 
1.0 
controls 
In 90 
days, 
prior 
22.0 
cases 
18.3 
controls 
aOR: 
0.9 
CI, 0.8-
1.1 
 
17.4 
 
nr nr nr nr nr nr nr nr 
Dial et al.,  
UK, 2006 
 
 
Case 317 
Control 
3167 
using UK 
clinical 
research 
database 
GPRD 
65 36.6 =m NR 54.9 cases 
12.8 
controls 
aOR: 8.2 
CI, 6.1-11 
IBD 
5.7%cases 
0.2 
controls 
aOR: 
46.1CI, 
14.5-
146.7 
 
 
19.2% 
cases 
5% 
controls 
aOR:3.
5 
CI, 2.3-
5.2 
nr nr nr nr nr nr nr nr nr 
Dial et al.,  
Canada, 2008 
 
 
Matched 
nested 
Case 836 
Control 
8360  
2-database 
data merge, 
hospital 
admits  
 
79.8 
cases 
77.5 
contr
ols 
RR#: 
1.45 
CL, 
1.3-
1.5 
p<0.0
05 
 
66.3%=f 
cases 
59.1% =f 
controls 
RR: 1.3 
CI1.0-1.4 
All cases 
over 65 
47.1 % 
cases 
7.6 
%controls 
aRR: 10.6 
CI,8.9-12.8 
IBD 
4.9%cases 
1.1 
controls 
 
aRR: 4.1 
CI, 2.6-
6.6 
 
aRR: 
1.6 
CI, 
nr nr nr nr nr nr nr nr nr 
Marwick et 
al., Scotland, 
2013 
 
 
Matched 
nested c-c 
of 
databases 
81 72.6%=f All cases 
over 65 
30.1% 
<0.001 
nr 27.6 
p.001 
nr nr nr nr nr More 
risk in 
postal 
codes of 
affluent 
nr 20.3/100,
000 pop’n 
nr 
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Study information Demographics Risk Factors Temporal Spatial 
Geno-
typing Outcome 
 
 
 
Author/  
origin/ 
year 
Study 
design 
Me-
dian 
age 
Male 
n (%); 
Female n 
(%) Age 65 
Antimicro-
bial use up 
to 8 weeks 
prior to CDI 
GI co-
morbidi-
ties, 
including 
surgery 
Use of 
PPI 
Cortico- 
steroids 
Laxa-
tives 
Pre-
vious 
sur-
gery 
Pre-
vious 
CDI 
Seasonal 
patterns 
Geo 
pattern 
urban/ 
rural 
index Strains 
Incidence 
per 
100,000 
pt years 
Mortality 
(attribut-
able death 
in 30 d) 
or 
morbidity 
Kuntz et al., 
US, 2011 
Retrospec-
tive  
nested 
Case 304 
Control 
3040  
nr cases 
60.53%=
f 
51.64% 
controls 
Charlson 
comorbid 
index 
cases=0.17 
controls=0.
05 
aOR 1.33 
CI,0.98-
1.97 
73.3%cases 
30.26 
controls 
aOR: 6.09 
CI, 4.59-
8.08 
IBD 3.95 
%cases 
0.13 
%controls 
aOR:41.8
9 
CI, 11.83-
148.35 
18.9% 
cases 
5.16% 
control
s 
aOR:2.
3 
CI, 
1.56-
3.39 
nr nr nr nr nr nr nr 11.6/100,
000 pop’n 
77 of 304 
cases 
were 
hospitaliz
ed  
 
* nr: not reported 
 
# RR: Rate ratio when greater than 1 implies that the rate of hospital admission because of CDI was greater amongst patients with the 
particular exposure than amongst those without.  
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Figures 
 
Figure 3.1 – Flow diagram of the literature search conducted for the scoping review of 
community-acquired Clostridium difficile, using the PRISMA (Preferred Reporting Items for 
Systematic Reviews and Meta-Analysis) template. 
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Abstract 
Objectives: To compare the epidemiology of hospitalized patients with community-acquired 
Clostridium difficile infections (CA-CDI) and those with healthcare-associated Clostridium 
difficile infections (HA-CDI). 
Design: A retrospective case series analysis was conducted. 
Setting: Niagara Health System, a multi-site hospital amalgamation in the Niagara Region, 
Ontario, Canada.  
Participants: Hospitalized patients with confirmed CA-CDI and HA-CDI, between September 
2011 and December 2013. 
Methods: Patients with Clostridium difficile infections (CDI) were identified through 
surveillance and laboratory testing, then stratified in two groups: CA-CDIs and HA-CDIs. Data 
were obtained from the Infection Prevention and Control (IPAC) surveillance database and the 
Decision Support database. Nonparametric descriptive statistics were applied to compare the 
characteristics of patients with CA-CDI and HA-CDI. 
Results: Of 628 hospitalized patients identified with CDI, 315 (50.2%) had CA-CDI and 313 
(49.8%) had HA-CDI. Compared to patients with HA-CDI, patients with CA-CDI were younger 
(median age 72 years, interquartile range (IQR) 26, versus 77 years, IQR 18; p.001), had less 
exposure to antibiotics (52% versus 83%, p<.001), and used fewer proton pump inhibitors (PPI) 
(30% versus 52%, p<.001). Gender proportions were similarly distributed between the two 
groups (58% of CA-CDI and 55% of HA-CDI were female, p=.38). There were differences in 
the proportion of comorbidities between CA-CDI and HA-CDI as follows: presence of an 
inflammatory bowel disease (18% of CA-CDI versus 40% of HA-CDI, p<.001) and surgery in 
the past three months (13% of CA-CDI versus 23% of HA-CDI; p<.001).  
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Conclusion: CA-CDI must be considered as a potential diagnosis in patients admitted to hospital 
with diarrhea, even in the absence of conventional CDI risk factors. 
Keywords: Epidemiology, Clostridium difficile, infections, community-acquired. 
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Introduction 
The incidence and severity of healthcare-associated Clostridium difficile infections (HA-
CDI) have been increasing since the emergence and the epidemic spread of the invasive strain 
BI/NAP1/027 (Khanna & Pardi, 2010; Khanna et al., 2013; Barbut & Petit, 2001; Freeman et al., 
2010). Concern is also growing that Clostridium difficile (C. difficile), historically considered a 
healthcare-associated infection, is increasingly a cause of diarrhea in the community, causing 
community-associated Clostridium difficile infections (CA-CDI) (Khanna & Pardi, 2010; 
Khanna et al., 2012). Although many studies have explored the increasing burden of HA-CDI, 
more research is required to fully understand the epidemiology of patients hospitalized with CA-
CDI (Levy et al., 2015; Dumyati et al., 2012). 
 In the summer of 2011, the Niagara Health System (NHS) in Ontario experienced an 
unusual increase in hospitalized HA-CDI and CA-CDI cases, combined with multiple HA-CDI 
outbreaks. To this end, this paper describes the clinical characteristics and the epidemiology of 
patients admitted to NHS hospitals with CA-CDI and compares them to the epidemiology of 
patients admitted with HA-CDI during the same period.  
Methods 
Setting. 
NHS is a large, multi-site hospital network in the Niagara Region in Ontario, Canada. 
The region has 12 municipalities and a population of 427,421 (Statistics Canada, 2016). NHS 
consists of six hospital sites providing a wide range of healthcare services. The subjects of this 
study were hospitalized patients confirmed to have Clostridium difficile infections (CDI). During 
the study period, NHS hospitals experienced a significantly higher than usual number of cases 
and clusters of CDI.  
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Study period and study design. 
In a case-series retrospective study of consecutive patients admitted to all NHS hospitals 
with confirmed CDI between September 2011 and the end of December 2013, we analysed the 
patients’ demographic information, comorbidities, antibiotic history, and presence of 
conventional risk factors for CDI. Table 4.1 lists the evidence-based covariates evaluated in this 
study, and their implications.   
Case identification, data sources, and privacy. 
Case definitions used in this study for CDI, HA-CDI, and CA-CDI are listed in Table 4.2. 
Hospitalized patients suspected as having CDI were identified by active daily surveillance using 
a standardized (NHS) surveillance tool based on signs and symptoms manifestation, followed by 
positive laboratory testing. Final case confirmation was done after positive laboratory toxin 
testing and case review by an infectious diseases physician and the Infection Prevention and 
Control (IPAC) personnel at NHS hospitals.  
Data for this study were electronically obtained from IPAC surveillance databases and 
the administrative databases from NHS hospitals. The surveillance, clinical information, and 
demographics files for the study period from NHS hospitals were combined, creating one large 
file that was reviewed by a member of the Decision Support Department for completeness of 
data elements. Deficiencies in demographics and clinical or surveillance information were 
reviewed on a case-by-case basis. In cases of missing information, the electronic record of the 
patient was matched with the paper records, using name, admission date, and the site-specific 
medical records number. Missing information was then retrieved from the paper copies of the 
surveillance forms and medical records. A de-identified dataset was used for final analysis of this 
study’s objectives. 
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Laboratory methods and testing for CDI. 
 From September 2011 to April 2012, NHS sent CDI samples for diagnostic testing to a 
nearby academic centre that used an in-house developed Polymerase-Chain Reaction (PCR) 
method using the BD GeneOhm™ Cdiff Assay, with a sensitivity and specificity of 93.8% and 
95.5% respectively (BD Diagnostics GSCI: BD GeneOhm™ Cdiff assay, 2010). From April 
2012 to December 2013, NHS sent samples to an external commercial laboratory that used BD 
MAX ™ Cdiff, a Nucleic Acid Amplification Test (NAAT) with a sensitivity of 96.3% and a 
specificity of 92.4% (Dalpke, Hofko, Zorn, & Zimmerman, 2013). 
Statistical analysis. 
Descriptive statistics for age are presented using the median value (and interquartile 
range [IQR]) (Moore & McCabe, 2003). Significance in the difference between the age median 
for HA-CDI and CA-CDI cases was evaluated using the Mann-Whitney U test (Pagano & 
Gauvreau, 2000). Categorical covariates, including gender, age≧65, previous CDI (previous is 
defined as eight weeks before the onset of CDI symptoms), previous surgery (past three months), 
previous laxative use, proton pump inhibitor (PPI) or antibiotic use, and previous inflammatory 
bowel disease, were dichotomized and presented as proportions. Differences in proportions of all 
covariates were tested using Chi-Square. In the event of missing data, complete-case analysis 
was conducted. Data were analyzed using SPSS software, version 21.0 (IBM Corp., Armonk, 
NY). 
Ethical considerations. 
The protocol for this study was approved by York University’s Research Ethics Board 
and the Niagara Health Service’s Research Ethics Board. De-identified data were retrospectively 
accessed from hospital administrative databases; therefore, the requirement for informed consent 
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was waived.  
Results 
Surveillance and classification of cases. 
During the study period, 1,051 cases of CDI were identified by surveillance and 
confirmed by laboratory testing. A breakdown of patient classification and the criteria of the 
eligible and ineligible cases is presented in Figure 4.1. Overall, 423 cases did not meet the case 
definition (relapse, colonized or transferred cases from other facilities) and were eliminated from 
further analysis, leaving 628 cases that fulfilled the criteria for case definitions for CA-CDI and 
HA-CDI (see Supplement for detailed information). 
Demographics, clinical characteristics, and comorbidities. 
Out of the 628 patients, 315 (50.2%) cases were categorized as CA-CDI and 313 (49.8%) 
as HA-CDI. The median age of CA-CDI patients (72 years, IQR 26) was lower than that of the 
HA-CDI group (77 years, IQR 18, p<.001). The proportion of patients aged ≧65 was 60% for 
CA-CDI and 79% for HA-CDI (p<.001). There were no significant differences in the gender 
proportions of the two groups; 58% of the CA-CDI cases were female and 55% of HA-CDI cases 
were female (p=0.38).  
Report on CDI risk factors. 
Approximately half of patients with CA-CDI used antimicrobials prior to the onset of 
their CDI; the proportion was higher in patients with HA-CDI (52% of CA-CDIs versus 83% of 
HA-CDIs, p<.001). Cephalosporins and fluoroquinolones were used more than other 
antimicrobials in both groups but were prescribed less often for patients with CA-CDI during the 
eight to12 weeks prior to the onset of their CDI infection than for HA-CDI patients (51% and 
37% for CA-CDIs and 67% and 56% for HA-CDIs for cephalosporins and fluoroquinolones 
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respectively, p<.001).  
Similarly, a smaller proportion of CA-CDI cases compared to HA-CDI cases used PPI 
(30% of CA-CDI versus 52% of HA-CDI, p<.001) and laxatives (8% of CA-CDI versus 31% of 
HA-CDI, p<.001). Patients with a previous inflammatory bowel disease (18% of CA-CDI and 
40% of HA-CDI, p<.001) and those who had had a previous surgery (13% of CA-CDI versus 
23% of HA-CDI, p<.001) were proportionally lower amongst patients with CA-CDI than those 
with HA-CDI. Fewer CA-CDI cases had no history of CDI compared to HA-CDI cases (32% 
and 45% respectively, p=.002). The comparison of patient characteristics and the risk factors for 
hospitalized patients with CA-CDI and HA-CDI is presented in Table 4.3 in more detail. Table 
4.4 lists the proportion of antimicrobials used prior to the onset of CA-CDI and HA-CDI. 
CDI treatment. 
Of the patients with CA-CDI (n=315), 218 (69%) had a documented record of antibiotic 
treatment after their CDI infection was confirmed; of these, 54 patients (54/218=24%) were 
treated with vancomycin and 150 patients (150/218=69%) received metronidazole. Of the 
patients with HA-CDI (n=313), 251 (80%) had a documented record of antibiotic treatment post-
infection; of these, 74 (74/251=29%) were treated with vancomycin and 159 (159/251=63%) 
received metronidazole. 31% of the CA-CDI and 20% of HA CDI did not have a documented 
record of their treatment.  
Discussion 
This retrospective case-series study compared the epidemiology of patients hospitalized 
with CA-CDI with that of patients hospitalized with HA-CDI. The study found that hospitalized 
CA-CDI patients accounted for slightly more than half of all hospitalized CDI cases; they were 
younger than HA-CDI patients and, overall, had a lower proportion of established CDI risk 
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factors. 
In this study, CA-CDI patients comprised a substantially larger proportion of the total 
hospitalized patients with CDI than has been reported elsewhere. A North Carolina study 
conducted on laboratory confirmed cases of CDI reported patients with CA-CDI represented 
20% of all hospitalized CDI patients, while another American study reported 40%  and a 
Swedish study reported 22%-28% (Kutty et al., 2010; Khanna, Pardi, Aronson, Kammer, & 
Baddour, 2012; Karlstrom, Fryklun, Tullus, & Burman, 1998; Norén et al., 2004). One potential 
explanation could be the rural nature of the Niagara Region and the role of the environment in 
harboring C. difficile spores. Natural sources of surface water, which are common in the Niagara 
Region, have been known to harbour C. difficile, as well as dried airborne debris that can carry 
spores (AL Saif & Brazier, 1996; Lin, Wade, & Hilborn, 2015). C. difficile, including the 
invasive strain PCR Ribotype 027, has also been isolated from dairy calves, beef calves, and 
adult cattle (Rodriguez-Palacios, Staempfli, Duffield, & Weese, 2007; Weese, Avery, Rousseau, 
& Reid-Smith, 2009; Weese, Reid-Smith, Avery, & Rousseau, 2010), and the Niagara Region 
has a large farming community. 
The median age of CA-CDI patients was significantly lower than that of patients with 
HA-CDI, a finding consistent with those of other studies (CDC, 2008; Fellmeth, Yarlagadda, & 
Lyer, 2010). However, our CA-CDI median age was notably higher than that reported elsewhere 
(72 versus ~50 years) (Dumyati et al., 2012; Khanna et al., 2012). A study in England conducted 
in a similar geographical setting on community patients who tested positive for CDI reported that 
almost all cases of CA-CDI occurred in individuals younger than 65 (Fellmeth et al., 2010). 
Similarly, studies from rural areas in the US based on laboratory confirmation of a mixed 
community and hospitalized cohort found that only 30% of CA-CDI cases were older than 65 
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(CDC, 2008; Khanna et al., 2012; Gupta & Khanna, 2014). These differences might be explained 
by the relatively higher population-level median age in the Niagara Region (median age 44.4 
years in the 2011 census, compared with 39.9 years for the south of England, reported in 2014) 
(Statistics Canada, 2016). 
Our finding of a uniform distribution of CDI in males and females does not follow the 
pattern reported elsewhere. Almost all studies of CA-CDI regardless of the study settings, report 
a higher proportion of women with CA-CDI (Khanna et al., 2012; Gupta & Khanna, 2014). Some 
studies have considered this could be a result of more antibiotic exposure due to more 
healthcare-seeking behaviour by women, or as a result of exposure while changing diapers 
Khanna et al., 2012; Gupta & Khanna, 2014; Leffler & Lamont, 2011). The equal proportions of 
male and female CA-CDI infections could not be explained by differences in the population 
construct, as a comparison of the population pyramids of the Niagara Region and those in 
Connecticut and Monroe County in the US reveals similar proportions of men and women 
(Statistics Canada, 2016; United States Census, 2016). Other environmental factors or sources of 
exposure, such as occupation, must be explored to understand this difference.  
While exposure to antimicrobial agents is known to be a key risk factor for HA-CDI, a 
recent study reported less of an association with CA-CDI (Kutty et al., 2010). In a case control 
study of antibiotic utilization, Wilcox et.al. indicated that approximately 50% of the CA-CDI 
cases in their study used antibiotics prior to the onset of their infection (Wilcox, Mooney, 
Bendall, Settle, & Fawley, 2008). Similarly, fewer patients with CA-CDI received PPI than did 
patients with HA-CDI; this echoes finding of a case-control study of antimicrobial-naïve CA-
CDIs that found only 50% of patients with CA-CDI had received PPI (Freedberg & Abrams, 
2013). Our findings also confirmed previous studies, in that CA-CDI cases in NHS had lower 
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proportions of previous inflammatory bowel disease and surgery compared to HA-CDI cases 
(Barbut & Petit, 2001; Pépin, Valiquette, & Cossette, 2005). Our results suggest the risk factors 
for CA-CDI are different than for HA-CDI and should be explored further.   
Although the convenience of a sizable dataset was one of the advantages of this study, 
our surveillance and demographics reports were missing some data elements. Despite our best 
efforts to complete missing data, there were still a notable number of missing data elements that 
could introduce bias (Wood & White, 2004; Stern et al., 2009). In addition, the use of hospital-
based administrative data reduced the generalizability and comparability of our findings to non-
hospitalized CA-CDI cases.  
CA-CDI is emerging as an important cause of diarrhea in patients without healthcare 
exposure; it accounted for half of all hospitalized cases of CDI in our study. CA-CDI affects a 
younger, healthier population and can occur even in the absence of the risk factors traditionally 
associated with this infection. Lack of the conventional risk factors suggests the possibility of 
novel community reservoirs. More research on CA-CDI is required to understand the scope of 
this infection, to determine additional or different risk factors in the community, and to devise 
preventive measures that enable and inform clinical and public health policies and practices. 
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Tables 
Table 4.1 – List of selected independent covariates, supporting rationale and implications based 
on a review of the literature. 
 
Supporting Literature: 
Author and Study Year 
Predisposing Risk 
Factor 
Justification and Implications 
Demographics and patient characteristics 
Pépin & Valiquette et al., 2005 
Barbut & Petit, 2001 
Southern & Rahmani et al., 2005 
Brown et al.,1990 
Age≧65 years Increased incidence explained by old age 
comorbidities 
Increased risk: OR* 114.1  
(CI** 95%) 1.4–141 
Aronsson & Mollby et al., 1985, 
CDC 2008, 
Lessa & Mu et al., 2014 
Being female Increased incidence due to healthcare-
seeking behaviour or changing diapers 
Increased incidence: RR1.9  
(CI 95%) 1.5-2.5 
Comorbidities and clinical history 
Thibault et al.,1991 
Gupta & Khanna, 2014 
Inflammatory bowel 
Disease  
 
Disease flare ups may lead to colonization 
Increased risk: OR 4.7  
(CI 95%) 1–21 
Brown et al.,1990 
 
Gastrointestinal 
surgery 
Intestinal stasis may predispose to CDI  
Increased risk: OR 23.2  
(CI 95%) 2.1–255 
Fekety & McFarland et al., 1997 
Modena & Gollamoudi et al., 
2006 
History of CDI Failure of treatment due to other antibiotics 
Reported in up to 20% of cases  
 
Medication use 
Aronsson & Mollby et al., 1985  
Bauer & Veenendaal et al., 2009  
Southern & Rahmani et al., 2010 
Baxter & Ray et al., 2008 
Deshpande et al., 2013  
Use of antimicrobial 
agents 
Increased incidence as a result of 
imbalance of normal flora of the intestines 
Increased risk: OR 6.91  
 
(95% CI) 4.17-11.44 
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Supporting Literature: 
Author and Study Year 
Predisposing Risk 
Factor 
Justification and Implications 
Wern & Ahmed et al., 2005  
Batajoo & Weber et al., 2015 
McFarland et al.,1990 
 
Use of laxatives or 
stool softeners 
 
Positive result on CDI testing  
Increased risk: OR 3.26  
(CI 95%) 1.51–7.02 
 
Dial & Alrasadi et al., 2004 
Deshpande & Pant et al., 2012 
Use of PPI  Increased risk due to reduced gastric acid 
Increased Risk: OR 2.7  
(CI 95%) 1.4–5.2 
*  OR: Odds Ratio 
** CI: Confidence Interval 
  RR: Relative risk 
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Table 4.2 – NHS definitions of CDI, HA-CDI and CA-CDI used between September 2011 and 
December 2013 for surveillance and case identification. 
 
CDI definition 
• A patient with diarrhea with laboratory confirmation of a positive toxin assay (A/B) 
for Clostridium difficile, or  
• Visualization of pseudomembranes on sigmoidoscopy, or  
• Colonoscopy, or histological/pathological diagnosis of pseudomembranous colitis.  
 Definition of HA-CDIs  Definition of CA-CDIs 
An HA-CDI case is defined as a patient 
who has not had CDI in the past eight 
weeks, but meets one of the following 
criteria: 
• He or she does not present with CDI 
upon admission but shows onset of 
symptoms >72 hours after admission. 
• The infection was present at time of 
admission but was related to a previous 
admission to the same facility within 
the last four weeks. 
A CA-CDI case matches the case definition 
for CDI and does not match the HA-CDI 
definitions: In other words: 
• The symptoms of CDI were present 
upon admission, or symptom onset was 
less than 72 hours after admission. 
• No exposure to any healthcare facility 
occurred within the last four weeks, or 
the source of infection cannot be 
determined and the patient has not had 
HA- CDI in the last eight weeks. 
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Table 4.3 – Patient characteristics and risk factors: A univariate analysis of patients with CA-
CDI and HA-CDI for hospitalized patients in NHS hospitals between September 2011and 
December 2013. 
 
Characteristics  
and Risk Factors 
CA-CDI 
(n=315) 
(50.2%) 
 
HA-CDI 
(n=313) 
(49.8%) 
p-value 
Demographics 
Age, median 
Age ≧ 65 
72 (IQR=26) 
 
190 (60%) 
77 (IQR=18) 
 
247 (79%) 
<.001 
 
<.001 
 
Female 183 (58%) 170 (55%) .38 
Comorbidities and clinical history 
History of an 
inflammatory bowel 
disease  
   Yes 
   No 
   Not documented 
 
 
 
       56 (18%) 
49 (16%) 
210 (66%) 
 
 
   125 (40%) 
29 (9%) 
159 (51%) 
 
 
          <.001 
Previous surgery 
   Yes 
   No 
   Not documented 
 
 
      41 (13%) 
92 (29%) 
182 (58%) 
 
        71 (23%) 
100 (32%) 
142 (45%) 
 
 
          <.001 
 
History of previous CDI 
   Yes 
   No 
   Not documented 
 
 
12 (5%) 
100 (32%) 
203 (63%) 
 
15 (5%) 
140 (45%) 
158 (50%) 
 
 
.002 
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Medication use 
Characteristics  
and Risk Factors 
CA-CDI 
(n=315) 
(50.2%) 
 
HA-CDI 
(n=313) 
(49.8%) 
p-value 
Previous exposure to 
antimicrobials 
   Yes 
   No 
   Not documented 
 
 
163 (52%) 
152 (48%) 
N/A 
 
 
259 (83%) 
54 (17%) 
N/A 
 
 
<.001 
 
Proton Pump Inhibitor 
(PPI) use 
   Yes 
   No 
   Not documented 
      
 
93 (30%) 
58 (18%) 
164 (52%) 
   
 
163 (52%) 
45 (14%) 
105 (34%) 
 
 
<.001 
Previous laxative use 
   Yes 
   No 
   Not documented 
 
26 (8%) 
71 (22%) 
217 (70%) 
 
98 (31%) 
56 (18%) 
159 (51%) 
 
         
           <.001 
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Table 4.4 – Proportion of patients receiving antimicrobial agents prior to the onset of CDI, 
stratified by CA-CDI and HA-CDI. 
 
 Patients who received 
antimicrobials prior to the onset of 
CDI 
 
 CA-CDI  
(n= 315) 
HA-CDI 
(n=313) 
p value 
Number of patients that 
used at least one 
antimicrobial during the 
past 8 to12 weeks 
preceding the onset of 
CDI * 
 
163 (52%) 
 
259 (83%) 
 
<.001 
Cephalosporins 83 (83/163) 
(51%) 
174 (174/259) 
(67%) 
<.001 
Fluoroquinolones 61 (61/163) 
(37%) 
146 (146/259) 
(56%) 
<.001 
Clindamycin 
 
9 (9/163) 
(6%) 
11 (11/259) 
(4%) 
.55 
Vancomycin 7 (7/163) 
(4%) 
37 (37/259) 
(14%) 
<.001 
Macrolides 
 
14 (14/163) 
(9%) 
23 (23/259) 
(9%) 
.92 
Sulfonamides 
 
4 (4/163) 
(2%) 
13 (13/259) 
(5%) 
.20 
Others  
 
93 (93/163) 
(57%) 
229 (229/259) 
(88%) 
<.001 
 
*Some patients received more than one antimicrobial prior to onset of their symptoms. 
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Figures 
 
 
 
Figure 4.1 – Decision process flowchart describing the case inclusion and exclusion procedure 
among 1051 cases with toxin positive C. difficile test results. 
  
Total CDI cases identified through 
laboratory testing and surveillance: 
1,051
Incomplete 
information-
inconclusive: 
13
HA-CDI from other 
hospitals outside of 
NHS hospitals group: 
22
HA-CDI from a 
previous admission: 
34
Non HAI (CA-CDI) 
relapse or recurrent: 
170
Non HAI (CA-CDI) 
Colonized: 
135
Non HAI (CA-CDI) 
Other from facilities: 
49
HA-CDI: 
313
CA-CDI: 
315
Total hospitalized CDI 
cases  that met the case 
definition
628
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Abstract 
Objectives: To investigate and compare the incidence, geographical distribution, temporal 
patterns, and genetic relatedness of hospitalized patients with community-acquired Clostridium 
difficile infections (CA-CDI) and healthcare-associated Clostridium difficile infections (HA-
CDI) in the Niagara Region, Ontario, over the time of a large, multi-hospital outbreak.  
Method: We conducted a retrospective case series study of the consecutive hospitalized 
confirmed CDI cases between September 2011 and December 2013, using SaTScan statistics and 
Statistical Process Control. We used multiple-locus variable-number tandem-repeat analysis to 
identify the strain of the CDI of patients associated with a registered outbreak. 
Results: Using provincial guidelines on classification of C. difficile cases, we identified 629 
cases of CDI, 318 were CA-CDI and 311 were HA-CDI. The rate per 100,000 population for the 
hospitalized CA-CDIs was 14.84 in 2011; 33.22 in 2012, and 25.5 in 2013and for HA-CDIs, 3.8 
CDIs /1000 patient days for the entire study period. We identified spatial clusters for CA-CDIs 
using the first three digits of the patients’ home postal codes. A temporal cluster of HA-CDI was 
identified after a period when a high number of CA-CDI cases were hospitalized. Molecular 
typing related to outbreaks was performed on 6% (59/1051) of the cases, of which 4% (n=13) 
were CA-CDI and 9% (n=27) were HA-CDI. The majority of the NAP1 strains (12 cases (3.8%) 
of 311) were seen in patients with HA-CDI.  
Conclusion: CA-CDIs and HA-CDIs had geographical clustering, temporal features, and 
genotypic features that appeared to be unique to CID cases in the community and unlike those in 
the hospital. Understanding the potentially bi-directional transmission pathways between 
hospitalized CA-CDI incidence and HA-CDI manifestation, as well as the community drivers of 
CA-CDIs, can inform clinical and public health patient safety and prevention policies.  
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Introduction 
Clostridium difficile (C. difficile) has been emerging as a significant source of infectious 
diarrhea beyond hospital settings, with an increasing number of community-acquired 
Clostridium difficile infections (CA-CDI) being reported (Gupta & Khanna, 2014; Khanna & 
Pardi, 2010). The reservoirs of CA-CDI in the community remain unclear, and many of those 
infected with CA-CDI do not have the conventionally established risk factors for healthcare-
associated Clostridium difficile infections (HA-CDI) (Gupta & Khanna, 2014; Khanna et al., 
2012). CA-CDI has been linked to various environmental sources, such as floodwater, rivers, 
lakes, marine sediments, food, farm animals, and household pets (Gupta & Khanna, 2014; 
Hoover & Rodriguez-Palacios, 2013; Lin, Wade, & Hilborn, 2015). Unlike other gastrointestinal 
infections, increases in CA-CDI rates in the Northern hemisphere have not been associated with 
the warmer summer months (Furuyama-Kanamori et al., 2015; Brown, Daneman, Arora, 
Moineddin, & Fisman, 2013; Burckhardt, Friedrich, Beier, & Eckmanns, 2008). Yet research has 
pointed to the increased use of antimicrobials in winter and spring months as a contributing risk 
factor in both CA-CDIs and HA-CDIs (Furuya-Kanamori et al., 2015; Brown et al., 2013). 
Scholars also debate whether asymptomatic hospitalized patients can be a source of transmission 
in the community or if hospitalized CA-CDI plays a role in spreading the spores in hospital 
settings (Walker et al., 2012; Sethi, Al-Nassir, Nerandzic, Bobulsky, & Donskey, 2015).  
In a bid to answer these questions, we investigated and compared the geographical 
distribution, temporal patterns, and genetic relatedness of CA-CDI and HA-CDI cases admitted 
to the Niagara Health System (NHS) between the summer of 2011 and the winter of 2013, a 
period when a series of C. difficile outbreaks had occurred in the hospitals of this region.  
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Method 
Study design, study period, and setting. 
The design featured a retrospective case-series study of consecutive patients with 
confirmed CDI infections hospitalized in NHS hospitals between September 2011 and December 
2013. NHS hospitals are the service providers for the Niagara Region in Ontario; they offer a 
wide range of programs and services to a catchment area spanning 12 municipalities with a 
population of approximately 430,000 (Statistics Canada, 2016). 
Case definition, identification, data source, and privacy. 
Case definition and eligibility criteria followed the provincial guidelines for CDI 
prevention in healthcare settings (Public Health Agency of Canada, 2013), as reflected in the 
policies of the infection prevention and control (IPAC) at NHS (see Appendix A).  
Cases of CDI were identified after laboratory testing of stool samples from symptomatic 
patients. Daily surveillance by IPAC service personnel at NHS sites confirmed the laboratory 
testing results. Confirmed cases were then approved and finalized in consultation with an 
external infectious diseases and infection control physician. 
Data for this study were aggregated in a central database; data came from all IPAC 
offices of the various NHS hospitals and from the administrative database and medical records of 
NHS hospitals. For more accurate data collection, expert personnel in the Decision Support (DS) 
department of NHS conducted a retrospective query in the databases. Where data were missing, 
an electronic record review and a paper chart review were conducted using name, date of 
admission, and site-specific medical records numbered to match the records. A de-identified 
dataset was used for final analysis. 
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Clostridium difficile testing and strain typing methods. 
Between September 2011 and April 2012, all CDI samples were sent to an academic 
hospital laboratory that used an in-house-developed DNA amplification technique to identify 
toxin-producing CDI strains. The BD GeneOhm™ Cdiff Assay had a sensitivity of 93.8% and a 
specificity of 95.5% (Becton, 2008). From April 2012 to December 2013, NHS sent the CDI 
samples to an external commercial laboratory that used a Nucleic Acid Amplification Test 
(NAAT), BD MAX™Cdiff, with a sensitivity of 96.3% and a specificity of 92.4% (Dalpke, 
Hofko, Zorn, & Zimmermann, 2013). 
 The provincial reference laboratory performed the strain typing of the C. difficile isolates, 
using a pulsed-field gel electrophoresis (PFGE) technique. A fraction of the culture prepared for 
PFGE was also used to extract DNA using the Bio-Rad Instagene reagent and following the 
manufacturer’s protocol. Extracted DNA was analyzed by modified, multiple-locus, variable-
number, tandem-repeat analysis (MMLVA), according to the protocol developed at Public 
Health Ontario’s laboratory (Alfa et al., 2000). PFGE and MMLVA data were processed with the 
BioNumerics software (v.5, Applied Maths) to identify genetic profiles and relatedness of 
isolates. A standard set of 12 PFGE profiles from NML was used to classify pulsotypes; those 
not matching any of the 12 were assigned arbitrary letter designations. MMLVA profiles with a 
difference of less than 3% were considered to belong to the same strain.  
Statistical analysis. 
We stratified the CDI cases using the incidence of CA-CDI and HA-CDI. Data included 
CDI discreet count values, month and year of laboratory testing, the first three digits of the postal 
codes or forward sortation area (FSA) of the eligible CDI patients, and total patient days for all 
NHS sites per month for rate calculation. Rate per 1000 patient days was computed for each CDI 
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category, and rate per 100,000 population was calculated for CA-CDIs. We used information on 
the Niagara Region’s population from Statistics Canada’s 2011 census when needed for analysis 
of data. Monthly incidence measures were calculated and out-of-control ranges searched using 
Statistical Process Control. 
We performed a purely spatial and spatio-temporal scan of the CA-CDI and HA-CDI 
cases to test for the presence of patterns in their approximate geographical origin and conducted 
a space-time permutation study to identify clusters independent of time and location. To evaluate 
the temporal pattern of the CDIs, we used a purely temporal statistics test for the investigation of 
non-random clustering with hospital cases, considered cases, and community cases, considered 
controls.  
Using the additive seasonal cases, a mean was calculated for each season to allow us to 
test for seasonality in our relatively small datasets. 
Data were combined and stored in SPSS software, version 21.0 (IBM Corp., Armonk, 
NY) and Microsoft® Excel for Mac, Version 15.27(161010). To determine the spatial and 
temporal scan statistics, we used SaTScan version 9.4.4 64-bit (Kulldorff and Information 
Management Services 2009) (Kulldorff, 2005). Information on geocodes for FSAs was accessed 
from GPSVisualizer (Schneider, 2003).  
We categorized the results of molecular testing for each category as discreet counts and 
as proportions of the total specimens tested.  
Ethics statement. 
The protocol for this study was approved by York University’s Research Ethics Board 
and Niagara Health Service’s Research Ethics Board. This study entirely consisted of secondary 
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data analysis of de-identified quality improvement patient data; therefore, the requirement for 
informed consent was waived.  
Results 
A total of 1,051 CDI cases were identified through laboratory detection of toxins 
produced by C. difficile strains, 629 of which met the eligibility criteria; 318 (50.1%) were CA-
CDI, and 311 (49.4%) were HA-CDI. 
The rate per 100,000 population for hospitalized CA-CDIs was 14.84 in 2011; 33.22 in 
2012, and 25.5 in 2013. The rate per 1000 patient days for HA-CDI was 3.83 for the entire study 
period. Table 5.1 lists the rate for each study year for the two CDI categories.  
Spatial scan statistics 
Figures 5.1a, 5.1b, and 5.1c provide the scan statistics of the purely temporal, spatio-
temporal, and time-space permutations, respectively, of the hospitalized CA-CDI cases in the 
Niagara Region. Cluster (p<0.005) identification was based on their specimen collection date and 
their residential FSA information. Figures 5.2a, 5.2b, and 5.2c present the scan statistics of the 
purely temporal, spatio-temporal, and time-space permutations, respectively, for HA-CDI cases. 
Clusters (p<0.005) identified in each category are listed in the relevant figure. The identified 
clusters have different geocodes, and the radii of the circular windows were set for 1 kilometre 
for each cluster. CA-CDI scan statistics identified five very localized, purely spatial clusters 
(p<0.05), with one FSA attributing to each cluster; the analysis found a less contained and a 
larger number of FSAs for HA-CDI cases. 
Time series analyses and statistical process control charts. 
Figures 5.3a, 5.3b, and 5.3c explore the time series pattern of CDIs in NHS hospitals. 
When the control limit is set at 2 sigma, the control chart for CA-CDIs indicates many months 
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of higher than average CA-CDI rates, with no out-of-control range. The control charts show an 
out-of-control period for HA-CDIs starting in January 2013 and lasting until April 2013. To 
confirm this result, and to understand whether the increase in CA-CDI and HA-CDI cases co-
occurred, we turned to purely temporal analysis.  
Temporal scan statistics. 
The diagram in Figure 5.4 illustrates a cluster identified between December 2012 and 
April 2013. Identification of a cluster rejects our null hypothesis that the cases in hospitals and 
the community happened at the same time. Instead, cases acquired in the community occurred at 
a different time than those acquired in hospitals during the period of the cluster.  
Test of seasonality. 
The crude grand mean for the study period for all seasons was 35 for CA-CDIs and 36 for 
HA-CDIs. To better understand the effect of the seasons as an influencing factor on the 
prevalence of CA- and HA-CDIs, we calculated the additive seasonal indexes and numerically 
plotted the computed seasonal effects for all seasons in the study period. Graphical evaluation of 
the crude and seasonally adjusted cases for CA- and HA-CDIs indicated a lower seasonal 
influence in the former than the latter (see Figures 5.5a and 5.5b).  
C. difficile strain typing. 
Molecular typing on 6% (59/1051) of CDI patients in the Niagara Region was conducted. 
Nineteen strain typing results were excluded from our analysis as they did not meet the case 
definition for our study (relapse or colonized patients). 6% (40/ 629) of the study cases were 
tested for molecular typing. Four percent (13/318) of CA-CDI specimens were tested, and PFGE 
identified various strains, including two (0.6%) NAP1 strains; the rest (3.5%) were other 
unrelated strains (A, B, C, D, I, N, M). Nine percent (26/311) of the HA-CDIs were tested for 
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strain identification: 12 cases (3.86%) were NAP1strain, two (0.6%) were non-NAP1, and the 
rest (3.86%) were other unrelated strains (A, B, D, L, M, N, O, T, V).  
Discussion 
In our case series study, we found some notable differences between the temporal 
patterns and the spatial distribution of the hospitalized CA-CDI and HA-CDI cases. Our study 
did not reveal a seasonality pattern for the CA-CDI cases, and we discovered that cases of CA-
CDI and HA-CDI were temporally independent. Although our study was conducted on only 
hospitalized patients with CA-CDI, the overall incidence was notably higher for the Niagara 
Region (14.84 in 2011; 33.22 in 2012, and 25.5 in 2013) than for the UK in 2004 (22.0 per 
100,000 population), Connecticut in 2006 (6.9 per 100,000 population), and Philadelphia in 2005 
(7.6 per 100,000 population) (Centers for Disease Control, 2008). Similarly, given the fact that 
the region experienced many outbreaks during the study period, HA-CDI rates in the Niagara 
Region were markedly higher (3.83/1000 patient days) than the average rates/1000 patient days 
for the entire province of Ontario, which were 0.30 and 0.33 in 2011-12 and 2012-13, 
respectively (Health Quality Ontario, 2014). 
The localized geographical clustering of CA-CDI cases in our study did not copy the 
spatial distribution of HA-CDIs. Although most published studies have reported proximity to 
livestock as a risk factor, the clustering of CA-CDI cases in the Niagara Region was 
predominantly positioned in urban zones. Recent studies have suggested a positive association 
between environmental elements, such as flooding (Lin et al., 2015), rainfall, exposure to 
agricultural structures (exposure to soil, animals, or raw animal products), bathing in potentially 
contaminated watercourses, and an increased risk of CA-CDI (Furuya-Kanamori et al., 2014; 
Kistemann, Zimmer, Vagsholm, & Andersson, 2004; Anderson et al., 2017). However, our 
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discovery of urban clusters of the CA-CDI cases in the Niagara Region (Figures 5.1a, 5.1b, and 
5.1c compared with Figures 5.2a, 5.2b and 5.2c) reduced the applicability of previous findings to 
our study. Upon further exploration and plotting of public dwellings and communal residences 
(such as nursing homes, shelters, schools, and group homes), we noticed multiple assisted-living 
supportive housing demarcations within the perimeters of the spatial clusters of CA-CDI. In a 
spatial study conducted by Anderson et al. in North Carolina, proximity to nursing homes was a 
risk factor for CA-CDI (Anderson et al., 2017). In Ontario, the Long-Term Care Homes Act 
(S.O.2007, c.8.) and the Retirement Homes Act (S.O.2010, c.11) specify the need for infection 
prevention and control training and practices in these settings, but the legislation does not pertain 
to other fast-growing communal dwellings, such as assisted living or supportive housing (Long 
Term Care Homes Act, 2007; Retirement Homes Act, 2010).  
Despite studies suggesting an increase of CA-CDI in the winter months in both the 
southern and northern hemispheres (Brown et al., 2013; Gilca, Fortin, Frenette, Longtin, & 
Gourdeau, 2012; Kuntz, Chrischilles, Pendergast, Herwaldt, & Polgreen, 2011), the detection of 
more CA-CDI cases in the summer months, especially in the southern hemisphere, does not 
substantiate the role of antibiotic prescribing practices as a reason for the surge of CDIs in the 
winter months (Furuyama-Kanamori et al., 2015). The seasonal associations found in other CDI 
studies were not evident in our NHS study; this may be explained by the presence of C. difficile 
in retail meat, farm services, soil, pets, and domestic animals (Borriello, Honour, Turner, & 
Barclay, 1983; Baumgartner, 2012; Rodriguez-Palacio, Staempfli, Duffield, & Weese, 2007; 
Weese, Avery, Rousseau, & Reid-Smith, 2009; Stone et al., 2016; Anderson et al., 2014). 
However, our purely temporal study of the CA-CDI and HA-CDI cases also establishes a 
hospital-associated cluster spanning from December 2012 to April 2013, where a rise in CA-CDI 
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cases predated the HA-CDI’s temporal cluster (see Figures 5.3 and 5.4). One hypothesis could be 
that the asymptomatic carriage of HA-CDIs after discharge from NHS hospitals in the weeks or 
months before our study period may have contributed to an increase of CA-CDI cases in the 
community. Another possibility is that the admission to hospitals of non-suspected CA-CDI 
cases due to a lack of established risk factors might have prompted HA-CDI outbreaks.  
Our analysis of the C. difficile strain results associated with hospital outbreaks did not 
show homogeneity within the outbreak isolates, but we found similar unrelated strains amongst 
the CA-CDI and HA-CDI cases tested (including a NAP1 isolate in the CA-CDI samples). Thus, 
considering the lack of an anticipated genomic uniformity in HA-CDI cases, our study suggests 
that not all HA-CDI cases were acquired from a healthcare-associated source, and perhaps CA-
CDIs had an effect on the increase of CDI cases in NHS hospitals.  
The temporal independence of the CA- and HA-CDI cases, the higher than expected 
number of hospitalized CA-CDI cases, and the multiple reported HA-CDI outbreaks with 
unrelated molecular patterns all point to a possible association between the appearance of 
hospitalized CA-CDI cases and the hospital outbreaks. Other studies have hypothesised a 
positive correlation between increased rates of HA-CDI in hospitals and community prevalence 
and have suggested that hospital cases could be a driver of CDI in the community (Walker et al., 
2012; Furuya-Kanamori et al., 2016; Yakob, Riley, Paterson, & Marquess, 2014). Some studies 
have postulated a community reservoir as a potential attributing base for the arrival of this 
infection in hospitals (Lin et al., 2015; Rodriguez-Palacios et al., 2007; Weese et al., 2009). Only 
comprehensive epidemiological studies can answer these questions.  
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Limitations 
Our study was limited to hospitalized CA-CDI cases; we have no knowledge of the CA-
CDI patients who did not need hospitalization, and this limits the generalizability of our findings. 
Moreover, because we lacked access to the full postal code information, we could not document 
the precise location of the CA-CDIs. This reduced our ability to pinpoint the location of potential 
public sources of infection in the community. Our strain typing assessment was limited to the 
CDI cases that were tested as a result of an outbreak investigation and composed a small 
proportion of all CDIs.  
The risk of misclassification of CDI cases in this study was reduced by using the 
surveillance database, which was based on case definition, case confirmation, and expert 
consultation. Epidemiological evaluation by means of administrative and quality improvement 
databases allowed for a large-scale dataset.  
Recommendations for Future Research 
Identification of space and time patterns suggests that environmental factors have a role 
in the causation of CDI (Gordis, 2000) and could yield to better understanding of the 
epidemiology of these infections. We therefore suggest that when added to the traditional 
surveillance methods used in hospitals or community health facilities, spatial and temporal 
monitoring software can offer early identification of disease clusters and facilitate more efficient 
preventive measures. Using a combination of conventional and novel tools for comprehensive 
epidemiological evaluation can reveal illustrative and informative details on risk factors and 
initial causes of CDI in the community. Given the increasing numbers of the elderly and their 
dependence on supportive housing structures, community level reporting and detailed 
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surveillance programs identified through spatial heterogeneity should be included on public 
health agendas (Furuya-Kanamori et al., 2014).  
Conclusion 
Although the study points to the temporal independence of CA-CDI and HA-CDI, it also 
finds molecular heterogeneity and an increase in hospitalized CA-CDI activity before HA-CDI 
cases appear. The concentrated spatial distribution of CA-CDI could suggest undiscovered 
community sources of CDI that could be a transmission source and a driver of hospital 
outbreaks. Availability of a complete genotyping, added to a comprehensive epidemiological 
assessment, can reveal information about the transmission pathways of CA-CDI. Novel research 
programs that combine hospital and community findings can detect the direction of transmission 
of CA-CDI. Understanding the epidemiology of the community drivers of CA-CDI will guide 
hospital and community patient safety policies, inform public health programs, and improve 
quality of health at a population level.  
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Tables 
Table 5.1 – Rate of hospitalized CA-CDI and HA-CDI for NHS hospitals, between  
September 2011 and December 2013.  
 
 
 CA-CDI HA-CDI Ontario 
hospitals 
International 
literature 
Rate/1000 patient days 
Overall rate  
for study period 3.9  3.83 
  
2011  5.26 3.7 0.3*  
2012  4.15  3.36  0.35*  
2013  3.2 4.34  0.33*  
Rate /100,000 population 
2011  14.84   
11.6  
(in Kuntz et al., 
2011) 
2012  33.22   
2013 25.5   
 
Note. Data source: Health Quality Ontario, 2014 
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Figures 
 
Figure 5.1a – Purely spatial scan statistics of CA-CDI cases in the Niagara Region, based on 
their FSA, between September 1, 2011, and December 31, 2013.  
 
Number of significant clusters (p< 0.05):  
5 FSA of the significant clusters: L3K; L2G; L2E; L2N; L3B 
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Figure 5.1b – Spatio-temporal scan statistics of the CA-CDI cases in the Niagara Region, based 
on their FSA, between September 1, 2011, and December 31, 2013. 
 
Number of significant clusters (p< 0.05), identified with an arrow on the image:  
9 FSA of the significant clusters: L2M; L3C; L2N; L3K; L2G; L3B; L2E; L2J; L2V 
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Figure 5.1c – Space-time permutation scan statistics of CA-CDI cases in the Niagara Region, 
based on their FSA, between September 1, 2011, and December 31, 2013.  
 
Number of significant clusters (p< 0.05):  
3 FSA of the significant clusters: (L3K, L3B, L3C); (L2E, L2J, L2H, L2G); (L7T, L9A, L3M, 
L0R, L2R, L2N, L2S, L2M) 
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Figure 5.2a – Purely spatial scan statistics of HA-CDI cases in the Niagara Region, based on 
their FSA, between September 1, 2011, and December 31, 2013. 
 
Number of significant clusters (p< 0.05): 
1 FSA of the significant clusters: L2E, L2J, L2H, L2G, L2V, L2P, L2T, L2M, L2S, L2N, L2R, 
L3B, L3C 
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Figure 5.2b – Spatio-temporal scan statistics of the HA-CDI cases in the Niagara Region, based 
on their FSA, between September 1, 2011, and December 31, 2013.  
 
Number of significant clusters (p< 0.05):  
2FSA of the significant clusters: (L2E, L2J, L2H, L2G, L2V, L2P, L2T, L2M, L2S, L2N); (L3K, 
L3B, L3C, L0S) 
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Figure 5.2c – Space-time permutation scan statistics of HA-CDI cases in the Niagara Region, 
based on their FSA, between September 1, 2011, and December 31, 2013. 
Number of significant clusters (p< 0.05):  
3 FSA of the significant clusters: (L4K, L4A, L7T, L3M, L9A, L2N, L2M, L2R, L0R, L2P, L2S, 
L2T, L2V); (L3B, L3C, L0S, L3K); (L2G, L2H, L2E) 
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Figure 5.3a – Temporal visualization of CDI cases in the Niagara Region. 
Comparison of time series trends of CA-CDI and HA-CDI patients hospitalized in NHS hospitals 
between September 2011 and December 2013. 
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Figure 5.3b – Statistical process control display of hospitalized CA-CDI rates per 1000 
admissions hospitalized in NHS hospitals between September 2011 and December 2013. 
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Figure 5.3c – Statistical process control display of hospitalized HA-CDI rates per 1000 
admissions hospitalized in NHS hospitals between September 2011 and December 2013. 
  
 167 
 
 
 
Figure 5.4 – Purely temporal analysis scanning for clusters with high rates: A retrospective 
study of the CDI cases in NHS hospitals between September 2011 and December 2013, using the 
Bernoulli model, SaTScan v9.4.4 
 
Information on the detected temporal cluster: Time frame: 2012/12/1 to 2013/4/30;  
Log likelihood ratio: 12.027272; Monte Carlo rank: 1/1000; P-value: 0.001 
 
A cluster is statistically significant when its log likelihood ratio is greater than the critical value, 
which is, for significance level: 
Gumbel Critical Values: 0.00001: 13.971596; 0.0001: 11.659499 
Standard Monte Carlo Critical Values: 0.001: 8.060346; 0.01: 7.215835;0.05: 5.575158 
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Figure 5.5a – Crude and seasonality adjusted values for CA-CDI cases in the Niagara Region 
between September 2011 and December 2013.  
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Figure 5.5b – Crude and seasonality adjusted values for HA-CDI cases in the Niagara Region 
between September 2011 and December 2013.  
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Appendix 
Appendix A – NHS definitions of CDI, HA-CDI, and CA-CDI used between September 2011 
and December 2013 for surveillance and case identification. 
 
CDI definition 
• A patient with diarrhea with  
• Laboratory confirmation of clostridium difficile (e.g. by positive toxin A/B assay, or 
PCR) or  
• Visualization of pseudomembranes on sigmoidoscopy, or  
• Colonoscopy, or histological/pathological diagnosis of pseudomembranous colitis.  
 Definition of HA-CDI  Definition of CA-CDI 
An HA-CDI case is defined as a patient 
who has not had CDI in the past eight 
weeks, but meets one of the following 
criteria: 
• He or she does not present with CDI 
upon admission, but shows onset of 
symptoms >72 hours after admission. 
• The infection was present at time of 
admission but was related to a 
previous admission to the same 
facility within the last four weeks. 
A CA-CDI case matches the case definition 
for CDI and does not match the HA-CDI 
definitions: in other words: 
• The symptoms of CDI were present 
upon admission, or symptom onset was 
less than 72 hours after admission. 
• No exposure to any healthcare facility 
occurred within the last four weeks, or 
the source of infection cannot be 
determined and the patient has not had 
HA-CDI in the last eight weeks. 
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Chapter Six – Conclusion 
Value of a Complex Adaptive Systems View for Exploring Health Problems 
A panoramic view of the many agents contributing to health and their interplay is 
necessary if we are to improve health at an individual and a population level (Westley, 
Zimmermann, & Patton, 2007). The quality of an individual’s health and wellbeing cannot be 
enriched without considering all physiological processes, nor can it be isolated from biological 
and environmental interactions. Accordingly, population health researchers working in the area 
of health disparities have been using approaches that recognize multiple functioning systems, 
such as the reciprocal relationship between health and income (Diez Roux, 2011). Nonlinear 
dynamics between multiple, diverse, and interconnected agents resulting in unpredictable 
patterns, such as in healthcare, are characteristic of complex systems. Therefore, an expanded 
view of processes, structures, rules, and patterns is necessary to construct, organize, and achieve 
quality population-level health strategies.  
This dissertation proposes the use of Complex Adaptive Systems (CAS) theory as an 
example of an expanded theoretical viewpoint. CAS-based frameworks offer toolkits to 
researchers that allow them detect macro-level patterns as an outcome of operational interactions 
and process multiplicity, at different levels and between various subsystems. The dynamics 
operating within a CAS framework guide the research process toward the ultimate objective of 
inquiry by unraveling postulations from multiple perspectives. Mintzberg (1987) denotes this as 
achieving a balance between crafting “umbrella strategies” and creating “process strategies” that 
enable the emergence of feedback loops in a complex system. Whereas the umbrella strategy is 
stationary and does not reflect the needs of the various parts of a complex system, the feedback 
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loops generated by a strategy based on process permit a system to be flexible and to evolve and 
change. 
The dissertation has explored its research questions using a framework grounded in CAS, 
with an intent to unveil new and different epidemiological findings and to initiate useful 
feedback loops by discovering novel health equity leverage points. This final chapter 
summarizes the findings from the three manuscripts comprising the dissertation (Chapters Three, 
Four, and Five) and discusses the implications of the theoretical framework to the findings in 
each case. It concludes by suggesting prospective feedback loops emerging as a result of the 
adaptability of the subsystems as topics of future study. 
Summary of Findings and Contribution to the Literature using a CAS framework 
Together, the three manuscripts prepared for this dissertation shape a broad 
understanding of the scope of available knowledge on CA-CDI, specifically, in the Niagara 
Region of Ontario, Canada. The study is unique; it is one of the first comprehensive Canadian 
studies to evaluate CA-CDI through a systems lens, and it combines this focus with an 
epidemiological disease transmission dynamics framework to formulate policy recommendations 
that could enhance equity in health. More precisely, Chapter Three applies a scoping review 
methodology to determine the overall extent of our knowledge of the epidemiology of CA-CDI.  
Chapters Four and Five comprise an epidemiological analysis of hospitalized CA-CDI patients in 
the Niagara Region and compare their characteristics with those of HA-CDI patients during the 
study period, in an attempt to clarify the extent of the CDI problem. The results of these chapters 
quantify and visualize variables that could lead to health equity policy leverage points.  
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Epidemiology of Community-acquired Clostridium difficile infections (CA-CDI): A 
scoping review. 
Chapter Three constitutes a scoping study of CA-CDI. The purpose was to review the 
literature on risk factors for CA-CDI. I applied the protocols suggested by The Joanna Briggs 
Institute (JBI) Reviewers’ Manual 2015, Methodology for JBI Scoping Reviews (The Joanna 
Briggs Institute, 2015). I searched three life sciences databases for studies on the epidemiological 
aspects of CA-CDI: The Cumulative Index to Nursing and Allied Health Literature (CINAHL), 
the Nursing and Allied Health Source (ProQuest), and MEDLINE. After applying the inclusion 
and exclusion criteria and full article reviews, I was left with 22 peer reviewed articles. A 
reading of this work confirms that compared to HA-CDI, CA-CDI is seen more often in younger 
individuals and in female populations. Seasonal patterns are not consistently noticed in the 
literature, and only one spatial study finds proximity to animal farms, animal services, or nursing 
homes was associated with a higher incidence of CA-CDI within the community (Anderson et 
al., 2017). In terms of medications used, although exposure to antimicrobials and proton pump 
inhibitor (PPI) use are at the top of the list of medications connected with CA-CDI, the 
associations are not as strong as those for HA-CDI. Overall, the scoping review indicates that the 
number of CA-CDI cases with unique demographic patterns is gradually growing in 
communities, with more cases requiring hospitalization.  
While the scoping review provides insight into the research to date on CA-CDI, applying 
a systems lens highlights the complexity of this infection and its emergent behaviour between 
communities and healthcare settings. It is clear that CDI is no longer an issue specific to 
healthcare settings and hospitals. The patterns found in hospitalised cases could inform or 
influence the patterns in communities, or conversely, the agents or patterns in the community 
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could influence those in healthcare settings. This is supported by literature finding overlapping 
genetic strains in CA-CDI and HA-CDI cases. There are knowledge gaps in several areas, such 
as determining the incidence rate for CA-CDI as an operational baseline benchmark, establishing 
potential community-driven risk factors for CA-CDI, or explicating CA-CDI concentration 
within communities. Connectivity and co-evolution of the healthcare-associated and community-
associated arms of surveillance using a complex systems approach can inform the discourse on 
this infection until further targeted research is conducted.  
Epidemiology of patients hospitalized with Clostridium difficile infection in the 
Niagara Region, Ontario, Canada, between September 2011 and December 2013: A 
comparative analysis of community-associated and healthcare-associated Clostridium 
difficile infections. 
Chapter Four compares the epidemiology of hospitalized patients with CA-CDI and HA-
CDI though a retrospective case series analysis. The results show that patients with CA-CDI are 
younger, have less exposure to antibiotics, and use fewer PPIs than patients with HA-CDI. 
Gender proportions are similarly distributed between the two groups. However, my study finds a 
higher proportion of male CA-CDI patients than other studies. A systems evaluation of the 
patients’ characteristics and established risk factors concludes that CA-CDI is emerging as an 
important cause of diarrhea in patients with no previous healthcare-related exposure. Therefore, 
CDI must be considered as a potential diagnosis when patients are admitted to hospitals with 
diarrhea, even in the absence of conventional CDI risk factors. Changes in policies for isolation 
initiation on admission could potentially have a large impact on hospital infection rates for CDI; 
such changes would acknowledge the nonlinearities in an evolving CAS. I also conclude that 
CA-CDI affects a younger, healthier population and can occur even in the absence of the risk 
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factors traditionally associated with this infection. The lower proportion of the conventional risk 
factors in CA-CDI cases suggests the possibility of novel community reservoirs. Therefore, in 
the next chapter, I conduct a systems analysis of the data on all aspects of the disease 
transmission dynamics to investigate the epidemiology of this infection in the community. 
A spatial, temporal, and molecular epidemiological study of hospitalized patients 
infected with community-acquired or healthcare-associated Clostridium difficile in the 
Niagara Region, Ontario, Canada. 
In Chapter Five, I conduct a systems level evaluation of the incidence, geographical 
distribution, temporal patterns, and genetic relatedness of hospitalized CA-CDI patients in NHS 
hospitals and compare the results to those of NHS patients hospitalized with HA-CDI. The 
systems level evaluation identifies spatial clusters of CA-CDI localized in the urban forward 
sortation areas (FSAs) of the Niagara Region. This new and emergent pattern is unlike patterns 
seen in other published data for CA-CDI; most work to date associates this infection in the 
community with farmlands, animal farms, and rural areas (Anderson et al., 2017). When I look 
for the effects of communal dwellings such as shelters or group homes, I find that a number of 
assisted living accommodations present on the spatial map within the circular windows for high 
CDI concentration. Other interesting emergent findings from the evaluation of the systems 
connectivity are the presence and temporal independence of various unrelated strains in each 
category of CDI.  
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Interpretation and implications of results  
Epidemiological patterns of CA-CDI: The view through a Complex Adaptive 
Systems (CAS) lens. 
The inter-dependency of individuals is a dominant characteristic of the population-level 
health problems in the field of infectious and communicable diseases (Diez Roux, 2011). In a 
CAS, the physical interactions and environmental influences of the subsystems are critical to the 
success of the preventative measures and the effectiveness of the control processes. Findings 
from the scoping review in this dissertation establish that research to date has mainly focused on 
diagnosis, treatment, and preventive interventions in HA-CDI, with a dearth of studies on CA-
CDI. The CAS framework used in this research yields valuable information on the epidemiology 
of CA-CDI, detecting some of the contributing factors that add to the overall burden of this 
infection.  
Chapters Four and Five establish that hospitalized patients infected with CA-CDI present 
different characteristics from HA-CDI patients and display independent temporal and spatial 
patterns but share genetically similar strains. The connectivity of the various CAS elements 
considered in this study reveals that CDI is not always a problem associated with or originating 
in healthcare settings. Moreover, the coevolution and adaptation of multiple subsystems in this 
particular CAS result in the emergence of a positive feedback loop containing evidence that 
could be constructive for the NHS CAS. More specifically, the positive feedback loops could 
lead to role clarification and better specification of responsibilities; this, in turn, could lead to 
closer cooperation, connectivity and, ultimately, the coevolution of a hospital/ public health 
CAS. For example, modified surveillance processes, research priority setting or funding for CA-
CDI research may develop into additional findings able to guide decision-makers toward more 
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effective preventative processes and novel control strategies. In addition, the cooperation of 
interdependent subsystems could reveal the ambiguities in the direction of transmission 
pathways between hospitals and communities. Identifying emergent community patterns of 
infection transmission within subsystems would lead to planning for interventions and 
improvements in the overall CAS functions and goals. Ultimately, the self-organization of 
stakeholders in hospitals and communities, accompanied by their interaction and adaptation, 
would ensure improvements in the quality of the population health. 
Each manuscript of this dissertation presents a leverage point for strengthening health 
equity policies. The next section interprets each of these in turn, looking at horizontal and 
vertical equity concepts, as defined in Chapter One.  
Inequities in health: Can epidemiology motivate policy-makers? 
Comparative trans-population research and responsible analysis of the empirical results 
represent standards of practice to inform responsible policy decisions that impact population 
health (Schrecker, 2013). This is particularly effective when supporting evidence is challenged 
by political powers (Schrecker, 2013). Given the possibility of such challenges, selecting the 
right research design is essential. Scholars say reductionist approaches that consider a single 
variable at a time may dampen or cover the realities of health inequity (Murray, Gakidou, & 
Frenk, 1999; Rydin et al., 2012). The pluralist concept of “epidemiological worlds” has recently 
been proposed as a methodology to organize the process of research and inquiry in the healthcare 
field (Rydin et al., 2012). Many scholars argue that health inequities mirror the multi-
dimensional influences of the environment, with each influence having an amplifying effect on 
the others (Braveman, 2006; Kawachi, Subramanian, & Almeida-Filho, 2002). Given that 
environmental agents, neighbourhoods, and communities are increasingly recognized as factors 
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impacting health equity, it is very likely they will influence health outcomes at a population level 
(Braveman, 2006; Kawachi, Subramanian, & Almeida-Filho, 2002). 
A significant take-away from the scoping review is the message of under-researched 
areas of CA-CDI. In Canada, the imperative to improve the quality of population and public 
health is clear in the Canadian Institute of Health Research’s (CIHR) emphasis on strategic 
research priorities. CIHR defines coherent intersectoral action for population health 
improvement, scalable population health solutions, and equitable population health impacts as 
research primacies for Canadian scholars in health (Canadian Institute of Health Research, 
2017). From a health policy and equity perspective, the lack of available science to elucidate 
unique clinical care requirements (such as different treatment options for CA-CDI), along with 
the shortage of studies to inform preventative practices and policies, suggests the need for better 
allocation of research resources.  
Despite the undeniable impact of CA-CDI on hospital dynamics and on the quality of 
health and wellbeing within communities, the rate, possible risk factors, and epidemiological 
patterns of CA-CDI in Canada are under-explored. The dissertation’s visualization of communal 
places in its spatial analyses points to the presence of assisted living accommodations with a high 
concentration of CA-CDI in urban parts of the Niagara Region. This feedback provides thought-
provoking grounds for further exploration and raises the question of safety and environmental 
hygiene in these facilities. The Canada Health Act (CHA) requires provinces to deliver all 
necessary health services to every insured resident on a non-profit basis. In terms of disease 
prevention, the Act denotes that Canadians can achieve further improvements in their well-being 
by “combining individual lifestyles that emphasize fitness, prevention of disease and health 
promotion with collective action against the social, environmental and occupational causes of 
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disease, and that they desire a system of health services that will promote physical and mental 
health and protection against disease” (Canada Health Act, 1985). To complement the CHA, the 
Ontario provincial government protects the health and safety of the elderly in nursing homes and 
retirement homes through additional provisions related to safety, environmental hygiene, and 
infection prevention and control within the Long-Term Care Homes Act (S.O.2007, c.8.) and the 
Retirement Homes Act (2010, S.O. 2010, c. 11). The province mandates “The right to live in a 
safe and clean environment where he or she is treated with courtesy and respect and in a way, 
that fully recognizes the resident’s individuality and respects the resident’s dignity”. In 2017, the 
Long-Term Care Homes Act and the Retirement Home Act were amended to include provisions 
for infection prevention and control. Unfortunately, the legislation does not cover the fast-
growing area of assisted living accommodations.  
Public health seeks to improve the quality of life of the elderly population through 
numerous primary, secondary. and tertiary preventive programs, such as cardiovascular disease 
prevention programs, impairment of vision programs, and hearing or dementia programs 
(Schneider, 2006). The increase of the median age in Canada (5.7 years in the past 20 years), 
means that the number of older people with unique and complex medical needs is increasing 
(Statistics Canada, 2015). This creates a two-fold challenge for public health: to improve the 
health of people through prevention programs and to manage the cost control issue as a result of 
these additional programs in an equitable way. A fundamental concern of the dissertation was to 
reveal findings that can be used as leverage points to inform vertical and horizontal policies in 
equity, and, in fact, as the findings suggest, taking a complex systems approach to the CA-CDI 
problem has the potential to inform equitable public health policies supporting new preventative 
 180 
programs. Responding to increasing infections and preventing their complications in the 
community will improve population health and control the cost of ill-health. 
Dissertation limitations  
The studies conducted to answer the questions of this dissertation have undeniable 
strengths but show some common limitations as well. First, the use of CDI surveillance data 
provided a sizeable dataset, but retrospective studies are inherently embedded with a data 
confounding concept that influences dependent and independent variables. This could have 
affected the analyses of the risk factors. In addition, the surveillance reports were missing some 
data elements, possibly introducing the risk of missing data bias; to reduce bias, I used complete-
case analysis. Second, the research lacked access to information on CA-CDI cases that were not 
hospitalized. This reduced the generalizability of the outcomes, as hospitalized patients were 
potentially more ill than those who did not seek hospitalization. However, this would not have 
influenced the validity of the testing methods and statistical processes. Third, a limitation 
specific to the genetics evaluation is that the strain typing assessment was limited to the samples 
from outbreak investigations. A larger comparison of strain typing would have allowed a clearer 
understanding of the genetic relatedness of CA-CDI and HA-CDI.  
Future directions 
Several themes emerge from this research as priority recommendations for future 
research in epidemiology, public health, and hospitals. The outcomes also support advocacy of 
policy proposals geared toward health equity. Immediate future directions and policy proposals 
are forecasted and summarized in Figure 6.1. The figure shows how feedback loops that emerge 
from the recommended public health programs, hospital practices, and health policies will lead 
to the overall evolution of the system.  
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Recommendations for policy-makers. 
For policy advocates who influence health policies and decision-makers who allocate 
funding for improvement programs and research, the following two themes emerge from the 
outcomes of this research:   
1. This research demonstrates an urgent need for studies that improve our understanding of 
CA-CDI. We cannot wait until our communities are hit by multiple outbreaks to begin 
discussions of funding CA-CDI studies. Fiscal provisions for research and discovery 
must be enforced through policies that support systems level (community- and hospital-
based) studies that inform equitable health policies and evidence-informed 
recommendations for practices.  
2. There is a clear need for a national surveillance system to answer imminent CA-CDI 
questions and to create hypotheses for empirical research. This recommendation is 
aligned with the goals of Pan-Canadian Public Health Network (PCPHN) set by the 
Communicable and Infectious Diseases Steering Committee Antimicrobial Resistance 
Surveillance Task Group: an understanding of CA-CDI infection rates and identifying the 
surveillance data elements requirement for CA-CDI is essential for a robust Pan-
Canadian antimicrobial resistance surveillance system (Pan-Canadian Public Health 
Network, 2016). Currently, the only information on CA-CDI is captured by hospital 
surveillance programs, mostly in acute-care settings.  
Recommendations for research in epidemiology for hospitals and public health. 
For hospital administrators and federal, provincial, or local public health departments, the 
results of the research lead to both transdisciplinary and independent recommendations.    
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1. Hospitals must evaluate the impact of asymptomatic carriers and colonized patients on 
hospital environments to map out the overall CDI transmission pathways and to evaluate 
the feasibility of current practices in healthcare settings. Admission screening studies to 
quantify this question could contribute to our understanding of the bioburden and the role 
of asymptomatic carriers in hospital outbreaks. Australia, the United States, and several 
European countries have begun to emphasize systems level surveillance and evaluation of 
CA-CDI. Canada should follow their lead. Until we gain a better understanding of the 
CDI continuum, the use of only hospital surveillance and preventive measures cannot be 
completely successful in reducing the hospital cases or outbreaks. 
2. There is a limited understanding of the burden of CA-CDI on health care, as some cases 
are not captured by traditional hospital surveillance programs. The last published 
Canadian study to conduct a cost analysis of hospitalized and community-dwelling 
patients estimated the cost (based on the anticipated projection from HA-CDI) at $281 
million, 92%  of which ($260 million) was attributed to in-hospital costs, 4% ($12 
million) to direct medical costs, and 4% (10 million) to lost productivity costs (Levy et 
al., 2015). An accurate evaluation of the CA-CDI cost impact can encourage advocacy 
for policies that recommend and support CA-CDI research and funding.  
3. In addition to quantifiable empirical studies to inform the discourse of risk factors, 
treatment options, and environmental influences, we need community-based research on 
CA-CDI and its impact on quality of life (QOL). QOL is defined as “the degree to which 
a person enjoys the important possibilities of his/her life” (Raphael, 2010). CA-CDI is 
increasing in hospitals, with community cases progressively seeking hospitalization; it 
mostly targets the elderly, causing morbidities and creating tangible and intangible costs 
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to the patient, family members, or care providers in the community. Research has 
established a strong association between health status and QOL in older persons. 
Considering the growing proportion of the elderly in our communities, measurement of 
QOL in the affected elderly with CA-CDI can be used to directly evaluate the impact of 
existing services, programs, treatment options, and additional required health services 
(Raphael, 2010).  
Final statement  
Three complementary manuscripts answer the questions formulated in this dissertation; 
they evaluate the overall scope of our knowledge about CA-CDI and offer an epidemiological 
comparative analysis of CA-CDI in NHS hospitals. Each manuscript opens up opportunities for 
future research and suggests themes to inspire policies supporting health equity. The findings 
confirm that a CAS approach to research and analysis grounded in an epidemiological 
framework can detect leverage points toward improvement and equity in population health.  
In 2010, during a course on the political economy of health, there was an interesting 
discussion of the effects of living conditions on Canadians’ experiences with adult-onset 
diabetes. Included in the discussion was the fact that the incidence of Type II diabetes is noticed 
more in lower-income neighbourhoods (Mikkonen & Raphael, 2010). The discussion instigated 
the question of whether the incidence of community acquired infections that historically used to 
be hospital problems may be related to an equity element. This research begins to answer that 
question. Using a combined complex adaptive systems tenet and an epidemiological disease 
transmission triad, it evaluates the dynamics of one such community acquired infection.  
If they are heeded by policy-makers, the results could lead to immediate improvements in 
equitable health policies at a hospital and population level. Policy-makers could advise hospitals, 
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community stakeholders, and public health departments to take a multidisciplinary approach, 
examine the problem from every angle, create an infrastructure to share resources, and facilitate 
collaboration; this should give them the resources to tackle the CA-CDI issue.  
Forrester says: “In the complex system … causes are usually found, not in prior events, 
but in the structure and policies of the system …” (Forrester, 1969, pp. 9 &10). It is through 
systems thinking, exploration, and collaboration that evidence advises the structures and policies 
able to inform innovative ideas. 
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Figures 
 
Figure 6.1 – Recommendations for future directions for policy-makers, hospitals, and public 
health departments. 
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Supplement – Methodology 
Chapter Overview 
This supplemental chapter discusses the research methodology, along with the setting, 
participants, case definition, eligibility criteria, instrumentation, and measures. It explains the use 
of administrative data, the statistical analyses and software used for analysis, and the temporal 
and spatial analysis in Chapters Four and Five, and gives the ethical considerations.  
Study Design 
This study used a case series design to examine community-acquired Clostridium difficile 
infections (CA-CDI) cases identified at Niagara Health System (NHS) hospitals. The 
epidemiological characteristics of the cases, the molecular relatedness of Clostridium difficile, 
and the temporal and spatial patterns of CA-CDI cases were compared and contrasted with the 
cases acquired in hospitals, known as healthcare-associated Clostridium difficile infections (HA-
CDI). 
Setting 
The Niagara Region is located in southern Ontario, Canada. It has a total area of 1,852 
square kilometres and a total population of 427,421. The Niagara Region consists of 12 
municipalities: Fort Erie, Grimsby, Lincoln, Niagara-on-the-Lake, Niagara Falls, Pelham, Port 
Colborne, St. Catharines, Thorold, Wainfleet, Welland, and West Lincoln. Figure Supl.1 is a 
map of the Niagara Region and its municipalities, based on the 2011 census (Statistics Canada, 
2016). 
The NHS, which comprises six sites, is the largest multisite hospital amalgamation in 
Ontario, providing healthcare services to the entire Niagara Region. Approximately 26,000 
patients are admitted to NHS hospitals each year, where they have access to a complete range of 
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health programs and services (see Table Supl.1). Data for this study comprised CDI cases during 
the study period from all NHS sites. 
Participants 
Purposive sampling of the Infection Prevention and Control (IPAC) surveillance database 
identified 1052 cases of CDI in-patients admitted to all NHS hospitals between September 2011 
and December 2013. Overall, 425 cases did not meet the eligibility criteria and were eliminated 
from further analysis. This included recurrent and relapse cases (n=170), cases that were positive 
in another healthcare facility and were transferred or admitted to NHS with known CDI (n=49). 
Colonized cases that tested positive but had no clinical sign or symptoms of a typical CDI were 
also excluded (n=135). Thirteen patients had incomplete records that could not be resolved after 
a review of electronic and hard copies of their records. In purposive sampling, a non-probable 
group of samples based on a desired characteristic is selected from a population. The study used 
this technique because of its reliance on case confirmation for participant selection. The 
surveillance database was an Excel spreadsheet that compiled the cases of CDI. Data were 
manually entered in the surveillance spreadsheet (see Table Supl.2 for sample surveillance form), 
after reviewing patient charts and after case confirmation by laboratory reports of the positive 
cases of C. difficile toxin (see eligibility criteria section for case identification and confirmation). 
The surveillance database included patient demographics, admission date, specimen collection 
date, classification of community-acquired or healthcare-associated, and other relevant 
information to allow IPAC personnel to manage and perform investigation, assessment, and 
follow up of each case on a daily basis and to allow IPAC personnel to implement or discharge 
isolation requirements. The surveillance list also provided information to detect, track, and 
manage CDI outbreaks at NHS sites. 
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Eligibility Criteria and Case Definition 
Cases of CDI were detected through daily surveillance and symptoms exploration of 
hospitalized patients or by symptoms observation upon admission. A positive laboratory stool 
toxin test and clinical indications were used to finalize cases. All positive CDI cases were 
reviewed by an infectious diseases physician and by IPAC staff. Cases had to align with the 
criteria set out in NHS Policy 170 100 020 and NHS Procedure 170 100 021 (see Appendix B) 
and had to meet the CDI definition of HA-CDI or CA-CDI (see Table Supl. 3), as well as 
eligibility criteria based on laboratory findings and other significant clinical manifestations. 
CDI cases were defined as patients with diarrhea, with laboratory confirmation of a 
positive toxin assay (A/B) for Clostridium difficile, and/or with visualization of 
pseudomembranes on sigmoidoscopy, or colonoscopy, or histological/pathological diagnosis. 
Pending clinical verification, CDI cases were categorized into two groups: CA-CDI or HA-CDI.  
The definitions of HA-CDI and CA-CDI cases were based on the NHS policies for CDI 
infections derived from the provincial guidelines for management of Clostridium difficile 
infections in healthcare settings, summarized in Table Supl. 3 (Provincial Infectious Diseases 
Advisory Committee (PIDAC), 2011). 
A CA-CDI case was a case that matched the clinical case definition for CDI and met the 
criteria below:  
• The symptoms of CDI were present on admission, or symptoms onset occurred less than 72 
hours after admission. 
• No exposure to any healthcare facility had occurred within the last four weeks, or the source 
of infection could not be determined and the patient had not had HA-CDI in the last eight 
weeks. 
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An HA-CDI case was a case that met the clinical case definition of CDI and met one of 
the two criteria listed below: 
• The patient did not present with CDI on admission but showed onset of symptoms >72 
hours after admission. 
• The infection was present at the time of admission but was related to a previous 
admission to the same facility within the last four weeks. 
Testing for CDI 
From September 2011 to April 2012, NHS sent their CDI samples for diagnostic testing 
to St. Joseph’s Hospital in Hamilton, Ontario. They used a laboratory-developed Polymerase-
Chain Reaction (PCR) method using the BD GeneOhm™ Cdiff Assay, with a sensitivity and 
specificity of 93.8% and 95.5% respectively. This method used specific primers and a 
fluorescent-labeled TaqMan probe directed at the tcdC gene (toxin A and B regulator), the cdtA 
(binary toxin gene), and the rrnB gene (16Sr DNA internal control), documented key indicators 
of the presence of C. difficile. The TaqMan-based quantitative PCR is a highly selective and 
highly accurate method of detecting targeted strains, testing for as low as 103 cells/gram of stool 
of the specimen. The high sensitivity and specificity increase the accuracy of detection (Hiroyuki 
et al., 2014). From April 2012 to December 2013, NHS sent the samples for CDI diagnostic 
testing to Life Labs, which used BD MAX ™ Cdiff, a Nucleic Acid Amplification Test (NAAT), 
with a sensitivity of 96.3% and a specificity of 92.4% (Dalpke, Hofko, Zorn, & Zimmermann, 
2013).  
The provincial reference laboratory performed the strain typing of the C. difficile isolates, 
using a pulsed-field gel electrophoresis (PFGE) technique, a standard National Medical 
Laboratory procedure. A fraction of the culture medium prepared for PFGE was also used to 
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extract DNA using the Bio-Rad Instagene reagent and following the manufacturer’s protocol. 
Extracted DNA was analyzed by modified, multiple-locus, variable-number, tandem-repeat 
analysis (MMLVA), according to the protocol developed at Public Health Ontario’s laboratory 
(Alfa et al., 2000). PFGE and MMLVA data were processed with the BioNumerics software 
(v.5, Applied Maths) to identify genetic profiles and relatedness of isolates. A standard set of 12 
PFGE profiles from NML was used to classify pulsotypes; those not matching any of the 12 were 
assigned arbitrary letter designations. MMLVA profiles with a difference of less than 3% were 
considered to belong to the same strain. Whenever a specimen was canceled because of poor 
specimen quality, it was reported to the clinical wards, and repeat samples were sent to the 
laboratory for confirmation of C. difficile toxin. 
Data Source 
Surveillance data collection and data entry. 
 The processes of data collection and surveillance for HA-CDI and CA-CDI cases were 
carried out by certified and trained IPAC professionals on a daily basis as a part of their routine 
practice. The surveillance tool was an industry standard that was aimed to collect data elements 
for investigation of CDI cases (see Table Supl.2). Many evidence-based resources were used to 
develop the CDI surveillance tool (and the policies and procedures for CDI management and 
control in NHS), such as the guidelines developed by the Provincial Infectious Diseases 
Advisory Committee (PIDAC) in Ontario (PIDAC, 2011). Each case of CDI had a single 
surveillance form, and the CDI cases for each NHS hospital site were compiled in a database 
shared with the Decision Support department on a shared drive with restricted access. The Excel 
files were combined by matching cases through medical records numbers, creating one large file 
combining matched/aligned data from all the files in all NHS hospitals over the study period.  
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Data for postal codes of the CDI cases were added to the combined file for the cases 
detected through surveillance. FSA (forward sortation area—using the first three digits of the 
postal code) and admission diagnosis information were pulled from Meditech, the NHS database 
for demographics, history taking, and data collection upon admission. The strain testing results 
were accessed through public health laboratories and added to the data. 
The combined file was reviewed by a member of the Decision Support department for 
deficiencies in demographic information and surveillance records. In cases of missing 
information, the electronic record of the patient was matched with the paper record, using name, 
admission date, and a site-specific medical records number. Missing information was then 
retrieved from the paper copies of the surveillance forms and medical records. For privacy and 
confidentiality of patient information, a sequential number was assigned to the patients, and their 
medical records numbers were eliminated from the research file. A de-identified file of complied 
information was the final product. A list of the final variables used for data analysis is presented 
in Table Sup.4. 
Use of administrative data. 
Chapters Four and Five use administrative data to investigate the epidemiological 
patterns of CA-CDI in the Niagara Region. Administrative data are defined as secondary data, 
because they were collected initially by individuals other than the researcher and served another 
purpose (Mertens, 2010). Secondary data, such as quality improvement and organizational record 
databases, infection prevention and control surveillance databases, or decision support databases 
for patients’ discharge chart summary, are collected for quality improvement reporting and 
evaluation, managerial and organizational purposes. But they are useful for researchers as well. 
Secondary data give researchers access to a large repository of information relatively quickly and 
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efficiently and allow them to combine several databases (Williams & Young, 1996). The risks of 
recall bias, social desirability bias, or acquiescence bias are reduced, as the data gathering 
process does not rely on self-reports or the memory of the participants (Mertens, 2010). 
However, as the initial purpose of collecting the administrative data used in the dissertation was 
not for research, unfilled data fields may expose the study to the risk of missing outcome data 
(Stern et al., 2009). Therefore, during analysis, complete-case analysis was conducted when 
missing data were noted (missing data rates are listed in Chapter Four, Table 4.3).  
Structure of Variables 
Patient demographics, co-morbidities, exposure to certain medications (antimicrobials, 
corticosteroids and proton pump inhibitors), strain testing of C. difficile isolates, infection date 
(laboratory test date), and community location (based on the first three digits of the patient’s 
postal code) were variables of interest based on the literature search described in detail in 
Chapter Three.  
Many studies conclude that exposure to antimicrobials and disturbance of intestinal flora 
are among the main factors that lead to patients’ development of CA-CDI. However, some 
studies challenge this statement, arguing that antimicrobial exposure is not always a contributing 
factor. Nonetheless, the research must look for these as contributing factors. Similarly, for proton 
pump inhibitors (PPIs) and corticosteroids, despite contradictory reports on the contributing 
effects of these medications to an increased risk of CA-CDI, research must still connect exposure 
with the risk of CA-CDI acquisition. Association with gastrointestinal disorders has also been 
reported in some studies (see Chapter Four). Accordingly, the dissertation looks for the patterns 
of antimicrobial, PPI, steroids, and history of GI disorders, comparing the findings to those 
reported in other studies and/or findings on HA-CDI in NHS hospitals (see Table Supl.5). 
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The dissertation’s comparative evaluation of CA-CDI and HA-CDI patients queried 
possible differences in the distribution pattern of the disease between the two categories of CDI. 
It finds that HA-CDI often occurs in the elderly, while the majority of CA-CDI studies report a 
higher prevalence in younger individuals (aged 50 to 81) and in women (ranging from 11% to 
77% ( (Kutty et al., 2010).  
The dissertation’s evaluation of the strain variation between CA-CDI and HA-CDI 
samples (especially outbreak cases sent for strain testing) spoke to the genetic relatedness of the 
two categories and determined whether CA-CDI is genetically divergent from HA-CDI. In other 
words, did the community cases cause the hospital cases? Other studies have reported the 
presence of unique and different strains, pointing to the possibility of reservoirs in the 
community (Dumyati et al., 2012). 
Studies examining the seasonal variations in HA-CDI often report an increase in winter 
and spring months, a pattern attributed to the increased antibiotic use during the flu/pneumonia 
season and winter months. However, studies examining seasonality in CA-CDI mostly find no 
consistent patterns. This dissertation looked into seasonality, temporality, and spatial distribution 
to determine whether an increase in the community cases could lead to an increased risk of HA-
CDI in hospitals. It evaluated the temporal patterns of each category and assessed pattern 
dependencies. 
Spatial analysis of CA-CDI cases was used in one previous study, as noted in the scoping 
review in Chapter Three; this study found an association between CA-CDI and animal farms and 
animal production sites (Anderson et al., 2017). Unusual spatial concentrations of diseases in the 
community could be attributed to underlying risk factors that may potentially increase infections 
in certain neighbourhoods.  
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Overall, the dissertation’s selection of variables and their evaluation were determined by 
the fact that, to date, few Canadian studies have explored the epidemiological patterns of CA-
CDI in hospitals and in communities. Table Supl. 5 lists the variables analyzed in this research; it 
gives the rationale for their selection and some of the main references.   
Statistical Analysis 
Significant testing and descriptive analysis. 
Differences between the median age and gender of HA-CDI and CA-CDI cases were 
compared using the Mann-Whitney U test for independent samples and the Pearson Chi-Square. 
For significant testing of binary outcome data, the Mann-Whitney U test is recommended. To 
determine the significance of the variations of the categorical variables, the Chi-Square test for 
identifying differences in covariate properties is applicable. Descriptive and inferential analyses 
used the SPSS version 21 (IBM Corp., Armonk, NY).   
Spatial cluster analysis. 
Amongst the three main epidemiologic variables—time, person and place—the latter is 
often the more challenging to explore and visualize (Choi, 2013). Environmental influences on 
the health of individuals could be a random or non-random experience. However, technological 
advances offer researchers new opportunities to compare these phenomena and quantify the 
variations in geographical patterns, allowing them to make projections for managing, planning, 
and even preventing the need for public health interventions (Jacques, 2008). Spatial clustering 
has been defined as “a geographically bounded group of occurrences of sufficient size and 
concentration to be unlikely to have occurred by chance”(Aldstadt, 2009). Exploratory spatial 
data analysis identifies patterns through visualization and geo-statistics and recognizes the 
location and magnitude of the statistically significant descriptors. My use of this type of analysis 
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in the dissertation allowed me to test a hypothesis that attempts to interpret geographical patterns 
in epidemiological studies.  
Application of scan statistics. 
Descriptive maps have long been used for geographical investigations of epidemiological 
studies. Most maps show geographical patterns and areas of high or low outcome concentration 
that are visually apparent to the observer, regardless of the significance or randomness of the 
detected clusters. Therefore, complementing geographical distribution maps with spatial 
randomness statistical tests indicates whether the clustering is an act of chance or the result of an 
underlying risk factor. Some global clustering tests, such as Mantel-Bailar’s Test, evaluate the 
overall presence of clusters within an area of interest, without an indicative location of the 
cluster(s). Other global clustering tests, such as Cuzick-Edwards’ K-nearest Neighbor Test, are 
more powerful if used in rural structures because of the designations used to define the analysis. 
In contrast, statistical processes, such as Tango’s Maximized Excess Event Test, are statistically 
more powerful when used in an urban setting. 
The application of spatial scan statistics allows researchers to measure the significance 
and the location of a general or focused cluster (Kulldorff & Nagarwalla, 1995) that 
subsequently leads to clues about the disease under investigation. Spatial scan statistics employ a 
likelihood ratio test to assess clusters of various sizes and adjust for multiple testing (Heffernan 
et al., 2004). The Monte Carlo simulation of 999 randomization of the dataset ranks the 
likelihood of the cluster’s significance (Kulldorff, 1997).  Focused clusters are detected based on 
multiple circular (or other shaped) windows of variable sizes, scanning the given geographical 
area for the variable of interest. The null hypothesis of equivalent risk inside and outside the 
circular scan windows is rejected when the number of cases inside the cluster zone is more than 
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the expected number of cases, independent of the specific geographical locations and 
administrative boundaries. Appendix C provides the statistical processes used to calculate the 
likelihood test and the number of expected cases.  
1 – Purely spatial Scan Statistics for investigation of non-random clusters. 
Using a circular scan window centred on each possible point throughout the study area, 
this one-dimensional spatial Scan Statistic process compares the disease risk observed inside the 
window (cluster) with the risk outside the window (cluster). The most likely cluster has the 
highest likelihood ratio, with p values of 0.005 or less.  
2 – Spatio-temporal Scan Statistics for investigation of non-random clusters. 
The space-time Scan Statistics identify clusters throughout the study region by scanning 
for cases using a cylindrical window, where the base of the cylinder is centred on one of the 
multiple centroids within the study area. The height of the cylinder defines the time interval as a 
whole, for the entire study period. The cylindrical window then scans the geographic base while 
changing the radius of the base as well as scanning for possible time intervals (changing the 
height of the cylinder).   
3 – Space-time permutation Scan Statistics for investigating of independent clusters. 
This model identifies the increased risk of a disease or differences in geographical 
distribution at different times by adjusting for time and space. Therefore, the number of observed 
cases in a cluster is compared to the expected number of cases if all cases were independent of 
each other in terms of their temporal and spatial locations. 
For computation purposes, a Poisson distribution model was used while operating the 
SatScan software. The first three digits of individuals’ postal codes were used to identify the 
locations or smaller geographical units within the overall study area. The time precision was set 
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by the day. Temporal and geographical checks were in place to ensure that all cases, controls, 
and populations were within the specified temporal period and geographical area of the study. 
The maximum temporal cluster size was set for 50% of the study time and the maximum spatial 
cluster size was set for 50% of the study’s at-risk population. 
Temporal Cluster Analysis 
Statistical Process Control charts to investigate out-of-control abnormalities and 
outbreaks. 
As suggested in Benneyan (1998), the Statistical Process Control (SPC) approach was 
used to provide information on unusual variations and exceptional changes in CDI infection rates 
between months and seasons (Benneyan, 1998a). In this methodology, endemic or epidemic 
conditions can be identified based on the location of the plotted values and their relationship to 
the centre line (almost always the arithmetical mean of the plotted values) and the upper and 
lower control limits or the natural process limits (Benneyan, 1998b). In industry, a process is 
considered stable if data fall within 3 sigma limits. Therefore, deviance from 3 sigma limits 
identifies medium to large shifts in data. Although in an industrial environment, use of control 
charts with 3 sigma has been recommended (99.73% of all plot points in a normal distribution 
and stable process), use of a 3-sigma control limit is questionable for healthcare (Sellick, 1993). 
If an incidence is plotted above or below three standard deviations of the centre line, an 
erroneous event or phenomenon has caused the variation. Therefore, for epidemiological 
investigation of infections, more sensitive and less specific standards should be applied to 
increase the power and the confidence of the “out of statistical control” state of CDI (Benneyan, 
1998b). For this study, the control limits were set at 2-sigma, covering 95% of the plotted 
points; smaller variations in data could be identified that, in practice, are signals for thorough 
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epidemiological investigation (Sellick, 1993). Choosing a tighter control limit increases the rate 
of false positives or out of control points (type I error) to 5% for each plotted value (compared to 
0.27%); this can also be clarified by epidemiological investigation. 
Rare events of disease clustering in a given time period are best explained by the Poisson 
process (Benneyan, 1998b). Therefore, this analysis used u control charts for discrete data 
(numerator) with a varying size of monthly patient days (denominator) to monitor the total 
number of incidents per month (Benneyan, 1998a; Sellick, 1993). Control limits were set at  2-
sigma to allow the detection of out-of-range activities and outbreaks. The statistical process 
control charts were developed using MS Excel for Mac, Version 15.27(161010). 
Temporal Scan Statistics for investigation of non-random clusters.  
To further explore the temporal features of CA-CDI and HA-CDI in the Niagara Region, 
Scan Statistics using the Bernoulli binominal distribution were used to search for non-random 
temporal clusters of high CDI rates. Scan Statistics identifies and evaluates clusters of cases in a 
purely spatial, purely temporal, or space-time setting (Kulldorff, 2005). A Bernoulli distribution 
is a 0/1, case-control type of binary data. Scan Statistics uses multiple different window sizes to 
gradually scan across time and/or space and documents the number of observed and expected 
observations inside the windows. The risk inside the clusters compared to outside the clusters, 
measuring for irregularity of the potential cluster, is based on a likelihood ratio (Lawson, 
Banerjee, Haning, & Yugarte, 2016). The cluster that yields the most extreme ratio is least likely 
to be by chance (Lawson et al., 2016). 
For computation purposes, HA-CDI cases were assigned as cases and CA-CDI cases as 
controls. A purely temporal retrospective multivariate Scan Statistics was conducted, scanning 
for clusters with high rates using the Bernoulli model. The minimum temporal precision was set 
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at one month, and the maximum temporal cluster size was set at 50% of the study period. A 
maximum temporal cluster size limits the maximum size of the population at risk within the 
cluster to no more than 50% of the population at risk in the study (Elliott & Wartenberg, 2004; 
Kulldorff & Nagarwalla, 1995).  
Random replication of the dataset using computer simulation is a feature of Scan 
Statistics that adds to the power of the test. The number of replications under the null hypothesis 
for the standard Monte Carlo test was set at 999 to ensure statistical power for the Scan Statistic 
and the p-value calculation (Kulldorff, 2005). Under this setting, a high likelihood ratio rejects 
the null hypothesis and favours the clustering inside the scanning window(s) (Kulldorff, 2005). 
In this step of the temporal study, the null hypothesis assumes that the temporal clusters of 
hospitalized CA-CDI and HA-CDI occur at the same time. The alternative hypothesis suggests 
the presence of clusters in hospitalized CA-CDI that do not show up at the same time as those in 
HA-CDI.  
Test of seasonality. 
To find out whether seasonal properties have a role in the increase of CDI in certain 
periods, the time series data for both groups, CA-CDI and HA- CDI, were adjusted for a seasonal 
component (Carlberg, 2015).  Given the small number of seasonal points, an analytical approach 
was used rather than a graphical depiction of the seasonal influences (more common but mainly 
used for longer study periods). The additive seasonal indexes were calculated by subtracting the 
grand mean from each seasonal average. Subtracting each seasonal index from the associated 
seasonal measurement provided the seasonal adjusted values for each season (Carlberg, 2015).  
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Ethical Considerations 
The data used for the statistical analysis for this research were stored in administrative 
databases in the NHS Decision Support Department and the Infection Prevention and Control 
Department. The de-identified list of CDI patients was obtained from the central Decision 
Support department of the NHS only after obtaining REB approval at York University and NHS.  
Data were de-identified by the Decision Support staff to protect the private and personal 
information of the CDI cases in this study. All files were password protected, and the passwords 
were emailed to the researcher in a separate email.  
Use of administrative archival clinical data for quality improvement purposes is very 
common within the hospital environment. However, for this research and to follow the 
recommendations of the Canadian Institutes of Health Research (Canadian Institutes of Health 
Research, 2010) policy for “Ethical Conduct for Research Involving Humans,” relevant ethical 
approval was obtained from York University’s Research Ethics Board (see Appendix D) and the 
Niagara Health Service’s Research Ethics Board (see Appendix E).  
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Tables 
Table Supl.1 – NHS hospital sites and the programs and services offered in each site. 
NHS Hospital Site Programs and services 
• Douglas Memorial, in Fort Erie • Complex Care 
• Diagnostic Imaging 
• Laboratory 
• Ontario Breast Screening Clinic 
• Outpatient Clinics 
• Outpatient Mental Health Services 
• Urgent Care Services 
• Greater Niagara General, in Niagara 
Falls 
• Cardiology 
• Complex Care 
• Critical Care Services 
• Diagnostic Imaging 
• Emergency Department 
• Laboratory 
• Medicine 
• Off-site Niagara Falls dialysis centre 
• Ontario Breast Screening Clinic 
• Outpatient Clinics 
• Outpatient Mental Health Services 
• Regional Geriatric Assessment 
• Regional Stroke Services 
• Surgery 
• Pharmacy 
• Niagara-on-the-Lake  • Diagnostic Imaging 
• Laboratory 
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NHS Hospital Site Programs and services 
• Port Colborne  • Addictions Services 
• Complex Care 
• Diagnostic Imaging 
• Laboratory 
• Ontario Breast Screening Clinic 
• Outpatient Clinics 
• Urgent Care Services 
• St. Catharines  
 
• Cardiology Services 
• Children’s Health 
• Critical Care Services 
• Diagnostic Imaging 
• Emergency and Urgent Care 
• Kidney Care Program 
• Laboratory 
• Medicine 
• Mental Health and Addictions 
• Ontario Breast Screening Clinic 
• Outpatient Clinics 
• Pharmacy 
• Surgery 
• Walker Family Cancer Centre 
• Women’s and Babies Health 
• Welland  • Ambulatory Clinics 
• Complex Care 
• Critical Care Services 
• Diabetes Education Centre 
• Diagnostic Imaging 
• Emergency Department 
• Laboratory 
• Long-Term Care 
• Medicine 
• Ontario Breast Screening Clinic 
• Ophthalmology Program  
• Outpatient Mental Health Services 
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NHS Hospital Site Programs and services 
• Pharmacy 
• Satellite dialysis Centre 
• Surgery 
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Table Supl.2 –  Data elements on NHS surveillance form for CDI investigation. 
Surveillance data elements Comments 
Initiated IPAC personnel  
Completed IPAC Personnel  
Patient’s name  
Admission diagnosis  
Admission date  
Previous admission within 4 weeks  
Surgeries  
Patient ID#  
Specimen collection date  
Lab specimen #  
CDI attribution  
Unit attributed  
Other location attributed  
Room#  
Temperature (date and result)  
Albumin (date and result)  
Creatinine (date and result)  
White blood cells (date and result)  
Onset of diarrhea  
Recent negative  
Risk factors: Age>65, previous CDI, 
previous surgery, previous admission, 
laxative use, PPI use, other GI problems  
Antibiotic history, previous and current  
Current CDI treatment: Flagyl/Vancomycin  
Dialysis: Y/N  
Flag? IPAC measures on admission? Y/N  
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Table Supl.3 – NHS definition for CDI, HA-CDI, and CA-CDI based on the NHS policies for 
CDI infections derived from the provincial guidelines for management of Clostridium difficile 
infections in healthcare settings.  
 
CDI definition 
• A patient with diarrhea with laboratory confirmation of a positive toxin assay (A/B) 
for Clostridium difficile, or  
• Visualization of pseudomembranes on sigmoidoscopy, or  
• Colonoscopy, or histological/pathological diagnosis of pseudomembranous colitis.  
 Definition of HA-CDIs  Definition of CA-CDIs 
An HA-CDI case is defined as a patient 
who has not had CDI in the past eight 
weeks but meets one of the following 
criteria: 
• He or she does not present with CDI 
upon admission but shows onset of 
symptoms >72 hours after admission. 
• The infection was present at time of 
admission but was related to a previous 
admission to the same facility within 
the last four weeks. 
A CA-CDI case matches the case definition 
for CDI and does not match the HA-CDI 
definitions: in other words: 
• The symptoms of CDI were present 
upon admission, or symptom onset was 
less than 72 hours after admission. 
• No exposure to any healthcare facility 
occurred within the last four weeks, or 
the source of infection cannot be 
determined and the patient has not had 
HA-CDI in the last eight weeks. 
 
Note. Eligibility criteria are based on the case definitions for each category (PIDAC, 2011) . 
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Table Supl.4 – Research file data elements for CA-CDI study in the Niagara Region. 
 
Research data elements collected in a combined Excel file 
Coding number 
Gender 
Age 
Admission date 
Specimen collection date 
HA-CDI or CA-CDI 
Admission within four weeks of previous admission 
Admission diagnosis 
Age >65 
Previous CDI 
Previous surgery 
Laxative use 
Another inflammatory GI  
PPI use 
Previous antibiotics use  
Current antibiotics use 
Postal code (FSA) 
PFGE results: Toxin A, B or Binary? 
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Table Supl.5 – Variables of interest in study of CA-CDI in the Niagara Region: Rationale for 
selection and supporting references 
 
Variable Rationale Reference 
Antimicrobial 
exposure 
Increased incidence as a result 
of imbalance of normal flora of 
the intestines 
Increased risk: OR 6.91, (95% 
CI) 4.17-11.44 
 
Aronsson & Mollby et al., 
1985  
Bauer & Veenendaal et al., 
2009  
Southern & Rahmani et al., 
2010 
Baxter& Ray et al., 2008 
Deshpande et al., 2013  
Wern, Ahmed et al., 2005 
 
Use of proton pump 
inhibitors (PPEs) 
Increased risk due to reduced 
gastric acid 
Increased Risk: OR 2.7 (CI 
95%) 1.4–5.2 
 
Dial & Alrasadi et al., 2004 
Deshpande & Pant et al., 2012 
Use of laxatives or 
stool softeners 
 
Positive result on CDI testing  
Increased risk: OR 3.26 (CI 
95%) 1.51–7.02 
 
Batajoo & Weber et al., 2015 
McFarland et al.,1990 
 
Inflammatory bowel 
disease  
 
Disease flare ups may lead to 
colonization 
Increased risk: OR 4.7 (CI 95%) 
1–21 
 
Thibault et al.,1991 
Gupta & Khanna, 2014 
Gastrointestinal 
surgery 
Intestinal stasis may predispose 
to CDI  
Increased risk: OR 23.2 (CI 
95%) 2.1–255 
 
Brown et al.,1990 
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Variable Rationale Reference 
History of CDI Failure of treatment due to other 
antibiotics 
Reported in up to 20% of cases  
Fekety & McFarland et al. 
1997 
Modena & Gollamoudi et al., 
2006 
 
Demographics (age, 
gender)  
Looking for new and different 
patterns of disease distribution 
in demographics, usually higher 
incidence in old age and in 
female 
Aronsson & Mollby et al., 
1985, CDC, 2008 
Lessa & Mu et al., 2014 
Pépin & Valiquette et al., 2005 
Barbut & Petit, 2001 
Southern &Rahmani et al., 
2005 
Brown et al.,1990 
 
Genetic strain 
variations 
To confirm or rule out the 
genetic relatedness between 
CA-CDI and HA-CDI cases.  
 
Gupta et al., 2014 
Temporal or 
seasonal variations 
To search for temporal and 
seasonal patterns. Some studies 
on HA-CDI concluded 
association with flu season as a 
result of antimicrobial use  
 
Gilca et al., 2012 
Pépin et al., 2005 
Spatial variations To search for unusual and new 
distribution patterns  
 
Anderson et al., 2017 
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Figures 
 
 
Figure Supl.1 – An illustration of the Niagara Region and its population, based on data from the 
2011 Census (Statistics Canada, 2011). 
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Appendices 
Appendix B – Niagara Health System Policy and Procedure Documents. 
    a) NHS Policy: Document Number 170-100-020. 
 
 
TITLE:  Clostridium difficile Infection (CDI) POLICY 
DOCUMENT NUMBER:  170-100-020 PAGE 1 OF 2 
SECTION:  Infection Prevention and Control 
SUBSECTION:  Nosocomial Transmissions 
EFFECTIVE 
DATE:  
(DD/MM/YY) 
25/06/08 
APPROVED BY: 
Chair, Infection Control Committee 
Interim Chair, Medical Advisory Committee 
VP Clinical Services 
REVISION 
DATE:  
(DD/MM/YY) 
07/04/11 
 
1.0 Purpose   
To identify, prevent and control the spread of Clostridium difficile Infection (CDI).  
 
2.0 Scope  
Applies to all programs and services at all sites of the Niagara Health System (NHS).  
 
3.0 Definitions 
3.1 Diarrhea:  Loose/watery bowel movements (conforms to the shape of the container) the 
bowel movements are unusual or different for the patient; and there is no other recognized 
etiology for the diarrhea (for example, laxative use). 
 
3.2 Clostridium difficile Infection (CDI) case definition:  
Diarrhea (as defined above)   
WITH  
Laboratory confirmation of a positive toxin assay (A/B) for Clostridium difficile, 
OR  
Visualization of pseudomembranes on sigmoidoscopy or colonoscopy;  
OR   
Histological/pathological diagnosis of pseudomembranous colitis. 
 
3.3 New nosocomial case:  A case that meets the case definition for CDI; AND CDI was not 
present on admission (i.e. onset of symptoms >72 hours after admission); OR The 
infection was present at time of admission but was related to a previous admission to the 
same facility within the last 4 weeks; AND The case has not had CDI in the past 8 weeks.   
 
3.4 Nosocomial case attributed to other Health Care Facilities (HAI-Other) : 
a) A case that meets the case definition for CDI; AND CDI was present on admission; OR  
b) The case had symptoms onset <72 hours after admission: AND There was exposure 
to any health care facility within the last 4 weeks; AND The case has not had CDI in 
the past 8 weeks. 
 
3.5 Indeterminate case: The infection was present on admission or <72 hours after admission 
and there was no admission to the same facility within the last 4 weeks AND the case has 
not had CDI in the past 8 weeks.   
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3.6 Relapse: The patient has had a recurrence within 8 weeks of the completion of treatment 
for previous CDI.  
 
3.7 Cluster:  A grouping of cases within a specific time frame and geographic location 
suggesting a possible association between the cases with respect to transmission.  
 
4.0 Policy   
4.1 This document provides a guideline for the control of a CDI case within the NHS by early 
identification, appropriate isolation and timely communication following best practices for 
the management of CDI. 
 
5.0 Related Documents    
Appendix – NHS Sample Fact Sheets for Patients/Visitors (English Version) – 170-100-021C 
Appendix – NHS Sample Fact Sheets for Patients/Visitors (French Version) – 170-100-021D 
Appendix – CDI – NHS CDI Patient Data Collection – 170-100-021B 
Appendix – Educational Handout for Healthcare Workers – 170-100-021F 
Appendix – Diarrhea Algorithm – 170-100-021A 
Appendix – Outbreak Management Checklist – 170-100-021E 
Procedure – Clostridium difficile Infection (CDI) – 170-100-021 
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    b) NHS Procedure: Document Number 170-100-021. 
 
 
TITLE:  Clostridium difficile Infection 
(CDI) 
PROCEDURE 
DOCUMENT NUMBER:  170-100-021 PAGE 1 OF 6 
SECTION:  Infection Prevention and Control 
SUBSECTION:  Nosocomial Transmissions 
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DATE:  
(DD/MM/YY) 
25/06/08 
APPROVED BY: 
Chair, Infection Control Committee  
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DATE:  
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05/04/11 
 
1.0 Purpose   
To identify, prevent and control the spread of Clostridium difficile Infection (CDI). 
 
2.0 Scope  
Applies to all programs and services at all sites of the Niagara Health System (NHS).  
 
3.0 Definitions  
3.1 Diarrhea:   
Loose/watery bowel movements (conforms to the shape of the container) and the bowel 
movements that are unusual or different for the patient; and there is no other recognized 
etiology for the diarrhea (for example, laxative use). 
 
3.2 Clostridium difficile Infection (CDI) Case Definition:   
Diarrhea (as defined above)   
      WITH  
Laboratory confirmation of Clostridium difficile (e.g. by positive toxin A/B assay or PCR);  
      OR   
Visualization of pseudomembranes on sigmoidoscopy or colonoscopy;  
      OR   
Histological/pathological diagnosis of pseudomembranous colitis.  
 
3.3 New nosocomial case:   
A case that meets the case definition for CDI; AND The infection was not present at the 
time of admission (i.e. onset of symptoms >72 hours after admission); OR The infection is 
present at time of admission but is related to a previous admission to the same facility 
within the last 4 weeks; AND The case has not had CDI in the past 8 weeks.  
 
3.4 Nosocomial Cases Attributed to Other Health Care Facilities:  
A case that meets the case definition for CDI; AND CDI was present on admission; OR the 
case had symptoms onset <72 hours after admission; AND there was exposure to any 
health care facility (including long-term care) other than the reporting facility within the last 
4 weeks; AND the case has not had CDI in the past 8 weeks.  
 
3.5 Indeterminate Case:   
The infection was present on admission or <72 hours after admission and there was no 
admission to the same facility within the last 4 weeks AND the case has not had CDI in the 
past 8 weeks.  
 
3.6 Relapse:  
The patient has had a recurrence within 8 weeks of the completion of treatment for 
previous CDI.  
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3.7 Cluster:   
A grouping of cases within a specific time frame and geographic location suggesting a 
possible association between the cases with respect to transmission.  
 
4.0 Procedure 
4.1 Testing 
a) Nursing staff will watch for the signs and symptoms of diarrhea. Follow the C difficile 
management algorithm. (See Appendix A – Diarrhea Algorithm – 170-100-021A).  
b) Send stool specimen for C. difficile toxin assay to lab for all patients with suspected C 
difficile, except children under the age of 12 months.  
c) Specimen collection: Liquid stool must be collected in a sterile specimen container.  
Any patient with formed or semi-formed stool should not have stools collected.  Label 
sample and send to lab.  
d) For specimens sent for C. difficile, a test for VRE should be considered.  
e) Lab will notify Infection Control with positive lab results.  
f) Do not rely on a single negative result. If the patient continues to have diarrhea, send 
another specimen.   
Note: There is no screening test for C diff on patients who do not exhibit symptoms. 
Testing should be done for symptomatic patients only. 
 
4.2 Contact precautions 
a) The Nurse caring for the patient is empowered to institute additional precautions 
(contact precautions) at the onset of diarrhea. 
 
4.3 Responsibilities 
a) The Charge Nurse/Designate is responsible for notifying Infection Prevention and 
Control and Admitting departments of the institution of additional precautions for 
diarrhea/suspect C. difficile. 
b) The Charge Nurse/Designate is responsible for notifying Environmental Services 
through the Resource Centre that the room should be cleaned twice daily with 
sporicidal agent (eg. Rescue® gel). 
c) It is the responsibility of the Infection Control Practitioner to investigate all positive 
cases. An sample worksheet is provided in Appendix B – CDI Patient Data Collection – 
170-100-021B.  
4.4 Accommodation 
a) A private room with dedicated toileting facilities is recommended (private bathroom or 
dedicated commode chair). 
b) If not available, priority for accommodation should be cohorting CDI lab confirmed 
cases only under the direction of Infection Prevention and Control.  
c) If the patient has recurrent CDI, consideration may be given to leaving the patient in a 
private room even after resolution of symptoms to minimize the risk of transmission. 
 
4.5 Signage 
a) A “CONTACT PRECAUTIONS” sign is placed on the door of patient’s room as soon as 
CDI is suspected. 
 
4.6 Hand Hygiene and Personal Protective Equipment 
a) Refer to the procedure for Routine Practices and Additional Precautions. 
 
4.7 Equipment 
a) If a bedpan is used, it must be lined with a Hygie® bag. Following use, the bag must be 
securely tied and disposed of in patient’s room. 
b) Commode chairs must remain with the patient. The chair must be lined with a Hygie® 
bag. Following use, the bag must be securely tied and disposed of in patient’s room. 
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Commodes must be wiped with Virox by the nurse following each use. Commodes 
must cleaned/disinfected by Housekeeping each time the room is cleaned using a 
sporicidal agent for the recommended contact time (eg. Rescue® gel, 10 minutes 
contact time).  When precautions are discontinued, commodes and bedpans must be 
cleaned and disinfected as per department’s protocol. 
c) Ensure reusable equipment is not used for another patient until it has been cleaned 
and disinfected. 
d) Properly discard single-use items. 
e) Temperatures should not be taken rectally as rectal thermometers have been linked 
with spread of CDI. 
f) Dedicated patient care equipment should be provided. Stethoscope, thermometer, BP 
cuff, wheelchair, lifts, scales, glucometers, walker, commode, flashlight, recreational 
equipment, basins, bedpan and other personal equipment should be cleaned and 
disinfected after each use and before removing equipment from patient’s room. Follow 
manufacturer’s instructions for cleaning and disinfecting the product.  
g) Do not take patient’s medical chart into patient’s room.   
h) Only washable toys (no stuffed animals) are to be used in paediatric settings, waiting 
rooms, etc., and must be cleaned and disinfected. 
 
4.8 Dietary 
a) Routine practices are required for dishes and cutlery. Disposable meal trays are not 
required. 
 
4.9 Linen   
a) Use routine practices and contact precautions when disposing linen in a laundry bag in 
patient’s room. Remove laundry bag when ¾ full and when required and place a clean 
plastic laundry bag in patient’s room. Ensure each new shift has a clean laundry bag 
available. 
b) No special handling of linen is required. 
 
4.10 Garbage 
a) Follow routine practices and contact precautions.  
b) Hygie bags should be disposed of in the regular garbage in the patient room and the 
garbage must be removed as necessary and at least once each shift.. 
 
4.11 Environmental Cleaning 
a) All horizontal surfaces in the room and all items within patient’s reach should be 
cleaned twice daily. Include high touch surfaces such as bedside rails, telephone, call 
bells, light switches, door handles, faucets, commodes, toilets, etc.  Twice daily 
cleaning should be documented on the appropriate hospitality checklists. 
b) Apply disinfection solution directly onto all cleaning cloths, fully saturate before 
cleaning surfaces. Change cleaning cloths and mop heads frequently. Refer to 
Hospitality Procedures.  
c) Use sporicidal agent (eg. STBC® gel on toilets, sinks, commodes) twice daily.  
d) Commode is cleaned and disinfected whenever the room/bathroom is cleaned.  
e) Disposable toilet brushes should be used in the rooms of patients with CDI and should 
be left in the patient washroom and should be discarded when contact precautions are 
discontinued and the room is terminally cleaned or on discharge. 
f) After patient discharge/transfer/discontinuation of isolation, terminal cleaning is 
recommended using hospital approved germicide. This includes all curtains taken 
down and sent for laundering. Discard disposable items and toilet paper. Follow 
Hospitality Department’s terminal cleaning checklist. 
 
4.12 Discharges/Transfers to other Institutions 
a) Charge Nurse is to notify the receiving facility regarding patient status and complete 
transfer form. Advise transport personnel (eg. ambulance) of the need for additional 
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precautions when booking the transport prior to transfer.  All transport personnel will 
follow the transport guidelines below. 
b) If inpatient transfer necessary, Charge Nurses will notify receiving unit about the need 
for precautions. 
c) Charge Nurses will notify the diagnostic department if patient is C. difficile positive prior 
to testing, procedures, or therapies.  This department may schedule these patients at 
the end of the day for non-urgent cases.  Departmental personnel are to follow 
additional precautions and guidelines as indicated in this protocol.   
 
 
4.13 Transport Guidelines 
a) Refer to the Patient Transportation policy and procedure. (See Policy – Patient 
Transportation on Routine Practices and Additional Precautions – 170-100-030 and 
Procedure – Patient Transportation on Routine Practices and Additional Precautions – 
170-100-031). 
 
4.14 Other Activities (Day Pass, Physiotherapy)   
a) Patient participation in recreational activities, day pass or physiotherapy will be 
assessed on an individual basis in consultation with Infection Control.  
 
4.15 Visitors  
a) Instruct visitors regarding hand hygiene, routine practices and contact precautions. 
Provide Fact Sheets for patient and visitors on hand hygiene, proper donning and 
doffing PPE, and CDI information (See Appendix C – NHS Sample Fact Sheets for 
Patients/Visitors (English Version) – 170-100-021C and Appendix D – NHS Sample 
Fact Sheets for Patients/Visitors (French Version) – 170-100-021D). 
b) Visitors must not use patient’s bathroom or go into another patient’s bedspace/room. 
 
4.16 Discontinuation of Isolation Precautions 
a) Patient with Suspected CDI 
i) Patients on precautions for suspected CDI may, after consultation with Infection 
Prevention and Control, have the precautions discontinued when two (2) negative 
tests have been reported or the etiology has been identified as non-infectious.  
ii) If CDI is still suspected the clinician should evaluate the patient and consider 
other diagnostic modalities. 
b) Patient with confirmed CDI 
i) Contact precautions may be discontinued when the patient has completed 
treatment and has had at least 48 hours without diarrhea.  
ii) Contact precautions should only be discontinued in consultation with Infection 
Prevention and Control. 
iii) Retesting for C diff cytotoxin is not necessary to determine the end of isolation 
and should not be done unless symptoms recur. 
iv) Contact precautions should not be discontinued until the room has been terminally 
cleaned. 
 
4.17 Notification Thresholds  
a) The ICP must notify the Public Health Department when notification threshold has 
been reached. 
i) For units with > 20 beds:  
3 cases of nosocomial CDI identified within a 7-day period  
OR  
5 cases within a 4-week period   
 
OR  
ii) For units with <20 beds:   
2 cases of nosocomial CDI identified within a 7-day period  
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OR  
4 cases within a 4 week period  
 
OR   
iii) A site has baseline CDI rate for 2 months that is at or above the 80th percentile for 
comparator hospitals   
 
OR  
iv) A facility rate that is greater than or equal to 2 standard deviations above baseline  
 
4.18 It is the responsibility of the Infection Control Practitioner to provide timely notification that 
the alert threshold has been reached so that there is heightened vigilance and enhanced 
precautions can be implemented to avert an outbreak. Notification must be sent to the 
Manager of Infection Prevention and Control, Director of Infection Prevention and Control, 
Medical Director of Infection Prevention and Control, clinical manager(s) of the respective 
unit(s), and the Environmental Services director and Health Program Director for the site. 
 
4.19 CDI Outbreak Thresholds   
Declaration of an outbreak may be made by either the ICP following consultation with 
Niagara Regional Public Health or the Medical Officer of Health, following review of the 
number of cases, historic levels, trends, epidemiologic investigation and control measures.  
 
4.20 Outbreak Management  
Institute control measures. Follow Outbreak Management Checklist.  (See Appendix E – 
Outbreak Management Checklist – 170-100-021E).  
 
4.21 Education 
a) Reinforce all infection prevention and control measures for staff, including Routine 
Practices, Additional Precautions, hand hygiene, and environmental cleaning protocols 
(See Appendix F – Educational Handout for Healthcare Workers – 170-100-021F); 
b) Educate visitors on infection prevention and control measures, including the proper 
use of appropriate personal protective equipment. 
c) Health care workers must not consume food or beverages in patient care areas. 
d) Antimicrobial stewardship by Pharmacy – limiting inappropriate use of antimicrobials by 
optimizing antimicrobial selection, dosing, route of administration and duration of 
therapy. 
 
4.22 Evaluation   
Review CDI protocol on a regular basis for improvements based on new research, data 
and standards.  Periodic audits on environmental cleaning protocols should be carried out 
by both Infection Prevention/Control and Hospitality Departments. 
 
5.0 Related Documents   
Appendix – NHS Sample Fact Sheets for Patients/Visitors (English Version) – 170-100-021C  
Appendix – NHS Sample Fact Sheets for Patients/Visitors (French Version) – 170-100-021D 
Appendix – Outbreak Management Checklist – 170-100-021E 
Appendix – Educational Handout for Healthcare Workers – 170-100-021F 
Appendix – Diarrhea Algorithm – 170-100-021A   
Appendix – NHS CDI Patient Data Collection – 170-100-021B 
Policy – Clostridium difficile Infection (CDI) – 170-100-020 
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Appendix C – Statistical processes used by Sat Scan to calculate the likelihood ratio and the 
number of expected cases: Source for formulas a, b, c & d (Kulldorff, 2005). 
 
a) Likelihood ratio for Poisson distribution: 
 
 
 
b) Likelihood ratio for Bernoulli distribution: 
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c) Calculating the expected number of cases:  
 
 
 
d) Calculating the expected ratio:  
 
 
 
 
  
 
O: Number of observed cases inside or outside of the scan window. 
E: Number of  
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Appendix D – York University Research Ethics Board approval letter. 
 
 
 
Note: Letter is proportionally reduced in order to fit onto page. 
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Appendix E – Niagara Health System’s Research Ethics Board approval letter. 
 
 
Note: Letter is proportionally reduced in order to fit onto page. 
 
